--06-302025Q20001001250falsexbrli:sharesiso4217:USDiso4217:USDxbrli:sharesxbrli:pureel:positionel:agencyel:classActionel:caseel:segment00010012502024-07-012024-12-310001001250us-gaap:CommonClassAMember2025-01-280001001250us-gaap:CommonClassBMember2025-01-2800010012502024-10-012024-12-3100010012502023-10-012023-12-3100010012502023-07-012023-12-3100010012502024-12-3100010012502024-06-300001001250us-gaap:CommonClassAMember2024-06-300001001250us-gaap:CommonClassAMember2024-12-310001001250us-gaap:CommonClassBMember2024-12-310001001250us-gaap:CommonClassBMember2024-06-3000010012502023-06-3000010012502023-12-310001001250el:LargestCustomerMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMember2024-12-310001001250el:LargestCustomerMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMember2024-07-012024-12-310001001250el:LargestCustomerMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMember2024-06-300001001250el:LargestCustomerMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMember2023-07-012024-06-300001001250us-gaap:LandAndLandImprovementsMember2024-12-310001001250us-gaap:LandAndLandImprovementsMember2024-06-300001001250srt:MinimumMemberus-gaap:BuildingAndBuildingImprovementsMember2024-12-310001001250srt:MinimumMemberus-gaap:BuildingAndBuildingImprovementsMember2024-06-300001001250srt:MaximumMemberus-gaap:BuildingAndBuildingImprovementsMember2024-06-300001001250srt:MaximumMemberus-gaap:BuildingAndBuildingImprovementsMember2024-12-310001001250us-gaap:BuildingAndBuildingImprovementsMember2024-12-310001001250us-gaap:BuildingAndBuildingImprovementsMember2024-06-300001001250srt:MinimumMemberus-gaap:MachineryAndEquipmentMember2024-12-310001001250srt:MinimumMemberus-gaap:MachineryAndEquipmentMember2024-06-300001001250srt:MaximumMemberus-gaap:MachineryAndEquipmentMember2024-06-300001001250srt:MaximumMemberus-gaap:MachineryAndEquipmentMember2024-12-310001001250us-gaap:MachineryAndEquipmentMember2024-12-310001001250us-gaap:MachineryAndEquipmentMember2024-06-300001001250srt:MinimumMemberel:ComputerHardwareAndSoftwareMember2024-06-300001001250srt:MinimumMemberel:ComputerHardwareAndSoftwareMember2024-12-310001001250srt:MaximumMemberel:ComputerHardwareAndSoftwareMember2024-12-310001001250srt:MaximumMemberel:ComputerHardwareAndSoftwareMember2024-06-300001001250el:ComputerHardwareAndSoftwareMember2024-12-310001001250el:ComputerHardwareAndSoftwareMember2024-06-300001001250srt:MinimumMemberus-gaap:FurnitureAndFixturesMember2024-12-310001001250srt:MinimumMemberus-gaap:FurnitureAndFixturesMember2024-06-300001001250srt:MaximumMemberus-gaap:FurnitureAndFixturesMember2024-06-300001001250srt:MaximumMemberus-gaap:FurnitureAndFixturesMember2024-12-310001001250us-gaap:FurnitureAndFixturesMember2024-12-310001001250us-gaap:FurnitureAndFixturesMember2024-06-300001001250us-gaap:LeaseholdImprovementsMember2024-12-310001001250us-gaap:LeaseholdImprovementsMember2024-06-300001001250us-gaap:ConstructionInProgressMember2024-12-310001001250us-gaap:ConstructionInProgressMember2024-06-3000010012502024-09-300001001250srt:MinimumMember2024-12-310001001250srt:MaximumMember2024-12-310001001250el:SkinCareMember2024-06-300001001250el:MakeupMember2024-06-300001001250el:FragranceMember2024-06-300001001250el:HairCareMember2024-06-300001001250el:SkinCareMember2024-07-012024-12-310001001250el:MakeupMember2024-07-012024-12-310001001250el:FragranceMember2024-07-012024-12-310001001250el:HairCareMember2024-07-012024-12-310001001250el:SkinCareMember2024-12-310001001250el:MakeupMember2024-12-310001001250el:FragranceMember2024-12-310001001250el:HairCareMember2024-12-310001001250el:CustomerListsAndOtherMember2024-12-310001001250el:CustomerListsAndOtherMember2024-06-300001001250us-gaap:TrademarksMember2024-12-310001001250us-gaap:TrademarksMember2024-06-300001001250srt:AmericasMemberel:TOMFORDMemberel:FragranceMakeupAndOtherProductsMember2024-07-012024-12-310001001250srt:AmericasMemberel:TOMFORDMemberel:FragranceMakeupAndOtherProductsMember2024-10-012024-12-310001001250srt:AmericasMemberel:TooFacedMemberel:MakeupMember2024-10-012024-12-310001001250srt:AmericasMemberel:TooFacedMemberel:MakeupMember2024-07-012024-12-310001001250srt:AmericasMemberel:TooFacedMemberel:MakeupMember2024-12-310001001250srt:AmericasMemberel:TOMFORDMemberel:FragranceMakeupAndOtherProductsMember2024-12-310001001250el:TOMFORDAndTooFacedMember2024-07-012024-12-310001001250el:TOMFORDAndTooFacedMember2024-10-012024-12-310001001250el:TOMFORDAndTooFacedMember2024-12-310001001250srt:AmericasMemberel:TOMFORDMemberel:FragranceMember2024-10-012024-12-310001001250srt:AmericasMemberel:TOMFORDMemberel:FragranceMember2024-07-012024-12-310001001250srt:AmericasMemberel:TOMFORDMemberel:MakeupMember2024-07-012024-12-310001001250srt:AmericasMemberel:TOMFORDMemberel:MakeupMember2024-10-012024-12-310001001250srt:AmericasMemberel:TOMFORDMemberel:OtherProductsMember2024-07-012024-12-310001001250srt:AmericasMemberel:TOMFORDMemberel:OtherProductsMember2024-10-012024-12-310001001250el:RestructuringProgramMember2024-02-052024-02-050001001250el:RestructuringProgramMembersrt:MinimumMember2024-02-052024-02-050001001250el:RestructuringProgramMembersrt:MaximumMember2024-02-052024-02-050001001250el:RestructuringProgramMembersrt:MinimumMember2024-02-050001001250el:RestructuringProgramMembersrt:MaximumMember2024-02-050001001250el:RestructuringProgramMemberus-gaap:SubsequentEventMembersrt:MinimumMember2025-02-032025-02-030001001250el:RestructuringProgramMemberus-gaap:SubsequentEventMembersrt:MaximumMember2025-02-032025-02-030001001250el:RestructuringProgramMemberus-gaap:SubsequentEventMembersrt:MinimumMember2025-02-030001001250el:RestructuringProgramMemberus-gaap:SubsequentEventMembersrt:MaximumMember2025-02-030001001250us-gaap:SalesReturnsAndAllowancesMemberel:RestructuringProgramMember2024-06-300001001250us-gaap:CostOfSalesMemberel:RestructuringProgramMember2024-06-300001001250us-gaap:RestructuringChargesMemberel:RestructuringProgramMember2024-06-300001001250us-gaap:OtherOperatingIncomeExpenseMemberel:RestructuringProgramMember2024-06-300001001250el:RestructuringProgramMember2024-06-300001001250us-gaap:SalesReturnsAndAllowancesMemberel:RestructuringProgramMember2024-07-012024-12-310001001250us-gaap:CostOfSalesMemberel:RestructuringProgramMember2024-07-012024-12-310001001250us-gaap:RestructuringChargesMemberel:RestructuringProgramMember2024-07-012024-12-310001001250us-gaap:OtherOperatingIncomeExpenseMemberel:RestructuringProgramMember2024-07-012024-12-310001001250el:RestructuringProgramMember2024-07-012024-12-310001001250us-gaap:SalesReturnsAndAllowancesMemberel:RestructuringProgramMember2024-12-310001001250us-gaap:CostOfSalesMemberel:RestructuringProgramMember2024-12-310001001250us-gaap:RestructuringChargesMemberel:RestructuringProgramMember2024-12-310001001250us-gaap:OtherOperatingIncomeExpenseMemberel:RestructuringProgramMember2024-12-310001001250el:RestructuringProgramMember2024-12-310001001250el:RestructuringProgramMemberus-gaap:SalesReturnsAndAllowancesMemberus-gaap:SubsequentEventMember2025-01-012025-01-290001001250el:RestructuringProgramMemberus-gaap:CostOfSalesMemberus-gaap:SubsequentEventMember2025-01-012025-01-290001001250el:RestructuringProgramMemberus-gaap:RestructuringChargesMemberus-gaap:SubsequentEventMember2025-01-012025-01-290001001250el:RestructuringProgramMemberus-gaap:OtherOperatingIncomeExpenseMemberus-gaap:SubsequentEventMember2025-01-012025-01-290001001250el:RestructuringProgramMemberus-gaap:SubsequentEventMember2025-01-012025-01-290001001250el:RestructuringProgramMemberus-gaap:SalesReturnsAndAllowancesMemberus-gaap:SubsequentEventMember2025-01-290001001250el:RestructuringProgramMemberus-gaap:CostOfSalesMemberus-gaap:SubsequentEventMember2025-01-290001001250el:RestructuringProgramMemberus-gaap:RestructuringChargesMemberus-gaap:SubsequentEventMember2025-01-290001001250el:RestructuringProgramMemberus-gaap:OtherOperatingIncomeExpenseMemberus-gaap:SubsequentEventMember2025-01-290001001250el:RestructuringProgramMemberus-gaap:SubsequentEventMember2025-01-290001001250us-gaap:EmployeeSeveranceMemberel:RestructuringProgramMember2024-06-300001001250el:ImpairmentInValueOfAssetsMemberel:RestructuringProgramMember2024-06-300001001250us-gaap:ContractTerminationMemberel:RestructuringProgramMember2024-06-300001001250us-gaap:OtherRestructuringMemberel:RestructuringProgramMember2024-06-300001001250us-gaap:EmployeeSeveranceMemberel:RestructuringProgramMember2024-07-012024-12-310001001250el:ImpairmentInValueOfAssetsMemberel:RestructuringProgramMember2024-07-012024-12-310001001250us-gaap:ContractTerminationMemberel:RestructuringProgramMember2024-07-012024-12-310001001250us-gaap:OtherRestructuringMemberel:RestructuringProgramMember2024-07-012024-12-310001001250us-gaap:EmployeeSeveranceMemberel:RestructuringProgramMember2024-12-310001001250el:ImpairmentInValueOfAssetsMemberel:RestructuringProgramMember2024-12-310001001250us-gaap:ContractTerminationMemberel:RestructuringProgramMember2024-12-310001001250us-gaap:OtherRestructuringMemberel:RestructuringProgramMember2024-12-310001001250us-gaap:EmployeeSeveranceMemberel:RestructuringProgramMemberus-gaap:SubsequentEventMember2025-01-012025-01-290001001250el:ImpairmentInValueOfAssetsMemberel:RestructuringProgramMemberus-gaap:SubsequentEventMember2025-01-012025-01-290001001250us-gaap:ContractTerminationMemberel:RestructuringProgramMemberus-gaap:SubsequentEventMember2025-01-012025-01-290001001250us-gaap:OtherRestructuringMemberel:RestructuringProgramMemberus-gaap:SubsequentEventMember2025-01-012025-01-290001001250us-gaap:EmployeeSeveranceMemberel:RestructuringProgramMemberus-gaap:SubsequentEventMember2025-01-290001001250el:ImpairmentInValueOfAssetsMemberel:RestructuringProgramMemberus-gaap:SubsequentEventMember2025-01-290001001250us-gaap:ContractTerminationMemberel:RestructuringProgramMemberus-gaap:SubsequentEventMember2025-01-290001001250us-gaap:OtherRestructuringMemberel:RestructuringProgramMemberus-gaap:SubsequentEventMember2025-01-290001001250us-gaap:SalesReturnsAndAllowancesMemberel:RestructuringProgramMember2023-07-012024-06-300001001250us-gaap:CostOfSalesMemberel:RestructuringProgramMember2023-07-012024-06-300001001250us-gaap:RestructuringChargesMemberel:RestructuringProgramMember2023-07-012024-06-300001001250us-gaap:OtherOperatingIncomeExpenseMemberel:RestructuringProgramMember2023-07-012024-06-300001001250el:RestructuringProgramMember2023-07-012024-06-300001001250us-gaap:SalesReturnsAndAllowancesMemberel:RestructuringProgramMember2024-07-012024-09-300001001250us-gaap:CostOfSalesMemberel:RestructuringProgramMember2024-07-012024-09-300001001250us-gaap:RestructuringChargesMemberel:RestructuringProgramMember2024-07-012024-09-300001001250us-gaap:OtherOperatingIncomeExpenseMemberel:RestructuringProgramMember2024-07-012024-09-300001001250el:RestructuringProgramMember2024-07-012024-09-300001001250us-gaap:SalesReturnsAndAllowancesMemberel:RestructuringProgramMember2024-10-012024-12-310001001250us-gaap:CostOfSalesMemberel:RestructuringProgramMember2024-10-012024-12-310001001250us-gaap:RestructuringChargesMemberel:RestructuringProgramMember2024-10-012024-12-310001001250us-gaap:OtherOperatingIncomeExpenseMemberel:RestructuringProgramMember2024-10-012024-12-310001001250el:RestructuringProgramMember2024-10-012024-12-310001001250us-gaap:EmployeeSeveranceMemberel:RestructuringProgramMember2023-07-012024-06-300001001250el:ImpairmentInValueOfAssetsMemberel:RestructuringProgramMember2023-07-012024-06-300001001250us-gaap:ContractTerminationMemberel:RestructuringProgramMember2023-07-012024-06-300001001250us-gaap:OtherRestructuringMemberel:RestructuringProgramMember2023-07-012024-06-300001001250us-gaap:EmployeeSeveranceMemberel:RestructuringProgramMember2024-07-012024-09-300001001250el:ImpairmentInValueOfAssetsMemberel:RestructuringProgramMember2024-07-012024-09-300001001250us-gaap:ContractTerminationMemberel:RestructuringProgramMember2024-07-012024-09-300001001250us-gaap:OtherRestructuringMemberel:RestructuringProgramMember2024-07-012024-09-300001001250us-gaap:EmployeeSeveranceMemberel:RestructuringProgramMember2024-10-012024-12-310001001250el:ImpairmentInValueOfAssetsMemberel:RestructuringProgramMember2024-10-012024-12-310001001250us-gaap:ContractTerminationMemberel:RestructuringProgramMember2024-10-012024-12-310001001250us-gaap:OtherRestructuringMemberel:RestructuringProgramMember2024-10-012024-12-310001001250el:RestructuringProgramMembersrt:ScenarioForecastMember2025-01-012025-06-300001001250el:RestructuringProgramMembersrt:ScenarioForecastMember2025-07-012026-06-300001001250el:RestructuringProgramMembersrt:ScenarioForecastMember2026-07-012027-06-300001001250us-gaap:NondesignatedMember2024-12-310001001250el:TwoPointSixZeroZeroPercentSeniorNotesDueAprilTwentyThirtyMemberus-gaap:InterestRateSwapMemberus-gaap:FairValueHedgingMember2024-12-310001001250el:OnePointNineFiveZeroPercentSeniorNotesDueMarchTwentyThirtyOneMemberus-gaap:InterestRateSwapMemberus-gaap:FairValueHedgingMember2024-12-310001001250el:TwoPointSixZeroZeroPercentSeniorNotesDueAprilTwentyThirtyMemberus-gaap:InterestRateSwapMemberus-gaap:FairValueHedgingMember2024-07-012024-12-310001001250el:OnePointNineFiveZeroPercentSeniorNotesDueMarchTwentyThirtyOneMemberus-gaap:InterestRateSwapMemberus-gaap:FairValueHedgingMember2024-07-012024-12-310001001250us-gaap:CurrencySwapMemberus-gaap:FairValueHedgingMember2024-12-310001001250us-gaap:CurrencySwapMemberus-gaap:FairValueHedgingMember2024-07-012024-12-310001001250us-gaap:CurrencySwapMemberus-gaap:FairValueHedgingMember2024-06-300001001250us-gaap:ForeignExchangeForwardMemberus-gaap:CashFlowHedgingMember2024-12-310001001250us-gaap:CashFlowHedgingMember2024-12-310001001250us-gaap:CashFlowHedgingMember2024-06-300001001250el:ForeignExchangeForwardAndCurrencySwapMemberus-gaap:NetInvestmentHedgingMember2024-12-310001001250us-gaap:DerivativeMember2024-12-310001001250us-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMemberel:PrepaidExpensesAndOtherCurrentAssetsAndOtherAssetsMember2024-12-310001001250us-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMemberel:PrepaidExpensesAndOtherCurrentAssetsAndOtherAssetsMember2024-06-300001001250us-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:AccruedLiabilitiesMember2024-12-310001001250us-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:AccruedLiabilitiesMember2024-06-300001001250us-gaap:CurrencySwapMemberus-gaap:DesignatedAsHedgingInstrumentMemberel:PrepaidExpensesAndOtherCurrentAssetsAndOtherAssetsMember2024-12-310001001250us-gaap:CurrencySwapMemberus-gaap:DesignatedAsHedgingInstrumentMemberel:PrepaidExpensesAndOtherCurrentAssetsAndOtherAssetsMember2024-06-300001001250us-gaap:CurrencySwapMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:AccruedLiabilitiesMember2024-12-310001001250us-gaap:CurrencySwapMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:AccruedLiabilitiesMember2024-06-300001001250us-gaap:InterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2024-12-310001001250us-gaap:InterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2024-06-300001001250us-gaap:InterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:AccruedLiabilitiesMember2024-12-310001001250us-gaap:InterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:AccruedLiabilitiesMember2024-06-300001001250us-gaap:DesignatedAsHedgingInstrumentMember2024-12-310001001250us-gaap:DesignatedAsHedgingInstrumentMember2024-06-300001001250us-gaap:ForeignExchangeForwardMemberus-gaap:NondesignatedMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2024-12-310001001250us-gaap:ForeignExchangeForwardMemberus-gaap:NondesignatedMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2024-06-300001001250us-gaap:ForeignExchangeForwardMemberus-gaap:NondesignatedMemberus-gaap:AccruedLiabilitiesMember2024-12-310001001250us-gaap:ForeignExchangeForwardMemberus-gaap:NondesignatedMemberus-gaap:AccruedLiabilitiesMember2024-06-300001001250us-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherAssetsMember2024-12-310001001250us-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherAssetsMember2024-06-300001001250us-gaap:CurrencySwapMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherAssetsMember2024-12-310001001250us-gaap:CurrencySwapMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherAssetsMember2024-06-300001001250us-gaap:ForeignExchangeForwardMemberus-gaap:CashFlowHedgingMember2024-10-012024-12-310001001250us-gaap:ForeignExchangeForwardMemberus-gaap:CashFlowHedgingMember2023-10-012023-12-310001001250us-gaap:ForeignExchangeForwardMemberus-gaap:CashFlowHedgingMemberus-gaap:SalesMember2024-10-012024-12-310001001250us-gaap:ForeignExchangeForwardMemberus-gaap:CashFlowHedgingMemberus-gaap:SalesMember2023-10-012023-12-310001001250us-gaap:InterestRateContractMemberus-gaap:CashFlowHedgingMember2024-10-012024-12-310001001250us-gaap:InterestRateContractMemberus-gaap:CashFlowHedgingMember2023-10-012023-12-310001001250us-gaap:InterestRateContractMemberus-gaap:CashFlowHedgingMemberus-gaap:InterestExpenseMember2024-10-012024-12-310001001250us-gaap:InterestRateContractMemberus-gaap:CashFlowHedgingMemberus-gaap:InterestExpenseMember2023-10-012023-12-310001001250us-gaap:CashFlowHedgingMember2024-10-012024-12-310001001250us-gaap:CashFlowHedgingMember2023-10-012023-12-310001001250us-gaap:ForeignExchangeForwardMemberus-gaap:NetInvestmentHedgingMember2024-10-012024-12-310001001250us-gaap:ForeignExchangeForwardMemberus-gaap:NetInvestmentHedgingMember2023-10-012023-12-310001001250us-gaap:CurrencySwapMemberus-gaap:NetInvestmentHedgingMember2024-10-012024-12-310001001250us-gaap:CurrencySwapMemberus-gaap:NetInvestmentHedgingMember2023-10-012023-12-310001001250us-gaap:NetInvestmentHedgingMember2024-10-012024-12-310001001250us-gaap:NetInvestmentHedgingMember2023-10-012023-12-310001001250us-gaap:ForeignExchangeForwardMemberus-gaap:CashFlowHedgingMember2024-07-012024-12-310001001250us-gaap:ForeignExchangeForwardMemberus-gaap:CashFlowHedgingMember2023-07-012023-12-310001001250us-gaap:ForeignExchangeForwardMemberus-gaap:CashFlowHedgingMemberus-gaap:SalesMember2024-07-012024-12-310001001250us-gaap:ForeignExchangeForwardMemberus-gaap:CashFlowHedgingMemberus-gaap:SalesMember2023-07-012023-12-310001001250us-gaap:InterestRateContractMemberus-gaap:CashFlowHedgingMember2024-07-012024-12-310001001250us-gaap:InterestRateContractMemberus-gaap:CashFlowHedgingMember2023-07-012023-12-310001001250us-gaap:InterestRateContractMemberus-gaap:CashFlowHedgingMemberus-gaap:InterestExpenseMember2024-07-012024-12-310001001250us-gaap:InterestRateContractMemberus-gaap:CashFlowHedgingMemberus-gaap:InterestExpenseMember2023-07-012023-12-310001001250us-gaap:CashFlowHedgingMember2024-07-012024-12-310001001250us-gaap:CashFlowHedgingMember2023-07-012023-12-310001001250us-gaap:ForeignExchangeForwardMemberus-gaap:NetInvestmentHedgingMember2024-07-012024-12-310001001250us-gaap:ForeignExchangeForwardMemberus-gaap:NetInvestmentHedgingMember2023-07-012023-12-310001001250us-gaap:CurrencySwapMemberus-gaap:NetInvestmentHedgingMember2024-07-012024-12-310001001250us-gaap:CurrencySwapMemberus-gaap:NetInvestmentHedgingMember2023-07-012023-12-310001001250us-gaap:NetInvestmentHedgingMember2024-07-012024-12-310001001250us-gaap:NetInvestmentHedgingMember2023-07-012023-12-310001001250us-gaap:CurrencySwapMemberus-gaap:FairValueHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2024-10-012024-12-310001001250us-gaap:CurrencySwapMemberus-gaap:FairValueHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2023-10-012023-12-310001001250us-gaap:CurrencySwapMemberus-gaap:FairValueHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2024-07-012024-12-310001001250us-gaap:CurrencySwapMemberus-gaap:FairValueHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2023-07-012023-12-310001001250us-gaap:InterestRateContractMemberus-gaap:FairValueHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestExpenseMember2024-10-012024-12-310001001250us-gaap:InterestRateContractMemberus-gaap:FairValueHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestExpenseMember2023-10-012023-12-310001001250us-gaap:InterestRateContractMemberus-gaap:FairValueHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestExpenseMember2024-07-012024-12-310001001250us-gaap:InterestRateContractMemberus-gaap:FairValueHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestExpenseMember2023-07-012023-12-310001001250us-gaap:LongTermDebtMemberus-gaap:FairValueHedgingMember2024-07-012024-12-310001001250el:LongTermDebtIntercompanyMemberus-gaap:FairValueHedgingMember2024-07-012024-12-310001001250us-gaap:SalesMember2024-10-012024-12-310001001250us-gaap:SellingGeneralAndAdministrativeExpensesMember2024-10-012024-12-310001001250us-gaap:InterestExpenseMember2024-10-012024-12-310001001250us-gaap:SalesMember2023-10-012023-12-310001001250us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-10-012023-12-310001001250us-gaap:InterestExpenseMember2023-10-012023-12-310001001250us-gaap:InterestRateContractMemberus-gaap:FairValueHedgingMemberus-gaap:InterestExpenseMember2024-10-012024-12-310001001250us-gaap:InterestRateContractMemberus-gaap:FairValueHedgingMemberus-gaap:InterestExpenseMember2023-10-012023-12-310001001250us-gaap:CurrencySwapMemberus-gaap:FairValueHedgingMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2024-10-012024-12-310001001250us-gaap:CurrencySwapMemberus-gaap:FairValueHedgingMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2023-10-012023-12-310001001250us-gaap:SalesMember2024-07-012024-12-310001001250us-gaap:SellingGeneralAndAdministrativeExpensesMember2024-07-012024-12-310001001250us-gaap:InterestExpenseMember2024-07-012024-12-310001001250us-gaap:SalesMember2023-07-012023-12-310001001250us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-07-012023-12-310001001250us-gaap:InterestExpenseMember2023-07-012023-12-310001001250us-gaap:InterestRateContractMemberus-gaap:FairValueHedgingMemberus-gaap:InterestExpenseMember2024-07-012024-12-310001001250us-gaap:InterestRateContractMemberus-gaap:FairValueHedgingMemberus-gaap:InterestExpenseMember2023-07-012023-12-310001001250us-gaap:CurrencySwapMemberus-gaap:FairValueHedgingMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2024-07-012024-12-310001001250us-gaap:CurrencySwapMemberus-gaap:FairValueHedgingMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2023-07-012023-12-310001001250us-gaap:ForeignExchangeForwardMemberus-gaap:NondesignatedMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2024-10-012024-12-310001001250us-gaap:ForeignExchangeForwardMemberus-gaap:NondesignatedMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2023-10-012023-12-310001001250us-gaap:ForeignExchangeForwardMemberus-gaap:NondesignatedMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2024-07-012024-12-310001001250us-gaap:ForeignExchangeForwardMemberus-gaap:NondesignatedMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2023-07-012023-12-310001001250us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001001250us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001001250us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001001250us-gaap:FairValueMeasurementsRecurringMember2024-12-310001001250us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-06-300001001250us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-06-300001001250us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-06-300001001250us-gaap:FairValueMeasurementsRecurringMember2024-06-300001001250us-gaap:CarryingReportedAmountFairValueDisclosureMember2024-12-310001001250us-gaap:EstimateOfFairValueFairValueDisclosureMember2024-12-310001001250us-gaap:CarryingReportedAmountFairValueDisclosureMember2024-06-300001001250us-gaap:EstimateOfFairValueFairValueDisclosureMember2024-06-300001001250us-gaap:ForeignExchangeForwardMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2024-12-310001001250us-gaap:ForeignExchangeForwardMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2024-12-310001001250us-gaap:ForeignExchangeForwardMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2024-06-300001001250us-gaap:ForeignExchangeForwardMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2024-06-300001001250us-gaap:CurrencySwapMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2024-12-310001001250us-gaap:CurrencySwapMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2024-12-310001001250us-gaap:CurrencySwapMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2024-06-300001001250us-gaap:CurrencySwapMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2024-06-300001001250us-gaap:InterestRateContractMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2024-12-310001001250us-gaap:InterestRateContractMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2024-12-310001001250us-gaap:InterestRateContractMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2024-06-300001001250us-gaap:InterestRateContractMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2024-06-3000010012502023-09-3000010012502025-01-012024-12-3100010012502026-01-01el:MarcolinGroupMemberus-gaap:LicenseMember2024-12-3100010012502023-04-28el:MarcolinGroupMemberus-gaap:LicenseMember2024-12-310001001250country:USus-gaap:PensionPlansDefinedBenefitMember2024-10-012024-12-310001001250country:USus-gaap:PensionPlansDefinedBenefitMember2023-10-012023-12-310001001250us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMember2024-10-012024-12-310001001250us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMember2023-10-012023-12-310001001250us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2024-10-012024-12-310001001250us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2023-10-012023-12-310001001250country:USus-gaap:PensionPlansDefinedBenefitMember2024-07-012024-12-310001001250country:USus-gaap:PensionPlansDefinedBenefitMember2023-07-012023-12-310001001250us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMember2024-07-012024-12-310001001250us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMember2023-07-012023-12-310001001250us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2024-07-012024-12-310001001250us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2023-07-012023-12-3100010012502023-12-072024-01-2200010012502024-02-202024-02-200001001250el:CosmeticTalcumPowderMattersMember2024-12-310001001250el:CosmeticTalcumPowderMattersMember2024-06-300001001250el:CosmeticTalcumPowderMattersMember2024-07-012024-12-3100010012502024-08-012024-10-3100010012502024-07-012024-09-300001001250us-gaap:CommonClassAMember2024-07-012024-12-310001001250us-gaap:ShareBasedPaymentArrangementEmployeeMemberus-gaap:RestrictedStockUnitsRSUMemberus-gaap:CommonClassAMember2024-07-012024-12-310001001250us-gaap:ShareBasedPaymentArrangementEmployeeMemberus-gaap:RestrictedStockUnitsRSUMemberel:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingPeriodOneMemberus-gaap:CommonClassAMember2024-07-012024-12-310001001250us-gaap:ShareBasedPaymentArrangementEmployeeMemberus-gaap:RestrictedStockUnitsRSUMemberel:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingPeriodTwoMemberus-gaap:CommonClassAMember2024-07-012024-12-310001001250us-gaap:ShareBasedPaymentArrangementEmployeeMemberus-gaap:RestrictedStockUnitsRSUMemberel:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingPeriodThreeMemberus-gaap:CommonClassAMember2024-07-012024-12-310001001250us-gaap:ShareBasedPaymentArrangementEmployeeMemberus-gaap:PerformanceSharesMemberus-gaap:CommonClassAMember2024-07-012024-12-310001001250el:LongTermPerformanceSharesMembersrt:ExecutiveOfficerMember2024-09-032024-09-030001001250el:LongTermPerformanceSharesMembersrt:ExecutiveOfficerMember2024-07-012024-09-300001001250us-gaap:EmployeeStockOptionMember2024-10-012024-12-310001001250us-gaap:EmployeeStockOptionMember2023-10-012023-12-310001001250us-gaap:EmployeeStockOptionMember2024-07-012024-12-310001001250us-gaap:EmployeeStockOptionMember2023-07-012023-12-310001001250us-gaap:PerformanceSharesMember2024-10-012024-12-310001001250us-gaap:PerformanceSharesMember2023-10-012023-12-310001001250us-gaap:PerformanceSharesMember2024-07-012024-12-310001001250us-gaap:PerformanceSharesMember2023-07-012023-12-310001001250us-gaap:RestrictedStockUnitsRSUMember2024-10-012024-12-310001001250us-gaap:RestrictedStockUnitsRSUMember2023-10-012023-12-310001001250us-gaap:RestrictedStockUnitsRSUMember2024-07-012024-12-310001001250us-gaap:RestrictedStockUnitsRSUMember2023-07-012023-12-310001001250us-gaap:EmployeeStockOptionMember2024-10-012024-12-310001001250us-gaap:EmployeeStockOptionMember2023-10-012023-12-310001001250us-gaap:EmployeeStockOptionMember2024-07-012024-12-310001001250us-gaap:EmployeeStockOptionMember2023-07-012023-12-310001001250el:RestrictedStockUnitsAndPerformanceSharesMember2024-10-012024-12-310001001250el:RestrictedStockUnitsAndPerformanceSharesMember2023-10-012023-12-310001001250el:RestrictedStockUnitsAndPerformanceSharesMember2024-07-012024-12-310001001250el:RestrictedStockUnitsAndPerformanceSharesMember2023-07-012023-12-310001001250us-gaap:PerformanceSharesMemberus-gaap:CommonClassAMember2024-07-012024-12-310001001250us-gaap:PerformanceSharesMemberus-gaap:CommonClassAMember2023-07-012023-12-310001001250us-gaap:CommonStockMember2024-09-300001001250us-gaap:CommonStockMember2023-09-300001001250us-gaap:CommonStockMember2024-06-300001001250us-gaap:CommonStockMember2023-06-300001001250us-gaap:CommonStockMember2024-10-012024-12-310001001250us-gaap:CommonStockMember2023-10-012023-12-310001001250us-gaap:CommonStockMember2024-07-012024-12-310001001250us-gaap:CommonStockMember2023-07-012023-12-310001001250us-gaap:CommonStockMember2024-12-310001001250us-gaap:CommonStockMember2023-12-310001001250us-gaap:AdditionalPaidInCapitalMember2024-09-300001001250us-gaap:AdditionalPaidInCapitalMember2023-09-300001001250us-gaap:AdditionalPaidInCapitalMember2024-06-300001001250us-gaap:AdditionalPaidInCapitalMember2023-06-300001001250us-gaap:AdditionalPaidInCapitalMember2024-10-012024-12-310001001250us-gaap:AdditionalPaidInCapitalMember2023-10-012023-12-310001001250us-gaap:AdditionalPaidInCapitalMember2024-07-012024-12-310001001250us-gaap:AdditionalPaidInCapitalMember2023-07-012023-12-310001001250us-gaap:AdditionalPaidInCapitalMember2024-12-310001001250us-gaap:AdditionalPaidInCapitalMember2023-12-310001001250us-gaap:RetainedEarningsMember2024-09-300001001250us-gaap:RetainedEarningsMember2023-09-300001001250us-gaap:RetainedEarningsMember2024-06-300001001250us-gaap:RetainedEarningsMember2023-06-300001001250us-gaap:RetainedEarningsMember2024-10-012024-12-310001001250us-gaap:RetainedEarningsMember2023-10-012023-12-310001001250us-gaap:RetainedEarningsMember2024-07-012024-12-310001001250us-gaap:RetainedEarningsMember2023-07-012023-12-310001001250us-gaap:RetainedEarningsMember2024-12-310001001250us-gaap:RetainedEarningsMember2023-12-310001001250us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-09-300001001250us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-09-300001001250us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-06-300001001250us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-300001001250us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-10-012024-12-310001001250us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-10-012023-12-310001001250us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-07-012024-12-310001001250us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-07-012023-12-310001001250us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-310001001250us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310001001250us-gaap:TreasuryStockCommonMember2024-09-300001001250us-gaap:TreasuryStockCommonMember2023-09-300001001250us-gaap:TreasuryStockCommonMember2024-06-300001001250us-gaap:TreasuryStockCommonMember2023-06-300001001250us-gaap:TreasuryStockCommonMember2024-10-012024-12-310001001250us-gaap:TreasuryStockCommonMember2023-10-012023-12-310001001250us-gaap:TreasuryStockCommonMember2024-07-012024-12-310001001250us-gaap:TreasuryStockCommonMember2023-07-012023-12-310001001250us-gaap:TreasuryStockCommonMember2024-12-310001001250us-gaap:TreasuryStockCommonMember2023-12-310001001250us-gaap:ParentMember2024-12-310001001250us-gaap:ParentMember2023-12-310001001250el:RedeemableNoncontrollingInterestMember2024-09-300001001250el:RedeemableNoncontrollingInterestMember2023-09-300001001250el:RedeemableNoncontrollingInterestMember2024-06-300001001250el:RedeemableNoncontrollingInterestMember2023-06-300001001250el:RedeemableNoncontrollingInterestMember2024-10-012024-12-310001001250el:RedeemableNoncontrollingInterestMember2023-10-012023-12-310001001250el:RedeemableNoncontrollingInterestMember2024-07-012024-12-310001001250el:RedeemableNoncontrollingInterestMember2023-07-012023-12-310001001250el:RedeemableNoncontrollingInterestMember2024-12-310001001250el:RedeemableNoncontrollingInterestMember2023-12-310001001250us-gaap:CommonClassBMember2024-07-012024-09-300001001250us-gaap:CommonClassAMember2024-07-012024-09-300001001250us-gaap:CommonClassBMember2024-10-012024-12-310001001250us-gaap:CommonClassAMember2024-10-012024-12-310001001250us-gaap:CommonClassBMemberus-gaap:SubsequentEventMember2025-02-032025-02-030001001250us-gaap:CommonClassAMemberus-gaap:SubsequentEventMember2025-02-032025-02-030001001250us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-06-300001001250el:AccumulatedGainLossNetFairValueHedgeContractParentMember2024-06-300001001250us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-06-300001001250us-gaap:AccumulatedTranslationAdjustmentMember2024-06-300001001250us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-07-012024-12-310001001250el:AccumulatedGainLossNetFairValueHedgeContractParentMember2024-07-012024-12-310001001250us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-07-012024-12-310001001250us-gaap:AccumulatedTranslationAdjustmentMember2024-07-012024-12-310001001250us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-12-310001001250el:AccumulatedGainLossNetFairValueHedgeContractParentMember2024-12-310001001250us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-12-310001001250us-gaap:AccumulatedTranslationAdjustmentMember2024-12-310001001250us-gaap:ForeignExchangeForwardMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-10-012024-12-310001001250us-gaap:ForeignExchangeForwardMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-10-012023-12-310001001250us-gaap:ForeignExchangeForwardMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-07-012024-12-310001001250us-gaap:ForeignExchangeForwardMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-07-012023-12-310001001250us-gaap:InterestRateContractMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-10-012024-12-310001001250us-gaap:InterestRateContractMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-10-012023-12-310001001250us-gaap:InterestRateContractMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-07-012024-12-310001001250us-gaap:InterestRateContractMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-07-012023-12-310001001250us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-10-012024-12-310001001250us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-10-012023-12-310001001250us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-07-012024-12-310001001250us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-07-012023-12-310001001250el:AccumulatedGainLossNetFairValueHedgeContractParentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-10-012024-12-310001001250el:AccumulatedGainLossNetFairValueHedgeContractParentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-10-012023-12-310001001250el:AccumulatedGainLossNetFairValueHedgeContractParentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-07-012024-12-310001001250el:AccumulatedGainLossNetFairValueHedgeContractParentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-07-012023-12-310001001250us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-10-012024-12-310001001250us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-10-012023-12-310001001250us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-07-012024-12-310001001250us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-07-012023-12-310001001250us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-10-012024-12-310001001250us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-10-012023-12-310001001250us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-07-012024-12-310001001250us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-07-012023-12-310001001250us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-10-012024-12-310001001250us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-10-012023-12-310001001250us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-07-012024-12-310001001250us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-07-012023-12-310001001250us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-10-012024-12-310001001250us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-10-012023-12-310001001250us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-07-012024-12-310001001250us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-07-012023-12-310001001250el:SkinCareMember2024-10-012024-12-310001001250el:SkinCareMember2023-10-012023-12-310001001250el:SkinCareMember2023-07-012023-12-310001001250el:MakeupMember2024-10-012024-12-310001001250el:MakeupMember2023-10-012023-12-310001001250el:MakeupMember2023-07-012023-12-310001001250el:FragranceMember2024-10-012024-12-310001001250el:FragranceMember2023-10-012023-12-310001001250el:FragranceMember2023-07-012023-12-310001001250el:HairCareMember2024-10-012024-12-310001001250el:HairCareMember2023-10-012023-12-310001001250el:HairCareMember2023-07-012023-12-310001001250us-gaap:ProductAndServiceOtherMember2024-10-012024-12-310001001250us-gaap:ProductAndServiceOtherMember2023-10-012023-12-310001001250us-gaap:ProductAndServiceOtherMember2024-07-012024-12-310001001250us-gaap:ProductAndServiceOtherMember2023-07-012023-12-310001001250us-gaap:SalesReturnsAndAllowancesMember2024-10-012024-12-310001001250us-gaap:SalesReturnsAndAllowancesMember2023-10-012023-12-310001001250us-gaap:SalesReturnsAndAllowancesMember2024-07-012024-12-310001001250us-gaap:SalesReturnsAndAllowancesMember2023-07-012023-12-310001001250el:RestructuringAndRelatedCostIncurrentCostMember2024-10-012024-12-310001001250el:RestructuringAndRelatedCostIncurrentCostMember2023-10-012023-12-310001001250el:RestructuringAndRelatedCostIncurrentCostMember2024-07-012024-12-310001001250el:RestructuringAndRelatedCostIncurrentCostMember2023-07-012023-12-310001001250srt:AmericasMember2024-10-012024-12-310001001250srt:AmericasMember2023-10-012023-12-310001001250srt:AmericasMember2024-07-012024-12-310001001250srt:AmericasMember2023-07-012023-12-310001001250us-gaap:EMEAMember2024-10-012024-12-310001001250us-gaap:EMEAMember2023-10-012023-12-310001001250us-gaap:EMEAMember2024-07-012024-12-310001001250us-gaap:EMEAMember2023-07-012023-12-310001001250srt:AsiaPacificMember2024-10-012024-12-310001001250srt:AsiaPacificMember2023-10-012023-12-310001001250srt:AsiaPacificMember2024-07-012024-12-310001001250srt:AsiaPacificMember2023-07-012023-12-31
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________________________________________________________________
FORM 10-Q
(Mark One)
|
|
|
|
|
|
☒ |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended December 31, 2024
or
|
|
|
|
|
|
☐ |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission file number 1-14064
The Estée Lauder Companies Inc.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Delaware |
11-2408943 |
(State or other jurisdiction of
incorporation or organization)
|
(I.R.S. Employer Identification No.) |
|
|
|
|
|
|
767 Fifth Avenue, New York, New York |
10153 |
(Address of principal executive offices) |
(Zip Code) |
212-572-4200
(Registrant’s telephone number, including area code)
Not Applicable
(Former name, former address and former fiscal year, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
|
|
|
|
|
|
|
|
|
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered |
Class A Common Stock, $.01 par value |
EL |
New York Stock Exchange |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
|
|
|
|
|
|
|
|
|
|
|
|
Large accelerated filer |
☒ |
Accelerated filer |
☐ |
Non-accelerated filer |
☐ |
Smaller reporting company |
☐ |
|
|
Emerging growth company |
☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
At January 28, 2025, 234,173,416 shares of the registrant’s Class A Common Stock, $.01 par value, and 125,542,029 shares of the registrant’s Class B Common Stock, $.01 par value, were outstanding.
THE ESTÉE LAUDER COMPANIES INC.
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements.
THE ESTÉE LAUDER COMPANIES INC.
CONSOLIDATED STATEMENTS OF EARNINGS (LOSS)
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended December 31, |
|
Six Months Ended December 31, |
(In millions, except per share data) |
|
|
|
|
|
2024 |
|
2023 |
|
2024 |
|
2023 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales |
|
|
|
|
|
$ |
4,004 |
|
|
$ |
4,279 |
|
|
$ |
7,365 |
|
|
$ |
7,797 |
|
Cost of sales |
|
|
|
|
|
957 |
|
|
1,154 |
|
|
1,885 |
|
|
2,224 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit |
|
|
|
|
|
3,047 |
|
|
3,125 |
|
|
5,480 |
|
|
5,573 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating expenses |
|
|
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative |
|
|
|
|
|
2,585 |
|
|
2,544 |
|
|
4,883 |
|
|
4,893 |
|
Restructuring and other charges |
|
|
|
|
|
181 |
|
|
7 |
|
|
278 |
|
|
8 |
|
Impairment of goodwill and other intangible assets |
|
|
|
|
|
861 |
|
|
— |
|
|
861 |
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Talcum litigation settlement agreements |
|
|
|
|
|
— |
|
|
— |
|
|
159 |
|
|
— |
|
Total operating expenses |
|
|
|
|
|
3,627 |
|
|
2,551 |
|
|
6,181 |
|
|
4,901 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income (loss) |
|
|
|
|
|
(580) |
|
|
574 |
|
|
(701) |
|
|
672 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense |
|
|
|
|
|
90 |
|
|
98 |
|
|
182 |
|
|
193 |
|
Interest income and investment income, net |
|
|
|
|
|
23 |
|
|
40 |
|
|
58 |
|
|
81 |
|
Other components of net periodic benefit cost |
|
|
|
|
|
3 |
|
|
(3) |
|
|
5 |
|
|
(5) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings (loss) before income taxes |
|
|
|
|
|
(650) |
|
|
519 |
|
|
(830) |
|
|
565 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision (benefit) for income taxes |
|
|
|
|
|
(60) |
|
|
195 |
|
|
(84) |
|
|
205 |
|
Net earnings (loss) |
|
|
|
|
|
(590) |
|
|
324 |
|
|
(746) |
|
|
360 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net earnings attributable to redeemable noncontrolling interest |
|
|
|
|
|
— |
|
|
(11) |
|
|
— |
|
|
(16) |
|
Net earnings (loss) attributable to The Estée Lauder Companies Inc. |
|
|
|
|
|
$ |
(590) |
|
|
$ |
313 |
|
|
$ |
(746) |
|
|
$ |
344 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net earnings (loss) attributable to The Estée Lauder Companies Inc. per common share |
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
|
|
|
|
$ |
(1.64) |
|
|
$ |
.87 |
|
|
$ |
(2.07) |
|
|
$ |
.96 |
|
Diluted |
|
|
|
|
|
$ |
(1.64) |
|
|
$ |
.87 |
|
|
$ |
(2.07) |
|
|
$ |
.95 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
|
|
|
|
360.0 |
|
|
358.7 |
|
|
359.8 |
|
|
358.6 |
|
Diluted |
|
|
|
|
|
360.0 |
|
|
360.0 |
|
|
359.8 |
|
|
360.3 |
|
See notes to consolidated financial statements.
THE ESTÉE LAUDER COMPANIES INC.
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended December 31, |
|
Six Months Ended December 31, |
|
|
(In millions) |
|
|
2024 |
|
2023 |
|
2024 |
|
2023 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net earnings (loss) |
|
|
$ |
(590) |
|
|
$ |
324 |
|
|
$ |
(746) |
|
|
$ |
360 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income (loss): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash flow hedge gain (loss) |
|
|
55 |
|
|
(47) |
|
|
(2) |
|
|
(28) |
|
|
|
|
|
Cross-currency swap contract - fair value hedge gain (loss) |
|
|
(5) |
|
|
14 |
|
|
7 |
|
|
14 |
|
|
|
|
|
Retirement plan and other retiree benefit adjustments |
|
|
2 |
|
|
(1) |
|
|
4 |
|
|
(2) |
|
|
|
|
|
Translation adjustments |
|
|
(309) |
|
|
216 |
|
|
(201) |
|
|
96 |
|
|
|
|
|
Benefit (provision) for income taxes on components of other comprehensive income |
|
|
(27) |
|
|
38 |
|
|
(9) |
|
|
— |
|
|
|
|
|
Total other comprehensive income (loss), net of tax |
|
|
(284) |
|
|
220 |
|
|
(201) |
|
|
80 |
|
|
|
|
|
Comprehensive income (loss) |
|
|
(874) |
|
|
544 |
|
|
(947) |
|
|
440 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income attributable to redeemable noncontrolling interest: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net earnings |
|
|
— |
|
|
(11) |
|
|
— |
|
|
(16) |
|
|
|
|
|
Translation adjustments |
|
|
— |
|
|
(13) |
|
|
— |
|
|
(2) |
|
|
|
|
|
Total comprehensive income attributable to redeemable noncontrolling interest |
|
|
— |
|
|
(24) |
|
|
— |
|
|
(18) |
|
|
|
|
|
Comprehensive income (loss) attributable to The Estée Lauder Companies Inc. |
|
|
$ |
(874) |
|
|
$ |
520 |
|
|
$ |
(947) |
|
|
$ |
422 |
|
|
|
|
|
See notes to consolidated financial statements.
THE ESTÉE LAUDER COMPANIES INC.
CONSOLIDATED BALANCE SHEETS
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions, except share and per share data) |
|
December 31, 2024 |
|
June 30, 2024 |
|
|
|
|
|
ASSETS |
|
|
|
|
Current assets |
|
|
|
|
Cash and cash equivalents |
|
$ |
2,586 |
|
|
$ |
3,395 |
|
Accounts receivable, net |
|
1,611 |
|
|
1,727 |
|
Inventory and promotional merchandise |
|
2,002 |
|
|
2,175 |
|
Prepaid expenses and other current assets |
|
697 |
|
|
625 |
|
Total current assets |
|
6,896 |
|
|
7,922 |
|
|
|
|
|
|
Property, plant and equipment, net |
|
3,049 |
|
|
3,136 |
|
|
|
|
|
|
Other assets |
|
|
|
|
Operating lease right-of-use assets |
|
1,891 |
|
|
1,833 |
|
Goodwill |
|
2,073 |
|
|
2,143 |
|
Other intangible assets, net |
|
4,158 |
|
|
5,183 |
|
Other assets |
|
1,693 |
|
|
1,460 |
|
Total other assets |
|
9,815 |
|
|
10,619 |
|
Total assets |
|
$ |
19,760 |
|
|
$ |
21,677 |
|
|
|
|
|
|
LIABILITIES AND EQUITY |
|
|
|
|
Current liabilities |
|
|
|
|
Current debt |
|
$ |
4 |
|
|
$ |
504 |
|
Accounts payable |
|
1,133 |
|
|
1,440 |
|
Operating lease liabilities |
|
397 |
|
|
354 |
|
Other accrued liabilities |
|
3,497 |
|
|
3,404 |
|
Total current liabilities |
|
5,031 |
|
|
5,702 |
|
|
|
|
|
|
Noncurrent liabilities |
|
|
|
|
Long-term debt |
|
7,276 |
|
|
7,267 |
|
Long-term operating lease liabilities |
|
1,706 |
|
|
1,701 |
|
Other noncurrent liabilities |
|
1,578 |
|
|
1,693 |
|
Total noncurrent liabilities |
|
10,560 |
|
|
10,661 |
|
|
|
|
|
|
Commitments and contingencies |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity |
|
|
|
|
Common stock, $.01 par value; Class A shares authorized: 1,300,000,000 at December 31, 2024 and June 30, 2024; shares issued: 472,456,912 at December 31, 2024 and 471,018,569 at June 30, 2024; Class B shares authorized: 304,000,000 at December 31, 2024 and June 30, 2024; shares issued and outstanding: 125,542,029 at December 31, 2024 and June 30, 2024 |
|
6 |
|
|
6 |
|
Paid-in capital |
|
6,889 |
|
|
6,685 |
|
Retained earnings |
|
12,313 |
|
|
13,427 |
|
Accumulated other comprehensive loss |
|
(1,341) |
|
|
(1,140) |
|
|
|
17,867 |
|
|
18,978 |
|
Less: Treasury stock, at cost; 238,306,192 Class A shares at December 31, 2024 and 237,871,995 Class A shares at June 30, 2024 |
|
(13,698) |
|
|
(13,664) |
|
|
|
|
|
|
|
|
|
|
|
Total equity |
|
4,169 |
|
|
5,314 |
|
Total liabilities and equity |
|
$ |
19,760 |
|
|
$ |
21,677 |
|
See notes to consolidated financial statements.
THE ESTÉE LAUDER COMPANIES INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended December 31, |
(In millions) |
|
2024 |
|
2023 |
|
|
|
|
|
Cash flows from operating activities |
|
|
|
|
Net earnings (loss) |
|
$ |
(746) |
|
|
$ |
360 |
|
Adjustments to reconcile net earnings (loss) to net cash flows from operating activities: |
|
|
|
|
Depreciation and amortization |
|
415 |
|
|
408 |
|
Deferred income taxes |
|
(292) |
|
|
(83) |
|
Non-cash stock-based compensation |
|
180 |
|
|
189 |
|
Net loss on disposal of property, plant and equipment |
|
2 |
|
|
2 |
|
Non-cash restructuring and other charges |
|
17 |
|
|
4 |
|
Pension and post-retirement benefit expense |
|
37 |
|
|
27 |
|
Pension and post-retirement benefit contributions |
|
(50) |
|
|
(62) |
|
Impairment of goodwill and other intangible assets |
|
861 |
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other non-cash items |
|
7 |
|
|
14 |
|
Changes in operating assets and liabilities: |
|
|
|
|
Decrease (increase) in accounts receivable, net |
|
79 |
|
|
(279) |
|
Decrease in inventory and promotional merchandise |
|
132 |
|
|
405 |
|
Decrease (increase) in other assets, net |
|
(47) |
|
|
44 |
|
Decrease in accounts payable |
|
(298) |
|
|
(251) |
|
Increase in other accrued and noncurrent liabilities |
|
102 |
|
|
175 |
|
Decrease in operating lease assets and liabilities, net |
|
(12) |
|
|
(16) |
|
Net cash flows provided by operating activities |
|
387 |
|
|
937 |
|
|
|
|
|
|
Cash flows from investing activities |
|
|
|
|
Capital expenditures |
|
(273) |
|
|
(527) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchases of investments |
|
(1) |
|
|
(4) |
|
Settlement of net investment hedges |
|
(20) |
|
|
(26) |
|
Net cash flows used for investing activities |
|
(294) |
|
|
(557) |
|
|
|
|
|
|
Cash flows from financing activities |
|
|
|
|
Proceeds of current debt, net |
|
— |
|
|
780 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Repayments of commercial paper (maturities after three months) |
|
— |
|
|
(785) |
|
Repayments of long-term debt |
|
(502) |
|
|
(5) |
|
Net proceeds from stock-based compensation transactions |
|
15 |
|
|
19 |
|
Payments to acquire treasury stock |
|
(35) |
|
|
(33) |
|
|
|
|
|
|
Settlement of cross-currency swaps |
|
10 |
|
|
9 |
|
Dividends paid to stockholders |
|
(366) |
|
|
(474) |
|
|
|
|
|
|
Net cash flows used for financing activities |
|
(878) |
|
|
(489) |
|
|
|
|
|
|
Effect of exchange rate changes on Cash and cash equivalents |
|
(24) |
|
|
19 |
|
Net decrease in Cash and cash equivalents |
|
(809) |
|
|
(90) |
|
Cash and cash equivalents at beginning of period |
|
3,395 |
|
|
4,029 |
|
Cash and cash equivalents at end of period |
|
$ |
2,586 |
|
|
$ |
3,939 |
|
See notes to consolidated financial statements.
THE ESTÉE LAUDER COMPANIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
NOTE 1 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The accompanying consolidated financial statements include the accounts of The Estée Lauder Companies Inc. and its subsidiaries (collectively, the “Company”). All significant intercompany balances and transactions have been eliminated.
The unaudited interim consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. The unaudited interim consolidated financial statements furnished reflect all normal and recurring adjustments which are, in the opinion of management, necessary for a fair statement of the results for the interim periods presented. The results of operations of any interim period are not necessarily indicative of the results of operations to be expected for the full fiscal year. The interim consolidated financial statements should be read in conjunction with the consolidated financial statements and accompanying footnotes included in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2024.
Certain prior year amounts in the notes to the consolidated financial statements have been reclassified to conform to current year presentation.
Management Estimates
The preparation of financial statements and related disclosures in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses reported in those financial statements. Descriptions of the Company’s significant accounting policies are discussed in the notes to consolidated financial statements in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2024. Management evaluates the related estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, and makes adjustments when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ significantly from those estimates and assumptions. Significant changes, if any, in those estimates and assumptions will be reflected in the consolidated financial statements in future periods.
Currency Translation and Transactions
All assets and liabilities of foreign subsidiaries and affiliates are translated at period-end rates of exchange, while revenue and expenses are translated at monthly average rates of exchange for the period. Unrealized translation gains (losses), net of tax, reported as translation adjustments through other comprehensive income (loss) (“OCI”) attributable to The Estée Lauder Companies Inc. were $(323) million and $232 million, net of tax, during the three months ended December 31, 2024 and 2023, respectively, and $(208) million and $89 million, net of tax, during the six months ended December 31, 2024 and 2023, respectively. For the Company’s subsidiaries operating in highly inflationary economies, the U.S. dollar is the functional currency, and these subsidiaries are not material to the Company's consolidated financial statements or liquidity. Remeasurement adjustments in financial statements in a highly inflationary economy and other transactional gains and losses are reflected in earnings.
The Company enters into foreign currency forward contracts and may enter into option contracts to hedge foreign currency transactions for periods consistent with its identified exposures. The Company also uses cross-currency swap contracts to hedge the impact of foreign currency changes on certain intercompany foreign currency denominated debt. Additionally, the Company enters into foreign currency forward contracts and cross-currency swap contracts to hedge a portion of its net investment in certain foreign operations, which are designated as net investment hedges. See Note 4 – Derivative Financial Instruments for further discussion. The Company categorizes these instruments as entered into for purposes other than trading.
The accompanying consolidated statements of earnings (loss) include net exchange gains on foreign currency transactions of $25 million and $13 million during the three months ended December 31, 2024 and 2023, respectively, and $44 million and $29 million during the six months ended December 31, 2024 and 2023, respectively.
THE ESTÉE LAUDER COMPANIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Concentration of Credit Risk
The Company is a worldwide manufacturer, marketer and seller of skin care, makeup, fragrance and hair care products. The Company’s sales subject to credit risk are made primarily to retailers in its travel retail business, department stores, specialty multi-brand retailers and perfumeries. The Company grants credit to qualified customers. While the Company does not believe it is exposed significantly to any undue concentration of credit risk at this time, it continues to monitor its customers' abilities, individually and collectively, to make timely payments.
The Company’s largest customer as of December 31, 2024 sells products primarily in China travel retail. This customer accounted for $163 million, or 10%, and $206 million, or 12%, of the Company's accounts receivable at December 31, 2024 and June 30, 2024, respectively.
Inventory and Promotional Merchandise
Inventory and promotional merchandise consists of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions) |
|
December 31, 2024 |
|
June 30, 2024 |
Raw materials |
|
$ |
625 |
|
|
$ |
696 |
|
Work in process |
|
246 |
|
|
308 |
|
Finished goods |
|
877 |
|
|
903 |
|
Promotional merchandise |
|
254 |
|
|
268 |
|
Total inventory and promotional merchandise |
|
$ |
2,002 |
|
|
$ |
2,175 |
|
Property, Plant and Equipment
Property, plant and equipment consists of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions) |
|
December 31, 2024 |
|
June 30, 2024 |
Assets (Useful Life) |
|
|
|
|
Land and improvements(1) |
|
$ |
70 |
|
|
$ |
68 |
|
Buildings and improvements (10 to 40 years) |
|
979 |
|
|
929 |
|
Machinery and equipment (3 to 20 years) |
|
1,316 |
|
|
1,253 |
|
Computer hardware and software (4 to 10 years) |
|
1,934 |
|
|
1,861 |
|
Furniture and fixtures (5 to 10 years) |
|
136 |
|
|
137 |
|
Leasehold improvements |
|
2,493 |
|
|
2,418 |
|
Construction in progress |
|
401 |
|
|
500 |
|
Total property, plant and equipment, gross |
|
7,329 |
|
|
7,166 |
|
Less accumulated depreciation and amortization |
|
(4,280) |
|
|
(4,030) |
|
Total property, plant and equipment, net |
|
$ |
3,049 |
|
|
$ |
3,136 |
|
(1)Land improvements are depreciated over a 10 year useful life.
Depreciation and amortization of property, plant and equipment was $168 million and $163 million during the three months ended December 31, 2024 and 2023, respectively, and $336 million and $325 million during the six months ended December 31, 2024 and 2023, respectively. Depreciation and amortization related to the Company’s manufacturing process is included in Cost of sales, and all other depreciation and amortization is included in Selling, general and administrative expenses in the accompanying consolidated statements of earnings (loss).
THE ESTÉE LAUDER COMPANIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Income Taxes
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
December 31,
|
|
Six Months Ended
December 31,
|
|
2024 |
|
2023 |
|
2024 |
|
2023 |
Effective rate for income taxes |
9.2 |
% |
|
37.6 |
% |
|
10.1 |
% |
|
36.3 |
% |
Basis-point change from the prior-year period |
(2,840) |
|
|
|
|
(2,620) |
|
|
|
For the three months ended December 31, 2024, the decrease in the effective tax rate was primarily attributable to the impact of the discrete treatment of charges associated with restructuring and other activities, the impairment of goodwill and other intangible assets, as well as an unfavorable impact associated with previously issued stock-based compensation.
For the six months ended December 31, 2024, the decrease in the effective tax rate was primarily attributable to the impact of the discrete treatment of charges associated with restructuring and other activities, the impairment of goodwill and other intangible assets, the charge associated with the talcum litigation settlement agreements (See Note 8 - Commitments and Contingencies for further discussion) and an unfavorable impact associated with previously issued stock-based compensation.
On August 16, 2022, the U.S. federal government enacted the Inflation Reduction Act, including a tax provision implementing a 15% corporate alternative minimum tax based on global adjusted financial statement income. The corporate alternative minimum tax did not have an impact on the Company's consolidated financial statements for the three and six months ended December 31, 2024 and 2023.
On August 26, 2024, the U.S. Tax Court issued a decision in Varian Medical Systems, Inc. v. Commissioner. The decision related to the Tax Cuts and Jobs Act deduction for certain deemed foreign dividends otherwise subject to the Transition Tax on unrepatriated earnings of applicable foreign subsidiaries. Based on the Company's evaluation of the technical merits of this decision, the Company intends to timely file a protective refund claim with the U.S. Internal Revenue Service in fiscal 2025 claiming a Transition Tax payable reduction of approximately $73 million. Although the Company has accrued the $73 million estimated tax benefit in the provision for income taxes and reduced the Transition Tax payable in the fiscal 2025 first quarter by $73 million, at this time the Company believes it is more-likely-than-not that the intended Transition Tax payable reduction claim will not be sustained. As such, in the fiscal 2025 first quarter the Company correspondingly increased the provision for income taxes for the estimated $73 million tax benefit to establish an uncertain tax position reserve accrual for the estimated $73 million Transition Tax at issue. As a result, there was no net impact from this development in the provision for income taxes and accompanying consolidated statement of earnings (loss) for the three and six months ended December 31, 2024. In the accompanying consolidated balance sheet as of December 31, 2024, the $73 million Transition Tax payable reduction and offsetting $73 million uncertain tax position reserve accrual are included in Other noncurrent liabilities.
In December 2021, the Organization for Economic Cooperation and Development issued "Pillar Two" Global Anti-Base Erosion model rules for countries to enact into domestic law that would establish a 15% global minimum tax applied on a country-by-country basis for multinational companies. In certain countries that have enacted legislation incorporating the global minimum tax, it became effective for the Company at the beginning of fiscal 2025. The estimated tax impact of such legislation has been included in the provision for income taxes for the three and six months ended December 31, 2024 and was not material. We are continuing to monitor and evaluate the potential impact of newly enacted legislation incorporating the global minimum tax in additional countries.
As of December 31, 2024 and June 30, 2024, the gross amount of unrecognized tax benefits, exclusive of interest and penalties, totaled $139 million and $65 million, respectively. The total amount of unrecognized tax benefits at December 31, 2024 that, if recognized, would affect the effective tax rate was $129 million. The significant increase in the gross amount of unrecognized tax benefits as of December 31, 2024 as compared to June 30, 2024 was attributable to having established an uncertain tax position reserve accrual for the Transition Tax payable reduction position determined in the fiscal 2025 first quarter based on the August 26, 2024 U.S. Tax Court decision in Varian Medical Systems v. Commissioner, as discussed above. The total gross interest and penalties accrued related to unrecognized tax benefits during the three and six months ended December 31, 2024 in the accompanying consolidated statements of earnings (loss) was $1 million and $2 million, respectively. The total gross accrued interest and penalties in the accompanying consolidated balance sheets at December 31, 2024 and June 30, 2024, was $20 million and $17 million, respectively. On the basis of the information available as of December 31, 2024, the Company does not expect significant changes to the total amount of unrecognized tax benefits within the next twelve months.
THE ESTÉE LAUDER COMPANIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
During the fiscal 2025 second quarter, the Company received notification of the formal conclusion of the compliance process with respect to its fiscal 2023 income tax return under the U.S. Internal Revenue Service (“IRS”) Compliance Assurance Program (“CAP”), which had no impact on the Company’s consolidated financial statements for the three and six months ended December 31, 2024.
At December 31, 2024 and June 30, 2024, total Other assets of $1,693 million and $1,460 million included $1,250 million and $1,018 million of deferred tax assets, respectively.
Supplier Finance Programs
Under the Company's supplier finance programs, the Company agrees to pay the banks the stated amount of confirmed invoices from its designated suppliers on the due dates of the invoices. The Company may terminate the agreements upon written notice (with notice periods ranging from 30 to 60 days) or immediately upon a breach. The supplier invoices that have been confirmed as valid under the programs require payment in full within 90 days of the invoice date.
Outstanding obligations confirmed as valid totaling $70 million and $58 million as of December 31, 2024 and June 30, 2024, respectively, are included in Accounts payable in the accompanying consolidated balance sheets.
Other Accrued Liabilities
Other accrued liabilities consist of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions) |
|
December 31, 2024 |
|
June 30, 2024 |
Advertising, merchandising and sampling |
|
$ |
335 |
|
|
$ |
276 |
|
Employee compensation |
|
448 |
|
|
576 |
|
Accrued sales incentives |
|
334 |
|
|
426 |
|
Deferred revenue |
|
338 |
|
|
327 |
|
Payroll and other non-income taxes |
|
367 |
|
|
333 |
|
Accrued income taxes |
|
205 |
|
|
335 |
|
Sales return accrual |
|
265 |
|
|
248 |
|
Other |
|
1,205 |
|
|
883 |
|
Total other accrued liabilities |
|
$ |
3,497 |
|
|
$ |
3,404 |
|
Recently Adopted Accounting Standards
FASB ASU No. 2022-04 – Liabilities—Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations
In September 2022, the FASB issued authoritative guidance which is intended to enhance the transparency surrounding the use of supplier finance programs. The guidance requires companies that use supplier finance programs to make annual disclosures about the program’s key terms, the balance sheet presentation of related amounts, the confirmed amount outstanding at the end of the period and associated rollforward information. Only the amount outstanding at the end of the period must be disclosed in interim periods. The guidance does not affect the recognition, measurement or financial statement presentation of supplier finance program obligations.
Effective for the Company – The guidance became effective for the Company’s first quarter fiscal 2024 and has been applied on a retrospective basis, except for the requirement to disclose rollforward information annually which is effective prospectively for the Company beginning in fiscal 2025.
Impact on consolidated financial statements – The Company has supplier financing arrangements and applied the disclosure requirements as required by the amendments. Such information is included in Supplier Finance Programs above within Note 1 – Summary of Significant Accounting Policies.
THE ESTÉE LAUDER COMPANIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Recently Issued Accounting Standards
FASB ASU No. 2024-03 and 2025-01 – Disaggregation of Income Statement Expenses (Subtopic 220-40)
In November 2024 and January 2025, the FASB issued authoritative guidance requiring disclosures, in a tabular format in the notes to the consolidated financial statements, on the disaggregation of relevant expense captions that are included on the face of the consolidated statement of earnings within continuing operations. The relevant expense captions are required to be disaggregated into natural expense categories including purchases of inventory, employee compensation, depreciation and intangible asset amortization. The guidance also requires certain expenses, gains or losses that require disclosure under existing U.S. GAAP, and that are recorded in a relevant expense caption on the face of the consolidated statement of earnings, to be presented in the same tabular disclosure. Qualitative disclosures about any remaining amounts in relevant expense line items are required as well. In addition, companies are required to disclose the total amount of selling expenses and, on an annual basis, how it defines selling expenses.
Effective for the Company: The guidance is effective for the Company’s fiscal year ending June 30, 2028 Form 10-K and then in interim periods beginning in the Company’s first quarter of fiscal 2029. Early adoption is permitted. The guidance should be applied on a prospective basis; however, retrospective application is permitted.
Impact on the consolidated financial statements: The Company is currently evaluating the impact that this guidance will have on its consolidated financial statement disclosures.
FASB ASU No. 2023-07 – Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures
In November 2023, the FASB issued authoritative guidance to improve reportable segment disclosure requirements. Companies are required to disclose significant segment expenses by reportable segment if they are regularly provided to the chief operating decision maker (CODM). Companies are also required to disclose other segment items by reportable segment. The guidance clarifies that companies may disclose more than one measure of segment profit or loss used by the CODM, provided that at least one of the reported measures includes the segment profit or loss measure that is most consistent with U.S. GAAP measurement principles. All existing annual disclosures about segment profit or loss, as well as the new requirements, must now be provided on an interim basis. Additionally, on an annual basis, the CODM’s title and position is required, as well as an explanation of how the CODM uses the reported measure(s) and other disclosures. The guidance does not change how companies identify their operating segments, aggregate those operating segments, or apply the quantitative thresholds to determine their reportable segments.
Effective for the Company – The guidance is effective for the Company’s fiscal year ending June 30, 2025 Form 10-K and then in interim periods beginning in the Company’s first quarter of fiscal 2026. Early adoption is permitted. The guidance should be applied retrospectively unless impracticable.
Impact on consolidated financial statements – The Company is currently evaluating the impact that this guidance will have on its consolidated financial statement disclosures.
FASB ASU No. 2023-09 – Income Taxes (Topic 740): Improvements to Income Tax Disclosures
In December 2023, the FASB issued authoritative guidance to amend and enhance existing annual income tax disclosures primarily focusing on two reporting areas: (1) greater disaggregation of information in the effective tax rate reconciliations and (2) disclosure of income taxes paid, disaggregated by applicable jurisdiction.
Companies are required to use specific categories to prepare and disclose a tabular rate reconciliation (using both percentages and reporting currency amounts) of:
•the reported income tax expense (or benefit) from continuing operations and the product of the income (or loss) from continuing operations before income taxes and the applicable statutory federal income tax rate of the jurisdiction of domicile; and
•reconciling items within certain categories that are equal to or greater than a specified quantitative threshold, including the nature, effect, and underlying causes of the reconciling items and the judgment used in categorizing the reconciling items.
The guidance also requires companies to disclose the amount of income taxes paid (net of refunds received) disaggregated by federal, state, and foreign jurisdictions including individual jurisdictions with amounts paid equal to or greater than a specified quantitative threshold. The guidance also codifies existing SEC rules that require companies to disclose income (or loss) from continuing operations before income tax expense (or benefit) disaggregated between domestic and foreign as well as income tax expense (or benefit) from continuing operations disaggregated by federal, state, and foreign jurisdictions.
THE ESTÉE LAUDER COMPANIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Effective for the Company – The guidance is effective for the Company’s fiscal year ending June 30, 2026 Form 10-K. Early adoption is permitted. The guidance should be applied on a prospective basis with the option to apply the standard retrospectively.
Impact on consolidated financial statements – The Company is currently evaluating the impact that this guidance will have on its consolidated financial statement disclosures.
SEC Final Rule Release No. 33-11275 – The Enhancement and Standardization of Climate-Related Disclosures for Investors
In March 2024, the SEC adopted rules intended to enhance and standardize climate-related disclosures in registration statements and annual reports. The rules require significant effects of severe weather events and other natural conditions, amounts related to carbon offsets and renewable energy credits or certificates, as well as material impacts on financial estimates and assumptions that are due to severe weather events and other natural conditions or disclosed climate-related targets or transition plans to be disclosed in the annual financial statements in certain circumstances.
Effective for the Company – On April 4, 2024, the SEC issued an order staying the final rule on climate-related disclosures pending certain legal challenges. Under the rule as currently issued, the disclosure requirements related to the annual financial statements are expected to be effective for the Company's fiscal year ending June 30, 2026 Form 10-K. The Company is not required to provide comparative information in the year of adoption.
Impact on consolidated financial statements – The Company is currently evaluating the impact that this guidance will have on its annual consolidated financial statement disclosures.
NOTE 2 – GOODWILL AND OTHER INTANGIBLE ASSETS
Goodwill
The following table presents goodwill by product category and the related change in the carrying amount:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions) |
|
Skin Care |
|
Makeup |
|
Fragrance |
|
Hair Care |
|
Total |
Balance as of June 30, 2024 |
|
|
|
|
|
|
|
|
|
|
Goodwill, gross carrying amount |
|
$ |
1,612 |
|
|
$ |
1,116 |
|
|
$ |
253 |
|
|
$ |
353 |
|
|
$ |
3,334 |
|
Accumulated impairments |
|
(429) |
|
|
(732) |
|
|
(30) |
|
|
— |
|
|
(1,191) |
|
Total goodwill |
|
1,183 |
|
|
384 |
|
|
223 |
|
|
353 |
|
|
2,143 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Impairment charges |
|
— |
|
|
(13) |
|
|
— |
|
|
— |
|
|
(13) |
|
Translation adjustments, goodwill |
|
(72) |
|
|
— |
|
|
(2) |
|
|
(1) |
|
|
(75) |
|
Translation adjustments, accumulated impairments |
|
18 |
|
|
— |
|
|
— |
|
|
— |
|
|
18 |
|
|
|
(54) |
|
|
(13) |
|
|
(2) |
|
|
(1) |
|
|
(70) |
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of December 31, 2024 |
|
|
|
|
|
|
|
|
|
|
Goodwill, gross carrying amount |
|
1,540 |
|
|
1,116 |
|
|
251 |
|
|
352 |
|
|
3,259 |
|
Accumulated impairments |
|
(411) |
|
|
(745) |
|
|
(30) |
|
|
— |
|
|
(1,186) |
|
Total goodwill |
|
$ |
1,129 |
|
|
$ |
371 |
|
|
$ |
221 |
|
|
$ |
352 |
|
|
$ |
2,073 |
|
THE ESTÉE LAUDER COMPANIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Other Intangible Assets
Other intangible assets consist of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2024 |
|
June 30, 2024 |
(In millions) |
|
Gross Carrying Value |
|
Accumulated Amortization |
|
Total Net Book Value |
|
Gross Carrying Value |
|
Accumulated Amortization |
|
Total Net Book Value |
Amortizable intangible assets: |
|
|
|
|
|
|
|
|
|
|
|
|
Customer lists and other |
|
$ |
1,897 |
|
|
$ |
941 |
|
|
$ |
956 |
|
|
$ |
1,971 |
|
|
$ |
895 |
|
|
$ |
1,076 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-amortizable intangible assets: |
|
|
|
|
|
|
|
|
|
|
|
|
Trademarks |
|
|
|
|
|
3,202 |
|
|
|
|
|
|
4,107 |
|
Total other intangible assets, net |
|
|
|
|
|
$ |
4,158 |
|
|
|
|
|
|
$ |
5,183 |
|
The aggregate amortization expense related to amortizable intangible assets was $35 million and $37 million for the three months ended December 31, 2024 and 2023, respectively, and $71 million and $73 million for the six months ended December 31, 2024 and 2023, respectively.
The estimated aggregate amortization expense for the remainder of fiscal 2025 and for each of the next four fiscal years is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fiscal |
(In millions) |
|
2025 |
|
2026 |
|
2027 |
|
2028 |
|
2029 |
Estimated aggregate amortization expense |
|
$ |
65 |
|
|
$ |
136 |
|
|
$ |
119 |
|
|
$ |
94 |
|
|
$ |
93 |
|
Impairment Analysis During the Six Months Ended December 31, 2024
During the fiscal 2025 second quarter, the TOM FORD brand experienced lower-than-expected growth within key geographic regions and channels, including in mainland China, Asia travel retail and Hong Kong SAR. Also during the fiscal 2025 second quarter, the Too Faced reporting unit experienced lower-than-expected results in key geographic regions and channels. As a result, the Company made revisions to the internal forecasts relating to its TOM FORD brand and Too Faced reporting unit. Additionally, there were increases in the weighted average cost of capital for both the TOM FORD brand and Too Faced reporting unit as compared to the prior-year annual goodwill and other indefinite-lived intangible asset impairment testing as of April 1, 2024.
The Company concluded that the changes in circumstances in the TOM FORD brand and Too Faced reporting unit, along with increases in the weighted average cost of capital, triggered the need for interim impairment reviews of the TOM FORD trademark and the Too Faced trademark and goodwill. These changes in circumstances were also an indicator that the carrying amounts of Too Faced’s long-lived assets, including customer lists, may not be recoverable. Accordingly, the Company performed interim impairment tests for the TOM FORD and Too Faced trademarks and Too Faced goodwill as well as a recoverability test for the Too Faced long-lived assets as of December 31, 2024. The Company concluded that the carrying value of the trademark intangible assets exceeded their estimated fair values, which were determined utilizing the relief-from-royalty method, and recorded an impairment charge of $773 million for TOM FORD and $75 million for Too Faced. The Company concluded that the carrying amounts of the long-lived assets for Too Faced were recoverable. Additionally, as a result of the interim impairment review, the remaining carrying value of Too Faced’s goodwill was not recoverable and the Company recorded an impairment charge of $13 million, reducing the carrying value to zero. The significant assumptions used in the relief-from-royalty method include revenue growth rates and profit margins, terminal values, weighted average cost of capital used to discount future cash flows and royalty rates. The most significant unobservable input used to estimate the fair value of the TOM FORD and Too Faced trademark intangible assets was the weighted average cost of capital, which was 11.5% and 14%, respectively.
THE ESTÉE LAUDER COMPANIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
A summary of the impairment charges for the three and six months ended December 31, 2024 and the remaining trademark and goodwill carrying values as of December 31, 2024, for the TOM FORD brand and Too Faced reporting unit, are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Impairment Charges(1) |
|
Carrying Value |
(In millions) |
|
|
|
|
|
Three and Six Months Ended
December 31, 2024
|
|
As of December 31, 2024 |
Brand/Reporting Unit |
|
Geographic Region |
|
|
|
|
|
Trademark |
|
Goodwill |
|
Trademark(2) |
|
Goodwill |
TOM FORD |
|
The Americas |
|
|
|
|
|
$ |
773 |
|
|
$ |
— |
|
|
$ |
1,805 |
|
|
$ |
— |
|
Too Faced |
|
The Americas |
|
|
|
|
|
75 |
|
|
13 |
|
|
112 |
|
|
— |
|
Total |
|
|
|
|
|
|
|
$ |
848 |
|
|
$ |
13 |
|
|
$ |
1,917 |
|
|
$ |
— |
|
(1)The date of the fair value measurement for the TOM FORD and Too Faced trademark intangible assets and Too Faced reporting unit was December 31, 2024.
(2)The carrying values of the trademark intangible assets, subsequent to the impairment charges, are equal to their fair values.
The impairment charge related to the TOM FORD trademark intangible asset for the three and six months ended December 31, 2024 of $773 million was reflected in the fragrance, makeup and other product categories of $549 million, $170 million and $54 million, respectively. The trademark and goodwill impairment charges related to Too Faced were reflected in the makeup product category.
NOTE 3 – CHARGES ASSOCIATED WITH RESTRUCTURING AND OTHER ACTIVITIES
Restructuring Program Component of the Profit Recovery and Growth Plan
As announced on November 1, 2023, the Company launched the Profit Recovery and Growth Plan ("PRGP") to help progressively rebuild its profit margins in fiscal years 2025 and 2026.
The PRGP is focused on rebuilding stronger, more sustainable profitability, supporting sales growth acceleration and increasing speed and agility. The plan is designed to improve gross margin, lower the cost base and reduce overhead expenses, while increasing investments in key consumer-facing activities. Upon completion of this plan, the Company expects to have improved its gross margin and expense base to drive greater operating leverage for the future.
As a component of the PRGP, on February 5, 2024, the Company announced a two-year restructuring program. The restructuring program’s main focus included the reorganization and rightsizing of certain areas of the Company as well as simplification and acceleration of processes. The Company committed to this course of action on February 1, 2024.
In connection with the restructuring program, the Company estimated a net reduction in the range of approximately 1,800 to 3,000 positions globally, which was about 3-5% of its positions including temporary and part-time employees as of June 30, 2023. This reduction took into account the elimination of some positions as well as retraining and redeployment of certain employees in select areas.
The Company planned to substantially complete specific initiatives under the restructuring program through fiscal 2026. The Company expected that the restructuring program would result in restructuring and other charges totaling between $500 million and $700 million, before taxes, consisting of employee-related costs, contract terminations, asset write-offs and other costs associated with implementing these initiatives.
After reviewing additional potential initiatives and the progress of previously approved initiatives, on February 3, 2025, the Company committed to the expansion of the PRGP, including an expansion of the restructuring program.
The expansion of the overall PRGP is focused on three key areas. First, the Company plans to adopt a more competitive approach to procurement, a key pillar of savings, by further consolidating spending and strategically re-evaluating key supplier relationships. Second, the Company plans to further improve efficiencies within its supply chain network through a zero-waste approach, aiming to improve demand forecasting and innovation planning to minimize excess inventory and product destruction. Third, the Company is outsourcing select services to proven global partners.
THE ESTÉE LAUDER COMPANIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The expanded component of the restructuring program will begin during the Company’s fiscal 2025 third quarter with all initiatives to be approved by the end of fiscal 2026. Specific initiatives under the expanded component of the restructuring program are expected to be substantially completed by the end of fiscal 2027. The focus of the now expanded restructuring program (now, collectively the “Restructuring Program”) includes (i) reorganization and rightsizing of certain areas and (ii) simplification and acceleration of processes, along with the newly added focus on (i) outsourcing of select services and (ii) evolution of go-to-market footprint and selling models.
In connection with the Restructuring Program, the Company now estimates a net reduction in the range of approximately 5,800 to 7,000 positions globally, which is about 9-11% of its positions including temporary and part-time employees as of June 30, 2023. This net reduction takes into account the elimination of positions after retraining and redeployment of certain employees in select areas.
The Company now expects that the Restructuring Program will result in restructuring and other charges totaling between $1,200 million and $1,600 million, before taxes, consisting of employee-related costs, contract terminations, asset write-offs and other costs associated with implementing these initiatives, which other than the non-cash charges, are expected to result in future cash expenditures funded from cash provided by operations.
Restructuring Program Component of the Profit Recovery and Growth Plan Approvals
The Restructuring Program cumulative charges for initiatives approved by the Company as of December 31, 2024 and through January 29, 2025 were:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales Returns (included in Net Sales) |
|
Cost of Sales |
|
Operating Expenses |
|
Total |
(In millions) |
|
|
|
Restructuring Charges |
|
Other Charges |
|
Total Charges Approved |
|
|
|
|
|
|
|
|
|
|
Cumulative charges through June 30, 2024 |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
109 |
|
|
$ |
78 |
|
|
$ |
187 |
|
Six months ended December 31, 2024 |
|
1 |
|
|
9 |
|
|
257 |
|
|
25 |
|
|
292 |
|
|
|
|
|
|
|
|
|
|
|
|
Cumulative charges through December 31, 2024 |
|
1 |
|
|
9 |
|
|
366 |
|
|
103 |
|
|
479 |
|
January 1, 2025 - January 29, 2025 |
|
4 |
|
|
— |
|
|
47 |
|
|
7 |
|
|
58 |
|
Cumulative charges through January 29, 2025 |
|
$ |
5 |
|
|
$ |
9 |
|
|
$ |
413 |
|
|
$ |
110 |
|
|
$ |
537 |
|
Included in the above table, Restructuring Program cumulative restructuring charges for initiatives approved by the Company as of December 31, 2024 and through January 29, 2025 were:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions) |
|
Employee- Related Costs |
|
Asset- Related Costs |
|
Contract Terminations |
|
Other Exit Costs |
|
Total |
Restructuring Charges Approved |
|
|
|
|
|
|
|
|
|
|
Cumulative charges through June 30, 2024 |
|
$ |
93 |
|
|
$ |
7 |
|
|
$ |
— |
|
|
$ |
9 |
|
|
$ |
109 |
|
Six months ended December 31, 2024 |
|
245 |
|
|
6 |
|
|
— |
|
|
6 |
|
|
257 |
|
Cumulative charges through December 31, 2024 |
|
338 |
|
|
13 |
|
|
— |
|
|
15 |
|
|
366 |
|
January 1, 2025 - January 29, 2025 |
|
40 |
|
|
— |
|
|
3 |
|
|
4 |
|
|
47 |
|
Cumulative charges through January 29, 2025 |
|
$ |
378 |
|
|
$ |
13 |
|
|
$ |
3 |
|
|
$ |
19 |
|
|
$ |
413 |
|
Specific actions taken since the Restructuring Program inception to reorganize and right-size certain areas of the Company to drive future sales growth and productivity to rebuild gross and operating margin profitability include:
•Value Chain Optimization – The Company approved initiatives to reduce spans and layers and right-size organizational capability within its supply chain and research and development functions. These actions will primarily result in employee severance through a net reduction in workforce, as well as costs to decommission and relocate activities, and asset write-offs.
THE ESTÉE LAUDER COMPANIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
•Enabling Function Re-Invention – The Company approved initiatives to reorganize and right-size various corporate functions. These activities will primarily result in employee severance through a net reduction in workforce.
•Future of Brand-led Model – The Company approved initiatives to redesign spans and layers in its marketing and creative organization to make it leaner, faster, and more agile. These activities will primarily result in employee severance through a net reduction in workforce.
•Go-to-Market Operating Model Acceleration – The Company approved initiatives to optimize and right-size the organizational structure within its geographic regions to drive greater efficiency and effectiveness, as well as exit unprofitable brands from specific markets and distribution channels. These activities will result in employee severance through a net reduction in workforce, inventory write-offs, as well as costs associated with sales returns.
•Digital Organization Transformation – The Company approved initiatives to begin to reorganize and right-size its technology functions, which support its internal enterprise and commercial capabilities, to create a leaner, faster, more effective and more agile technology organization. These activities will primarily result in employee severance through a net reduction in workforce.
Once the relevant accounting criteria have been met, the Company expects to record restructuring and other charges of approximately $537 million (before tax) in connection with these initiatives, which other than the non-cash charges, are expected to result in future cash expenditures funded from cash provided by operations.
Restructuring Program Restructuring and Other Charges
The Company classifies restructuring charges as follows:
Employee-Related Costs – Employee-related costs are primarily comprised of severance and other post-employment benefit costs, calculated based on salary levels, prior service and other statutory minimum benefits, if applicable.
Asset-Related Costs – Asset-related costs primarily consist of asset write-offs or accelerated depreciation related to long-lived assets (including rights associated with commercial operating leases and operating lease right-of-use assets) that will be taken out of service prior to their existing useful life as a direct result of a restructuring initiative.
Contract Terminations – Costs related to contract terminations include continuing payments to a third party after the Company has ceased benefiting from the rights conveyed in the contract, or a payment made to terminate a contract prior to its expiration.
Other Exit Costs – Other exit costs related to restructuring activities generally include costs to relocate facilities or employees, recruiting to fill positions as a result of relocation of operations, and outplacement for separated employees.
The Company classifies other charges associated with restructuring activities as follows:
Sales Returns and Cost of Sales – Product returns (offset by the related cost of sales) and inventory write-offs or write-downs as a direct result of an approved restructuring initiative to exit certain businesses or locations will be recorded as a component of Net sales and/or Cost of sales when estimable and reasonably assured.
Other Charges – Other charges related to the design and implementation of approved initiatives, which are charged to Operating expenses as incurred and primarily include the following:
•Consulting and other professional services for organizational design of the future structures and processes as well as the implementation thereof;
•Temporary labor backfill;
•Costs to establish and maintain a Project Management Office for the duration of the Restructuring Program, including internal costs for employees dedicated solely to project management activities, and consulting services to assist with business case development; and
•Recruitment and training costs for new and reskilled employees to acquire and apply the capabilities needed to perform responsibilities as a direct result of an approved restructuring initiative.
THE ESTÉE LAUDER COMPANIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The Company records approved charges associated with restructuring and other activities once the relevant accounting criteria have been met.
Total cumulative charges recorded associated with restructuring and other activities for the Restructuring Program were:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales Returns (included in Net Sales) |
|
Cost of Sales |
|
Operating Expenses |
|
Total |
(In millions) |
|
|
|
Restructuring Charges |
|
Other Charges |
|
Total Cumulative Charges |
|
|
|
|
|
|
|
|
|
|
Cumulative charges through June 30, 2024 |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
92 |
|
|
$ |
23 |
|
|
$ |
115 |
|
Three months ended September 30, 2024 |
|
— |
|
|
9 |
|
|
85 |
|
|
12 |
|
|
106 |
|
Three months ended December 31, 2024 |
|
— |
|
|
— |
|
|
171 |
|
|
11 |
|
|
182 |
|
|
|
|
|
|
|
|
|
|
|
|
Cumulative charges through December 31, 2024 |
|
$ |
— |
|
|
$ |
9 |
|
|
$ |
348 |
|
|
$ |
46 |
|
|
$ |
403 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions) |
|
Employee- Related Costs |
|
Asset- Related Costs |
|
Contract Terminations |
|
Other Exit Costs |
|
Total |
Restructuring Charges |
|
|
|
|
|
|
|
|
|
|
Cumulative charges through June 30, 2024 |
|
$ |
90 |
|
|
$ |
2 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
92 |
|
Three months ended September 30, 2024 |
|
82 |
|
|
2 |
|
|
— |
|
|
1 |
|
|
85 |
|
Three months ended December 31, 2024 |
|
165 |
|
|
5 |
|
|
— |
|
|
1 |
|
|
171 |
|
|
|
|
|
|
|
|
|
|
|
|
Cumulative charges through December 31, 2024 |
|
$ |
337 |
|
|
$ |
9 |
|
|
$ |
— |
|
|
$ |
2 |
|
|
$ |
348 |
|
Changes in accrued restructuring charges from the Restructuring Program for the six months ended December 31, 2024 were:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions) |
|
Employee- Related Costs |
|
Asset- Related Costs |
|
Contract Terminations |
|
Other Exit Costs |
|
Total |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at June 30, 2024 |
|
$ |
88 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
88 |
|
|
|
|
|
|
|
|
|
|
|
|
Charges |
|
247 |
|
|
7 |
|
|
— |
|
|
2 |
|
|
256 |
|
Cash payments |
|
(26) |
|
|
— |
|
|
— |
|
|
(2) |
|
|
(28) |
|
Non-cash asset write-offs |
|
— |
|
|
(7) |
|
|
— |
|
|
— |
|
|
(7) |
|
Translation and other adjustments |
|
(8) |
|
|
— |
|
|
— |
|
|
— |
|
|
(8) |
|
Balance at December 31, 2024 |
|
$ |
301 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
301 |
|
|
|
|
|
|
|
|
|
|
|
|
Accrued restructuring charges at December 31, 2024 relating to the Restructuring Program are expected to result in cash expenditures funded from cash provided by operations of approximately $134 million, $156 million, and $11 million for the remainder of fiscal 2025 and for fiscal 2026 and 2027, respectively.
Charges associated with restructuring and other activities are not allocated to the Company's product categories or geographic regions because they are centrally directed and controlled, are not included in internal measures of product category or geographic region performance and result from activities that are deemed Company-wide initiatives to redesign, resize and reorganize select areas of the business.
Post-COVID Business Acceleration Program
The Company approved specific initiatives under the Post-COVID Business Acceleration Program (the “PCBA Program”) through fiscal 2022 and has substantially completed those initiatives. Additional information about the PCBA Program is included in the notes to consolidated financial statements in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2024.
THE ESTÉE LAUDER COMPANIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
NOTE 4 – DERIVATIVE FINANCIAL INSTRUMENTS
The Company addresses certain financial exposures through a controlled program of risk management that includes the use of derivative financial instruments. The Company does not utilize derivative financial instruments for trading or speculative purposes. Costs associated with entering into derivative financial instruments have not been material to the Company’s consolidated financial results. At December 31, 2024, the notional amount of derivatives not designated as hedging instruments was $3,443 million.
Fair Value Hedges
The Company enters into interest rate derivative contracts to manage the exposure to interest rate fluctuations on its funded indebtedness. At December 31, 2024, the Company has interest rate swap agreements, with notional amounts totaling $700 million and $300 million to effectively convert the fixed rate interest on its 2030 Senior Notes and 2031 Senior Notes, respectively, to variable interest rates based on the three-month fallback Secured Overnight Financing Rate ("SOFR") plus a margin. These interest rate swap agreements are designated as fair value hedges of the related long-term debt, and the changes in the fair value of the interest rate swap agreements are exactly offset by the change in the fair value of the underlying long-term debt.
The Company enters into cross-currency swap contracts to manage the exposure of foreign exchange rate fluctuations on its intercompany foreign currency denominated debt. At December 31, 2024, the Company has cross-currency swap contracts with notional amounts totaling $491 million, to hedge the impact of foreign currency changes on certain intercompany foreign currency denominated debt. The cross-currency swap contracts are designated as fair value hedges of the related intercompany debt, and the gains and losses representing hedge components included in the assessment of effectiveness are presented in the same income statement line item as the earnings effect of the hedged transaction. Gains and losses on the derivative representing hedge components excluded from the assessment of effectiveness are recognized over the life of the hedge on a systematic and rational basis. The earnings recognition of excluded components is presented in the same income statement line item as the earnings effect of the hedged transaction. Any difference between the changes in the fair value of the excluded components and amounts recognized in earnings will be recognized in Accumulated Other Comprehensive Loss ("AOCI").
The estimated net gain on the Company’s derivative instruments designated as fair value hedges as of December 31, 2024 that is expected to be reclassified from AOCI into earnings, net of tax, within the next twelve months is $14 million. The accumulated net loss on derivative instruments designated as fair value hedges in AOCI was less than $1 million and $7 million as of December 31, 2024 and June 30, 2024, respectively.
Cash Flow Hedges
The Company enters into foreign currency forward contracts, and may enter into foreign currency option contracts, to hedge anticipated transactions and receivables and payables denominated in foreign currencies, for periods consistent with the Company’s identified exposures. The purpose of the hedging activities is to minimize the effect of foreign exchange rate movements on the cash flows that the Company receives from foreign subsidiaries. The foreign currency forward contracts entered into to hedge anticipated transactions have been designated as cash flow hedges and have varying maturities through the end of September 2026. Hedge effectiveness of the foreign currency forward contracts is based on the forward method, which includes forward points in the effectiveness assessment. At December 31, 2024, the Company had cash flow hedges outstanding with a notional amount totaling $1,895 million.
For foreign currency hedge contracts that are no longer deemed highly effective, hedge accounting is discontinued and gains and losses in AOCI are reclassified to Net sales when the underlying forecasted transaction occurs. If it is probable that the forecasted transaction will no longer occur, then any gains or losses in AOCI are reclassified to current-period Net sales. As of December 31, 2024, the Company’s foreign currency cash flow hedges were highly effective.
The Company may enter into interest rate forward contracts to hedge anticipated issuance of debt for periods consistent with the Company’s identified exposures. The purpose of the hedging activities is to minimize the effect of interest rate movements on the cost of debt issuance.
THE ESTÉE LAUDER COMPANIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The estimated net gain on the Company’s derivative instruments designated as cash flow hedges as of December 31, 2024 that is expected to be reclassified from AOCI into earnings, net of tax, within the next twelve months is $27 million. The accumulated net gain on derivative instruments designated as cash flow hedges in AOCI was $74 million and $75 million as of December 31, 2024 and June 30, 2024, respectively.
Net Investment Hedges
The Company enters into foreign currency forward contracts and cross-currency swap contracts, designated as net investment hedges, to hedge a portion of its net investment in certain foreign operations. Forward points and cross-currency basis spreads, respectively, are excluded from the effectiveness assessment and are recognized under a systematic and rational method over the life of the hedging instrument in Selling, general and administrative expenses. The purpose of the hedging activities is to minimize the effect of foreign exchange rate movements on the Company’s net investment in these foreign operations. The net investment hedge contracts have varying maturities through the end of November 2029. Hedge effectiveness of the net investment hedge contracts is based on the spot method. At December 31, 2024, the Company had net investment hedges outstanding with a notional amount totaling $1,401 million.
Credit Risk
As a matter of policy, the Company enters into derivative contracts only with counterparties that have a long-term credit rating of at least A- or higher by at least two nationally recognized rating agencies. The counterparties to these contracts are major financial institutions. Exposure to credit risk in the event of nonperformance by any of the counterparties is limited to the gross fair value of contracts in asset positions, which totaled $206 million at December 31, 2024. To manage this risk, the Company has strict counterparty credit guidelines that are continually monitored. Accordingly, management believes risk of loss under these hedging contracts is remote.
THE ESTÉE LAUDER COMPANIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The fair values of the Company’s derivative financial instruments included in the consolidated balance sheets are presented as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Asset Derivatives |
|
Liability Derivatives |
|
|
|
|
Fair Value (1) |
|
|
|
Fair Value (1) |
(In millions) |
|
Balance Sheet Location |
|
December 31, 2024 |
|
June 30, 2024 |
|
Balance Sheet Location |
|
December 31, 2024 |
|
June 30, 2024 |
Derivatives Designated as Hedging Instruments: |
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency forward contracts(2) |
|
Prepaid expenses and other current assets; Other assets |
|
$ |
104 |
|
|
$ |
49 |
|
|
Other accrued liabilities |
|
$ |
3 |
|
|
$ |
4 |
|
Cross-currency swap contracts(3) |
|
Prepaid expenses and other current assets; Other assets |
|
88 |
|
|
80 |
|
|
Other accrued liabilities |
|
8 |
|
|
— |
|
Interest rate contracts |
|
Prepaid expenses and other current assets |
|
— |
|
|
— |
|
|
Other accrued liabilities |
|
138 |
|
|
145 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Derivatives Designated as Hedging Instruments |
|
|
|
192 |
|
129 |
|
|
|
149 |
|
149 |
Derivatives Not Designated as Hedging Instruments: |
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency forward contracts |
|
Prepaid expenses and other current assets |
|
14 |
|
|
19 |
|
|
Other accrued liabilities |
|
49 |
|
|
17 |
|
Total derivatives |
|
|
|
$ |
206 |
|
|
$ |
148 |
|
|
|
|
$ |
198 |
|
|
$ |
166 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)See Note 5 – Fair Value Measurements for further information about how the fair value of derivative assets and liabilities are determined.
(2)Included in the asset derivatives for the foreign currency forward contracts at December 31, 2024 and June 30, 2024 is $4 million and $2 million, respectively, classified within Other assets in the accompanying consolidated balance sheets.
(3)Included in the asset derivatives for the cross-currency swap contracts at December 31, 2024 and June 30, 2024 is approximately $67 million and $70 million, respectively, classified within Other assets in the accompanying consolidated balance sheets.
THE ESTÉE LAUDER COMPANIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The amounts of the gains and losses related to the Company’s derivative financial instruments designated as hedging instruments that are included in the assessment of effectiveness are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amount of Gain (Loss) Recognized in OCI on Derivatives |
|
Location of Gain (Loss) Reclassified
from AOCI into
Earnings (Loss)
|
|
Amount of Gain (Loss)
Reclassified from AOCI into Earnings (Loss)(1)
|
|
|
Three Months Ended
December 31,
|
|
|
Three Months Ended
December 31,
|
(In millions) |
|
2024 |
|
2023 |
|
|
2024 |
|
2023 |
Derivatives in Cash Flow Hedging Relationships: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency forward contracts |
|
$ |
70 |
|
|
$ |
(36) |
|
|
Net sales |
|
$ |
14 |
|
|
$ |
12 |
|
Interest rate contracts |
|
— |
|
|
— |
|
|
Interest expense |
|
1 |
|
|
(1) |
|
Total cash flow hedges |
|
70 |
|
|
(36) |
|
|
|
|
15 |
|
|
11 |
|
Derivatives in Net Investment Hedging Relationships(2)(3): |
|
|
|
|
|
|
|
|
|
|
Foreign currency forward contracts |
|
86 |
|
|
(47) |
|
|
|
|
— |
|
|
— |
|
Cross-currency swap contracts |
|
2 |
|
|
— |
|
|
|
|
— |
|
|
— |
|
Total net investment hedges |
|
88 |
|
|
(47) |
|
|
|
|
— |
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
Total derivatives |
|
$ |
158 |
|
|
$ |
(83) |
|
|
|
|
$ |
15 |
|
|
$ |
11 |
|
|
|
|
|
|
|
|
|
|
|
|
(1)The amount reclassified into earnings (loss) as a result of the discontinuance of cash flow hedges because it is probable that forecasted transactions will not occur by the end of the original time period was not material.
(2)During the three months ended December 31, 2024 and 2023, the gain recognized in earnings (loss) from net investment hedges related to the amount excluded from effectiveness testing was $8 million and $5 million, respectively.
(3)Included within translation adjustments as a component of AOCI on the Company’s consolidated balance sheets.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amount of Gain (Loss) Recognized in OCI on Derivatives |
|
Location of Gain (Loss) Reclassified
from AOCI into
Earnings (Loss)
|
|
Amount of Gain (Loss)
Reclassified from AOCI into Earnings (Loss)(1)
|
|
|
Six Months Ended
December 31,
|
|
|
Six Months Ended
December 31,
|
(In millions) |
|
2024 |
|
2023 |
|
|
2024 |
|
2023 |
Derivatives in Cash Flow Hedging Relationships: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency forward contracts |
|
$ |
23 |
|
|
$ |
(8) |
|
|
Net sales |
|
$ |
24 |
|
|
$ |
21 |
|
Interest rate contracts |
|
— |
|
|
— |
|
|
Interest expense |
|
1 |
|
|
(1) |
|
Total cash flow hedges |
|
23 |
|
|
(8) |
|
|
|
|
25 |
|
|
20 |
|
Derivatives in Net Investment Hedging Relationships(2)(3): |
|
|
|
|
|
|
|
|
|
|
Foreign currency forward contracts |
|
22 |
|
|
(17) |
|
|
|
|
— |
|
|
— |
|
Cross-currency swap contracts |
|
2 |
|
|
— |
|
|
|
|
— |
|
|
— |
|
Total net investment hedges |
|
24 |
|
|
(17) |
|
|
|
|
— |
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
Total derivatives |
|
$ |
47 |
|
|
$ |
(25) |
|
|
|
|
$ |
25 |
|
|
$ |
20 |
|
|
|
|
|
|
|
|
|
|
|
|
(1)The amount reclassified into earnings (loss) as a result of the discontinuance of cash flow hedges because it is probable that forecasted transactions will not occur by the end of the original time period was not material.
(2)During the six months ended December 31, 2024 and 2023, the gain recognized in earnings (loss) from net investment hedges related to the amount excluded from effectiveness testing was $15 million and $10 million, respectively.
(3)Included within translation adjustments as a component of AOCI on the Company’s consolidated balance sheets.
THE ESTÉE LAUDER COMPANIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amount of Gain (Loss)
Recognized in Earnings (Loss) on
Derivatives
|
|
|
|
|
|
|
Location of Gain (Loss) Recognized in Earnings (Loss) on Derivatives |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended December 31, |
|
Six Months Ended December 31, |
|
|
(In millions) |
|
|
2024 |
|
2023 |
|
2024 |
|
2023 |
|
|
|
|
Derivatives in Fair Value Hedging Relationships: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cross-currency swap contracts(1) |
|
Selling, general and administrative |
|
$ |
43 |
|
|
$ |
(24) |
|
|
$ |
(9) |
|
|
$ |
(11) |
|
|
|
|
|
Interest rate contracts(2) |
|
Interest expense |
|
$ |
(34) |
|
|
$ |
49 |
|
|
$ |
7 |
|
|
$ |
20 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)Changes in the fair value representing hedge components included in the assessment of effectiveness of the cross-currency swap contracts are exactly offset by the change in the fair value of the underlying intercompany foreign currency denominated debt. The gain recognized in earnings (loss) from cross-currency swap contracts related to the amount excluded from effectiveness testing during the three months ended December 31, 2024 and 2023 was $5 million and $4 million, respectively, and during the six months ended December 31, 2024 and 2023 was $9 million.
(2)Changes in the fair value of the interest rate contracts are exactly offset by the change in the fair value of the underlying long-term debt.
Additional information regarding the cumulative amount of fair value hedging gain (loss) recognized in earnings (loss) for items designated and qualifying as hedged items in fair value hedges is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions) |
|
|
|
|
Line Item in the Consolidated Balance Sheets in Which the Hedged Item is Included |
|
Carrying Amount of the Hedged Liabilities |
|
Cumulative Amount of Fair Value Hedging Gain (Loss) Included in the Carrying Amount of the Hedged Liability |
|
|
December 31, 2024 |
|
December 31, 2024 |
|
|
|
|
|
Long-term debt |
|
$ |
856 |
|
|
$ |
(138) |
|
Intercompany debt |
|
$ |
— |
|
|
$ |
77 |
|
|
|
|
|
|
THE ESTÉE LAUDER COMPANIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Additional information regarding the effects of fair value and cash flow hedging relationships for derivatives designated and qualifying as hedging instruments is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended December 31, |
|
|
2024 |
|
2023 |
(In millions) |
|
Net Sales |
|
Selling, General and Administrative |
|
Interest Expense |
|
Net Sales |
|
Selling, General and Administrative |
|
Interest Expense |
Total amounts of income and expense line items presented in the consolidated statements of earnings (loss) in which the effects of fair value and cash flow hedges are recorded |
|
$ |
4,004 |
|
|
$ |
2,585 |
|
|
$ |
90 |
|
|
$ |
4,279 |
|
|
$ |
2,544 |
|
|
$ |
98 |
|
The effects of fair value and cash flow hedging relationships: |
|
|
|
|
|
|
|
|
|
|
|
|
Gain (loss) on fair value hedge relationships – interest rate contracts: |
|
|
|
|
|
|
|
|
|
|
|
|
Hedged item |
|
N/A |
|
N/A |
|
34 |
|
|
N/A |
|
N/A |
|
(49) |
|
Derivatives designated as hedging instruments |
|
N/A |
|
N/A |
|
(34) |
|
|
N/A |
|
N/A |
|
49 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gain (loss) on fair value hedge relationships – cross-currency swap contracts: |
|
|
|
|
|
|
|
|
|
|
|
|
Hedged item |
|
N/A |
|
(43) |
|
|
N/A |
|
N/A |
|
24 |
|
|
N/A |
Derivatives designated as hedging instruments |
|
N/A |
|
43 |
|
|
N/A |
|
N/A |
|
(24) |
|
|
N/A |
|
|
|
|
|
|
|
|
|
|
|
|
|
Gain (loss) on cash flow hedge relationships – interest rate contracts: |
|
|
|
|
|
|
|
|
|
|
|
|
Amount of gain (loss) reclassified from AOCI into earnings |
|
N/A |
|
N/A |
|
1 |
|
|
N/A |
|
N/A |
|
(1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gain on cash flow hedge relationships – foreign currency forward contracts: |
|
|
|
|
|
|
|
|
|
|
|
|
Amount of gain reclassified from AOCI into earnings |
|
14 |
|
|
N/A |
|
N/A |
|
12 |
|
|
N/A |
|
N/A |
|
|
|
|
|
|
|
|
|
|
|
|
|
N/A (Not applicable)
THE ESTÉE LAUDER COMPANIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended December 31, |
|
|
2024 |
|
2023 |
(In millions) |
|
Net Sales |
|
Selling, General and Administrative |
|
Interest Expense |
|
Net Sales |
|
Selling, General and Administrative |
|
Interest Expense |
Total amounts of income and expense line items presented in the consolidated statements of earnings (loss) in which the effects of fair value and cash flow hedges are recorded |
|
$ |
7,365 |
|
|
$ |
4,883 |
|
|
$ |
182 |
|
|
$ |
7,797 |
|
|
$ |
4,893 |
|
|
$ |
193 |
|
The effects of fair value and cash flow hedging relationships: |
|
|
|
|
|
|
|
|
|
|
|
|
Gain (loss) on fair value hedge relationships – interest rate contracts: |
|
|
|
|
|
|
|
|
|
|
|
|
Hedged item |
|
N/A |
|
N/A |
|
(7) |
|
|
N/A |
|
N/A |
|
(20) |
|
Derivatives designated as hedging instruments |
|
N/A |
|
N/A |
|
7 |
|
|
N/A |
|
N/A |
|
20 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gain (loss) on fair value hedge relationships – cross-currency swap contracts: |
|
|
|
|
|
|
|
|
|
|
|
|
Hedged item |
|
N/A |
|
9 |
|
|
N/A |
|
N/A |
|
11 |
|
|
N/A |
Derivatives designated as hedging instruments |
|
N/A |
|
(9) |
|
|
N/A |
|
N/A |
|
(11) |
|
|
N/A |
|
|
|
|
|
|
|
|
|
|
|
|
|
Gain (loss) on cash flow hedge relationships – interest rate contracts: |
|
|
|
|
|
|
|
|
|
|
|
|
Amount of gain (loss) reclassified from AOCI into earnings |
|
N/A |
|
N/A |
|
1 |
|
|
N/A |
|
N/A |
|
(1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gain on cash flow hedge relationships – foreign currency forward contracts: |
|
|
|
|
|
|
|
|
|
|
|
|
Amount of gain reclassified from AOCI into earnings |
|
24 |
|
|
N/A |
|
N/A |
|
21 |
|
|
N/A |
|
N/A |
|
|
|
|
|
|
|
|
|
|
|
|
|
N/A (Not applicable)
THE ESTÉE LAUDER COMPANIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The amount of gains and losses related to the Company’s derivative financial instruments not designated as hedging instruments are presented as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amount of Gain (Loss)
Recognized in Earnings (Loss) on Derivatives
|
|
|
|
|
|
|
Location of Gain (Loss) Recognized in Earnings (Loss) on
Derivatives
|
|
Three Months Ended December 31, |
|
Six Months Ended December 31, |
|
|
(In millions) |
|
|
2024 |
|
2023 |
|
2024 |
|
2023 |
|
|
|
|
Derivatives Not Designated as Hedging Instruments: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency forward contracts |
|
Selling, general and administrative |
|
$ |
31 |
|
|
$ |
7 |
|
|
$ |
(19) |
|
|
$ |
13 |
|
|
|
|
|
The Company's derivative instruments are subject to enforceable master netting agreements. These agreements permit the net settlement of these contracts on a per-institution basis; however, the Company records the fair value on a gross basis on its consolidated balance sheets based on maturity dates, including those subject to master netting arrangements. The following table provides information as if the Company had elected to offset the asset and liability balances of derivative instruments, netted in accordance with various criteria in the event of default or termination as stipulated by the terms of netting arrangements with each of the counterparties:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31, 2024 |
|
As of June 30, 2024 |
|
|
(In millions) |
|
|
Gross Amounts of Assets / (Liabilities) Presented in Balance Sheet |
|
Contracts Subject to Netting |
|
Net Amounts of Assets / (Liabilities) |
|
Gross Amounts of Assets / (Liabilities) Presented in Balance Sheet |
|
Contracts Subject to Netting |
|
Net Amounts of Assets / (Liabilities) |
|
|
|
|
Derivative Financial Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative assets |
|
|
$ |
206 |
|
|
$ |
(86) |
|
|
$ |
120 |
|
|
$ |
148 |
|
|
$ |
(49) |
|
|
$ |
99 |
|
|
|
|
|
Derivative liabilities |
|
|
(198) |
|
|
86 |
|
|
(112) |
|
|
(166) |
|
|
49 |
|
|
(117) |
|
|
|
|
|
Total derivatives |
|
|
$ |
8 |
|
|
$ |
— |
|
|
$ |
8 |
|
|
$ |
(18) |
|
|
$ |
— |
|
|
$ |
(18) |
|
|
|
|
|
NOTE 5 – FAIR VALUE MEASUREMENTS
The Company records certain of its financial assets and liabilities at fair value, which is defined as the price that would be received to sell an asset or paid to transfer a liability, in the principal or most advantageous market for the asset or liability, in an orderly transaction between market participants at the measurement date. The accounting for fair value measurements must be applied to nonfinancial assets and nonfinancial liabilities that require initial measurement or remeasurement at fair value, which principally consist of assets and liabilities acquired through business combinations and goodwill, indefinite-lived intangible assets and long-lived assets for the purposes of calculating potential impairment. The Company is required to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The three levels of inputs that may be used to measure fair value are as follows:
Level 1: Inputs based on quoted market prices for identical assets or liabilities in active markets at the measurement date.
Level 2: Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.
Level 3: Inputs reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date. The inputs are unobservable in the market and significant to the instrument’s valuation.
THE ESTÉE LAUDER COMPANIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The following table presents the Company’s hierarchy for its financial assets and liabilities measured at fair value on a recurring basis as of December 31, 2024:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions) |
|
Level 1 |
|
Level 2 |
|
Level 3 |
|
Total |
Assets: |
|
|
|
|
|
|
|
|
Money market funds |
|
$ |
1,154 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
1,154 |
|
Foreign currency forward contracts |
|
— |
|
|
118 |
|
|
— |
|
|
118 |
|
Cross-currency swap contracts |
|
— |
|
|
88 |
|
|
— |
|
|
88 |
|
Total |
|
$ |
1,154 |
|
|
$ |
206 |
|
|
$ |
— |
|
|
$ |
1,360 |
|
|
|
|
|
|
|
|
|
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency forward contracts |
|
$ |
— |
|
|
$ |
52 |
|
|
$ |
— |
|
|
$ |
52 |
|
Interest rate contracts |
|
— |
|
|
138 |
|
|
— |
|
|
138 |
|
Cross-currency swap contracts |
|
— |
|
|
8 |
|
|
— |
|
|
8 |
|
Total |
|
$ |
— |
|
|
$ |
198 |
|
|
$ |
— |
|
|
$ |
198 |
|
The following table presents the Company’s hierarchy for its financial assets and liabilities measured at fair value on a recurring basis as of June 30, 2024:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions) |
|
Level 1 |
|
Level 2 |
|
Level 3 |
|
Total |
Assets: |
|
|
|
|
|
|
|
|
Money market funds |
|
$ |
1,507 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
1,507 |
|
Foreign currency forward contracts |
|
— |
|
|
68 |
|
|
— |
|
|
68 |
|
Cross-currency swap contracts |
|
— |
|
|
80 |
|
|
— |
|
|
80 |
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
1,507 |
|
|
$ |
148 |
|
|
$ |
— |
|
|
$ |
1,655 |
|
|
|
|
|
|
|
|
|
|
Liabilities: |
|
|
|
|
|
|
|
|
Foreign currency forward contracts |
|
$ |
— |
|
|
$ |
21 |
|
|
$ |
— |
|
|
$ |
21 |
|
Interest rate contracts |
|
— |
|
|
145 |
|
|
— |
|
|
145 |
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
— |
|
|
$ |
166 |
|
|
$ |
— |
|
|
$ |
166 |
|
The estimated fair values of the Company’s financial instruments are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2024 |
|
June 30, 2024 |
(In millions) |
|
Carrying Amount |
|
Fair Value |
|
Carrying Amount |
|
Fair Value |
Nonderivatives |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
2,586 |
|
|
$ |
2,586 |
|
|
$ |
3,395 |
|
|
$ |
3,395 |
|
Current and long-term debt |
|
7,280 |
|
|
6,636 |
|
|
7,771 |
|
|
7,174 |
|
|
|
|
|
|
|
|
|
|
Deferred consideration payable |
|
341 |
|
|
342 |
|
|
341 |
|
|
340 |
|
|
|
|
|
|
|
|
|
|
Derivatives |
|
|
|
|
|
|
|
|
Foreign currency forward contracts – asset (liability), net |
|
66 |
|
|
66 |
|
|
47 |
|
|
47 |
|
Cross-currency swap contracts - asset (liability), net |
|
80 |
|
|
80 |
|
|
80 |
|
|
80 |
|
Interest rate contracts – liability |
|
(138) |
|
|
(138) |
|
|
(145) |
|
|
(145) |
|
THE ESTÉE LAUDER COMPANIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The following methods and assumptions were used to estimate the fair value of the Company’s financial instruments for which it is practicable to estimate that value:
Cash and cash equivalents – Cash and all highly-liquid securities with original maturities of three months or less are classified as cash and cash equivalents, primarily consisting of cash deposits in interest bearing accounts, time deposits and money market funds (classified within Level 1 of the valuation hierarchy). Cash deposits in interest bearing accounts and time deposits are carried at cost, which approximates fair value, due to the short maturity of cash equivalent instruments.
Foreign currency forward contracts – The fair values of the Company’s foreign currency forward contracts were determined using an industry-standard valuation model, which is based on an income approach. The significant observable inputs to the model, such as swap yield curves and currency spot and forward rates, were obtained from an independent pricing service. To determine the fair value of contracts under the model, the difference between the contract price and the current forward rate was discounted using SOFR forward curves.
Cross-currency swap contracts – The fair values of the Company’s cross-currency swap contracts were determined using an industry-standard valuation model, which is based on the income approach. The significant observable inputs to the model, such as yield curves and currency spot and forward rates, were obtained from independent pricing services.
Interest rate contracts – The fair values of the Company’s interest rate contracts were determined using an industry-standard valuation model, which is based on the income approach. The significant observable inputs to the model, such as treasury yield curves, swap yield curves and SOFR forward curves, were obtained from independent pricing services.
Current and long-term debt – The fair value of the Company’s debt was estimated based on the current rates offered to the Company for debt with the same remaining maturities. To a lesser extent, debt also includes finance lease obligations for which the carrying amount approximates the fair value. The Company’s debt is classified within Level 2 of the valuation hierarchy.
Deferred consideration payable – The deferred consideration payable consists primarily of deferred payments associated with the fiscal 2023 fourth quarter acquisition of TOM FORD. The fair value of the payments treated as deferred consideration payable are calculated based on the net present value of cash payments using an estimated borrowing rate based on quoted prices for a similar liability. The Company’s deferred consideration payable is classified within Level 2 of the valuation hierarchy.
Nonfinancial assets measured at fair value on a nonrecurring basis
In connection with its interim goodwill and other indefinite-lived intangible asset impairment testing, the Company has measured certain nonfinancial assets at fair value on a nonrecurring basis, classified as Level 3 of the fair value hierarchy. Refer to Note 2 – Goodwill and Other Intangible Assets for discussion of the valuation techniques used to measure fair value, the description of the inputs and information used to develop those inputs.
NOTE 6 – REVENUE RECOGNITION
Accounts Receivable
Accounts receivable, net is stated net of the allowance for doubtful accounts, including credit losses, and customer deductions totaling $30 million and $26 million as of December 31, 2024 and June 30, 2024, respectively. Payment terms are short-term in nature and are generally less than one year.
Changes in the allowance for credit losses are as follows:
|
|
|
|
|
|
|
|
|
(In millions) |
|
December 31, 2024 |
Balance at June 30, 2024 |
|
$ |
14 |
|
|
|
|
Provision for expected credit losses |
|
5 |
|
Write-offs, net & other |
|
(1) |
|
Balance at December 31, 2024 |
|
$ |
18 |
|
THE ESTÉE LAUDER COMPANIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The remaining balance of the allowance for doubtful accounts and customer deductions of $12 million as of December 31, 2024 and June 30, 2024, relates to non-credit losses, which are primarily due to customer deductions.
Deferred Revenue
Changes in deferred revenue during the period are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended December 31, |
|
Six Months Ended December 31, |
(In millions) |
|
2024 |
|
2023 |
|
2024 |
|
2023 |
Deferred revenue, beginning of period |
|
$ |
567 |
|
|
$ |
581 |
|
|
$ |
560 |
|
|
$ |
572 |
|
Revenue recognized that was included in the deferred revenue balance at the beginning of the period |
|
(107) |
|
|
(96) |
|
|
(255) |
|
|
(249) |
|
Revenue deferred during the period |
|
104 |
|
|
124 |
|
|
258 |
|
|
293 |
|
Other |
|
(2) |
|
|
1 |
|
|
(1) |
|
|
(6) |
|
Deferred revenue, end of period |
|
$ |
562 |
|
|
$ |
610 |
|
|
$ |
562 |
|
|
$ |
610 |
|
Transaction Price Allocated to the Remaining Performance Obligations
At December 31, 2024, the combined estimated revenue expected to be recognized in the next twelve months related to performance obligations for customer loyalty programs, gift with purchase promotions, purchase with purchase promotions, gift card liabilities and the Marcolin license arrangement related to TOM FORD that are unsatisfied (or partially unsatisfied) is $338 million. The remaining balance of deferred revenue at December 31, 2024 will be recognized beyond the next twelve months, of which $217 million relates to the non-refundable upfront payment received as part of the Marcolin licensing arrangement that is being recognized on a straight-line basis over the estimated economic life of the license, which is 20 years.
Royalty Revenue – License Arrangements
The Company’s contractually guaranteed minimum royalty amounts due during future periods under its existing license arrangements is disclosed in the notes to consolidated financial statements in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2024.
NOTE 7 – PENSION AND POST-RETIREMENT BENEFIT PLANS
The Company maintains pension plans covering substantially all of its full-time employees for its U.S. operations and a majority of its international operations. The Company also maintains post-retirement benefit plans that provide certain medical and dental benefits to eligible employees. Descriptions of these plans are included in the notes to consolidated financial statements in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2024.
The components of net periodic benefit cost for the three months ended December 31, 2024 and 2023 consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pension Plans |
|
Other than Pension Plans |
|
|
U.S. |
|
International |
|
Post-retirement |
(In millions) |
|
2024 |
|
2023 |
|
2024 |
|
2023 |
|
2024 |
|
2023 |
Service cost |
|
$ |
9 |
|
|
$ |
9 |
|
|
$ |
7 |
|
|
$ |
7 |
|
|
$ |
— |
|
|
$ |
1 |
|
Interest cost |
|
12 |
|
|
11 |
|
|
4 |
|
|
4 |
|
|
2 |
|
|
2 |
|
Expected return on plan assets |
|
(12) |
|
|
(13) |
|
|
(6) |
|
|
(6) |
|
|
— |
|
|
— |
|
Amortization of: |
|
|
|
|
|
|
|
|
|
|
|
|
Actuarial loss (gain) |
|
5 |
|
|
1 |
|
|
(2) |
|
|
(2) |
|
|
— |
|
|
— |
|
Prior service cost |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
(1) |
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Special termination benefits |
|
— |
|
|
— |
|
|
1 |
|
|
— |
|
|
— |
|
|
— |
|
Net periodic benefit cost |
|
$ |
14 |
|
|
$ |
8 |
|
|
$ |
4 |
|
|
$ |
3 |
|
|
$ |
1 |
|
|
$ |
3 |
|
THE ESTÉE LAUDER COMPANIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The components of net periodic benefit cost for the six months ended December 31, 2024 and 2023 consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pension Plans |
|
Other than Pension Plans |
|
|
U.S. |
|
International |
|
Post-retirement |
(In millions) |
|
2024 |
|
2023 |
|
2024 |
|
2023 |
|
2024 |
|
2023 |
Service cost |
|
$ |
18 |
|
|
$ |
18 |
|
|
$ |
14 |
|
|
$ |
13 |
|
|
$ |
— |
|
|
$ |
1 |
|
Interest cost |
|
25 |
|
|
23 |
|
|
9 |
|
|
9 |
|
|
4 |
|
|
4 |
|
Expected return on plan assets |
|
(25) |
|
|
(27) |
|
|
(13) |
|
|
(12) |
|
|
— |
|
|
— |
|
Amortization of: |
|
|
|
|
|
|
|
|
|
|
|
|
Actuarial loss (gain) |
|
10 |
|
|
2 |
|
|
(3) |
|
|
(4) |
|
|
— |
|
|
— |
|
Prior service cost |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
(3) |
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Special termination benefits |
|
— |
|
|
— |
|
|
1 |
|
|
— |
|
|
— |
|
|
— |
|
Net periodic benefit cost |
|
$ |
28 |
|
|
$ |
16 |
|
|
$ |
8 |
|
|
$ |
6 |
|
|
$ |
1 |
|
|
$ |
5 |
|
The amounts recognized in the consolidated balance sheets related to the Company’s pension and post-retirement benefit plans consist of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions) |
|
December 31, 2024 |
|
June 30, 2024 |
Other assets |
|
$ |
124 |
|
|
$ |
125 |
|
Other accrued liabilities |
|
(44) |
|
|
(44) |
|
Other noncurrent liabilities |
|
(319) |
|
|
(339) |
|
Funded status |
|
(239) |
|
|
(258) |
|
Accumulated other comprehensive loss |
|
239 |
|
|
243 |
|
Net amount recognized |
|
$ |
— |
|
|
$ |
(15) |
|
NOTE 8 – COMMITMENTS AND CONTINGENCIES
Legal Proceedings
The Company is involved, from time to time, in litigation and other legal proceedings incidental to its business, including product liability matters (including asbestos-related claims), advertising, regulatory, employment, intellectual property, real estate, environmental, trade relations, securities, tax, and privacy. Management believes that the outcome of current litigation and legal proceedings will not have a material adverse effect upon the Company’s business, results of operations, financial condition or cash flows. However, management’s assessment of the Company’s current litigation and other legal proceedings could change in light of the discovery of facts with respect to legal actions or other proceedings pending against the Company not presently known to the Company or determinations by judges, juries or other finders of fact which are not in accord with management’s evaluation of the possible liability or outcome of such litigation or proceedings.
The Company establishes accruals for loss contingencies when it has determined that a loss is probable and that the amount of loss, or range of loss, can be reasonably estimated. Amounts accrued for legal contingencies often result from a complex series of judgments about future events and uncertainties that rely on estimates and assumptions including timing of related payments. Any such accruals are adjusted thereafter as appropriate to reflect changes in circumstances. The Company also determines estimates of reasonably possible losses or ranges of reasonably possible losses in excess of related accrued liabilities, if any, when it has determined that a loss is reasonably possible, and it is able to determine such estimates. Legal defense costs are recognized as incurred when the legal services are provided.
Reasonably possible losses in addition to the amounts accrued for such litigation and legal proceedings are not expected to be material to the Company’s consolidated financial statements (refer below for the Company’s Securities Class Action and Derivative Matters and Cosmetic Talcum Powder Matters and related assessment of these loss contingencies).
THE ESTÉE LAUDER COMPANIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Securities Class Action and Derivative Matters
On December 7, 2023 and January 22, 2024, the Company and its Chief Executive Officer and Chief Financial Officer were named as defendants in separate purported securities class action complaints filed in the United States District Court for the Southern District of New York. On February 20, 2024, those two purported securities class actions were consolidated into one action. On March 22, 2024, plaintiffs filed their consolidated amended class action complaint, which alleges that defendants made materially false and misleading statements during the period February 3, 2022 to October 31, 2023 in press releases, the Company’s public filings and during conference calls with analysts that artificially inflated the price of the Company’s stock in violation of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. Defendants intend to defend the action vigorously.
On February 1, 2024 and March 15, 2024, shareholder derivative action complaints were filed against certain of the Company’s officers, all the Company’s directors as of those dates and certain of the Company’s former directors as of those dates in the United States District Court for the Southern District of New York. In April 2024, both complaints were voluntarily dismissed without prejudice; and, subsequently, one of the former derivative plaintiffs made a litigation demand, requesting, among other things, that the Company's Board of Directors investigate potential claims on behalf of the Company based on the same alleged course of conduct identified in the securities case complaint (which were also reflected in the dismissed shareholder derivative actions complaints) described above. In June 2024, the other former derivative plaintiff made a books and records demand on the Company related to any documents relevant to the same alleged course of conduct referenced above.
As of December 31, 2024, it is not probable or reasonably possible that we will incur material losses as a result of the securities class action and derivative matters.
Cosmetic Talcum Powder Matters
The Company has been named as a defendant in civil actions alleging that certain cosmetic talcum powder products sold by the Company were contaminated with asbestos. Most of these actions involve a number of co-defendants from a variety of different industries. As of December 31, 2024, there were 84 individual cases pending against the Company in state and federal courts throughout the United States, as compared to 273 cases as of June 30, 2024. During the six months ended December 31, 2024, 43 new cases were filed and 232 cases were resolved by settlement or voluntary dismissal (including pursuant to the cases that were settled in the talcum litigation settlement agreements described below).
Due to the rising number of cases against the Company, as well as the evolving litigation landscape, there is an expectation that claims may increase in the future. In order to mitigate our future exposure, from the end of August 2024 through October 2024, the Company reached agreements with certain plaintiff law firms (collectively, the “talcum litigation settlement agreements”) for: (i) the resolution of over 200 pending cosmetic talcum powder matters handled by those firms as well as (ii) a process for resolving potential future cosmetic talcum powder claims expected to be brought on behalf of plaintiffs by those firms from January 1, 2025 through December 31, 2029, with annual capped amounts per year for each participating law firm.
To account for the talcum litigation settlement agreements, the Company recorded a charge of $159 million during the fiscal 2025 first quarter for the amount agreed to settle the current and potential future claims (amounts recorded for potential future claims is based on the best estimate of the probable loss and a reasonably possible loss beyond the amounts recorded is not expected to be material). As of December 31, 2024, $32 million is recorded in Other accrued liabilities and $89 million is recorded in Other noncurrent liabilities in the accompanying consolidated balance sheet related to the talcum litigation settlement agreements (inclusive of accruals recorded prior to the fiscal 2025 first quarter for any cases settled under these agreements).
There are and could be other plaintiff law firms outside of those included in the talcum litigation settlement agreements that bring claims against the Company. The value of other settlements outside of the talcum litigation settlement agreements, either individually or in the aggregate, for the three and six months ended December 31, 2024 and 2023 was not material. Given the inherent uncertainties of litigation, it is not possible to predict the outcome of all individual cases pending against the Company or potential unasserted claims, and therefore a specific estimate and associated provision is made for a small number of individual cases that have advanced to the later stages of legal proceedings. For the remaining filed cases, we record an estimate of exposure loss on an aggregated and ongoing basis, which takes into account the historical outcomes of cases we have resolved to date. Any adverse outcomes, either in an individual case or in the aggregate, could be material. While the Company and its legal counsel intend to continue to defend these cases vigorously, there can be no assurances regarding the ultimate resolution of these matters. The amounts recorded during the three and six months ended December 31, 2024 for such litigation, outside of the talcum litigation settlement agreements, are not material to the Company's consolidated financial statements. The range of reasonably possible losses in excess of accrued liabilities currently cannot be reasonably estimated.
THE ESTÉE LAUDER COMPANIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The Company believes that a portion of its costs incurred in defending and resolving these claims may be covered by insurance policies issued by several insurance carriers, subject to deductibles, exclusions, retentions and policy limits.
NOTE 9 – STOCK PROGRAMS
Additional information relating to the Company's stock programs are included in the notes to consolidated financial statements in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2024.
Total net stock-based compensation expense is attributable to the granting of, and the remaining requisite service periods of stock options, restricted stock units (“RSUs”), performance share units (“PSUs”), long-term PSUs, including long-term price-vested units and share units. Compensation expense attributable to net stock-based compensation was $106 million and $109 million for the three months ended December 31, 2024 and 2023, respectively, and was $180 million and $189 million for the six months ended December 31, 2024 and 2023, respectively.
Stock Options
During the six months ended December 31, 2024, the Company granted stock options in respect of approximately 0.9 million shares of Class A Common Stock with a weighted average exercise price per share of $91.36 and a weighted average grant date fair value per share of $29.26. The fair value of each option grant was estimated on the date of grant using the Black-Scholes option-pricing model.
Restricted Stock Units
During the six months ended December 31, 2024, the Company granted RSUs in respect of approximately 3.2 million shares of Class A Common Stock with a weighted average grant date fair value per share of $92.71 that, at the time of grant, are scheduled to vest at 1.2 million, 1.1 million, and 0.9 million shares per year, in fiscal 2026, fiscal 2027 and fiscal 2028, respectively. Vesting of RSUs is generally subject to the continued employment or the retirement of the grantees. The RSUs are generally accompanied by dividend equivalent rights, payable upon settlement of the RSUs either in cash or shares (based on the terms of the particular award) and, as such, were generally valued at the closing market price of the Company’s Class A Common Stock on the date of grant.
Performance Share Units
During the six months ended December 31, 2024, the Company granted PSUs with a target payout of approximately 0.3 million shares of Class A Common Stock with a grant date fair value per share of $92.87, which will be settled in stock subject to the achievement of the Company’s net sales, diluted net earnings per common share and return on invested capital goals for the three fiscal years ending June 30, 2027, all subject to continued employment or the retirement of the grantees. For PSUs granted, no settlement will occur for results below the applicable minimum threshold. PSUs are accompanied by dividend equivalent rights that will be payable in cash upon settlement of the PSUs and, as such, were valued at the closing market value of the Company’s Class A Common Stock on the date of grant.
For the PSUs with a performance period ended June 30, 2024, the target goals set at the time of issuance were not achieved, resulting in no shares of the Company’s Class A Common Stock issued related to these awards.
Long-term Performance Share Units
On September 3, 2024, the Company issued 195,940 shares of the Company’s Class A Common Stock to its then Chief Executive Officer in accordance with the terms of PSUs granted in February 2018. The total fair value of PSUs issued during the fiscal 2025 first quarter was $18 million.
THE ESTÉE LAUDER COMPANIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
NOTE 10 – NET EARNINGS (LOSS) ATTRIBUTABLE TO THE ESTÉE LAUDER COMPANIES INC. PER COMMON SHARE
Net earnings (loss) attributable to The Estée Lauder Companies Inc. per common share (“basic EPS”) is computed by dividing net earnings (loss) attributable to The Estée Lauder Companies Inc. by the weighted average number of common shares outstanding and shares underlying PSUs and RSUs where the vesting conditions have been met. Net earnings (loss) attributable to The Estée Lauder Companies Inc. per common share assuming dilution (“diluted EPS”) is computed by reflecting potential dilution from stock-based awards using the treasury stock method.
A reconciliation between the numerator and denominator of the basic and diluted EPS computations is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended December 31, |
|
Six Months Ended December 31, |
(In millions, except per share data) |
|
|
|
|
|
2024 |
|
2023 |
|
2024 |
|
2023 |
Numerator: |
|
|
|
|
|
|
|
|
|
|
|
|
Net earnings (loss) attributable to The Estée Lauder Companies Inc. |
|
|
|
|
|
$ |
(590) |
|
|
$ |
313 |
|
|
$ |
(746) |
|
|
$ |
344 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Denominator: |
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares outstanding – Basic |
|
|
|
|
|
360.0 |
|
|
358.7 |
|
|
359.8 |
|
|
358.6 |
|
Effect of dilutive stock options(1) |
|
|
|
|
|
— |
|
0.7 |
|
— |
|
1.0 |
Effect of PSUs(1) |
|
|
|
|
|
— |
|
0.1 |
|
— |
|
0.1 |
Effect of RSUs(1) |
|
|
|
|
|
— |
|
0.5 |
|
— |
|
0.6 |
Weighted average common shares outstanding – Diluted |
|
|
|
|
|
360.0 |
|
|
360.0 |
|
|
359.8 |
|
|
360.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net earnings (loss) attributable to The Estée Lauder Companies Inc. per common share: |
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
|
|
|
|
$ |
(1.64) |
|
|
$ |
.87 |
|
|
$ |
(2.07) |
|
|
$ |
.96 |
|
Diluted |
|
|
|
|
|
$ |
(1.64) |
|
|
$ |
.87 |
|
|
$ |
(2.07) |
|
|
$ |
.95 |
|
(1)For the three and six months ended December 31, 2024, the effects of potentially dilutive stock options, PSUs and RSUs were excluded from the computation of diluted EPS as they were anti-dilutive due to the net loss incurred during the period.
The shares of Class A Common Stock underlying stock options, RSUs and PSUs that were excluded in the computation of diluted EPS because their inclusion would be anti-dilutive were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
December 31,
|
|
|
Six Months Ended
December 31,
|
(In millions) |
2024 |
|
2023 |
|
|
2024 |
|
2023 |
Stock options |
8.5 |
|
6.6 |
|
|
8.1 |
|
5.7 |
RSUs and PSUs |
2.9 |
|
1.3 |
|
|
2.1 |
|
0.7 |
|
|
|
|
|
|
|
|
|
As of December 31, 2024 and 2023, 0.6 million and 0.4 million shares, respectively, of Class A Common Stock underlying PSUs have been excluded from the computation of diluted EPS as the number of shares ultimately issued is contingent on the achievement of applicable performance targets of the Company, as discussed in Note 9 – Stock Programs.
THE ESTÉE LAUDER COMPANIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
NOTE 11 – EQUITY AND REDEEMABLE NONCONTROLLING INTEREST
Total Stockholders’ Equity – The Estée Lauder Companies Inc.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended December 31, |
|
|
|
Six Months Ended December 31, |
(In millions, except per share data) |
|
2024 |
|
2023 |
|
|
|
|
|
2024 |
|
2023 |
Common stock, beginning of the period |
|
$ |
6 |
|
|
$ |
6 |
|
|
|
|
|
|
$ |
6 |
|
|
$ |
6 |
|
Stock-based compensation |
|
— |
|
|
— |
|
|
|
|
|
|
— |
|
|
— |
|
Common stock, end of the period |
|
6 |
|
|
6 |
|
|
|
|
|
|
6 |
|
|
6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Paid-in capital, beginning of the period |
|
6,778 |
|
|
6,249 |
|
|
|
|
|
|
6,685 |
|
|
6,153 |
|
Common stock dividends |
|
1 |
|
|
1 |
|
|
|
|
|
|
4 |
|
|
3 |
|
Stock-based compensation |
|
110 |
|
|
117 |
|
|
|
|
|
|
200 |
|
|
211 |
|
Paid-in capital, end of the period |
|
6,889 |
|
|
6,367 |
|
|
|
|
|
|
6,889 |
|
|
6,367 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Retained earnings, beginning of the period |
|
13,031 |
|
|
13,784 |
|
|
|
|
|
|
13,427 |
|
|
13,991 |
|
Common stock dividends |
|
(128) |
|
|
(239) |
|
|
|
|
|
|
(368) |
|
|
(477) |
|
Net earnings (loss) attributable to The Estée Lauder Companies Inc. |
|
(590) |
|
|
313 |
|
|
|
|
|
|
(746) |
|
|
344 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Retained earnings, end of the period |
|
12,313 |
|
|
13,858 |
|
|
|
|
|
|
12,313 |
|
|
13,858 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated other comprehensive loss, beginning of the period |
|
(1,057) |
|
|
(1,063) |
|
|
|
|
|
|
(1,140) |
|
|
(934) |
|
Other comprehensive earnings (loss) attributable to The Estée Lauder Companies Inc. |
|
(284) |
|
|
207 |
|
|
|
|
|
|
(201) |
|
|
78 |
|
Accumulated other comprehensive loss, end of the period |
|
(1,341) |
|
|
(856) |
|
|
|
|
|
|
(1,341) |
|
|
(856) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Treasury stock, beginning of the period |
|
(13,674) |
|
|
(13,634) |
|
|
|
|
|
|
(13,664) |
|
|
(13,631) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation |
|
(24) |
|
|
(29) |
|
|
|
|
|
|
(34) |
|
|
(32) |
|
Treasury stock, end of the period |
|
(13,698) |
|
|
(13,663) |
|
|
|
|
|
|
(13,698) |
|
|
(13,663) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total equity |
|
$ |
4,169 |
|
|
$ |
5,712 |
|
|
|
|
|
|
$ |
4,169 |
|
|
$ |
5,712 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Redeemable noncontrolling interest, beginning of the period |
|
$ |
— |
|
|
$ |
826 |
|
|
|
|
|
|
$ |
— |
|
|
$ |
832 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net earnings attributable to redeemable noncontrolling interest |
|
— |
|
|
11 |
|
|
|
|
|
|
— |
|
|
16 |
|
Translation adjustments |
|
— |
|
|
13 |
|
|
|
|
|
|
— |
|
|
2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Redeemable noncontrolling interest, end of the period |
|
$ |
— |
|
|
$ |
850 |
|
|
|
|
|
|
$ |
— |
|
|
$ |
850 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash dividends declared per common share |
|
$ |
.35 |
|
|
$ |
.66 |
|
|
|
|
|
|
$ |
1.01 |
|
|
$ |
1.32 |
|
THE ESTÉE LAUDER COMPANIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The following is a summary of quarterly cash dividends declared per share on the Company’s Class A and Class B Common Stock during the six months ended December 31, 2024:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Date Declared |
|
Record Date |
|
Payable Date |
|
Amount per Share |
August 16, 2024 |
|
August 30, 2024 |
|
September 16, 2024 |
|
$ |
.66 |
|
October 30, 2024 |
|
November 29, 2024 |
|
December 16, 2024 |
|
$ |
.35 |
|
|
|
|
|
|
|
|
On February 3, 2025, a dividend was declared in the amount of $.35 per share on the Company’s Class A and Class B Common Stock. The dividend is payable in cash on March 17, 2025 to stockholders of record at the close of business on February 28, 2025.
Common Stock
Beginning in December 2022, we suspended the repurchase of shares of our Class A Common Stock under our publicly announced program. We may resume repurchases in the future.
Accumulated Other Comprehensive Loss
The following table represents changes in accumulated other comprehensive loss, net of tax, by component for the six months ended December 31, 2024:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions) |
|
Net Cash Flow Hedge Gain (Loss) |
|
Cross-Currency Swap Contracts - Fair Value Hedge(2) |
|
Amounts Included in Net Periodic Benefit Cost |
|
Translation Adjustments |
|
Total |
Balance at June 30, 2024 |
|
$ |
57 |
|
|
$ |
(5) |
|
|
$ |
(183) |
|
|
$ |
(1,009) |
|
|
$ |
(1,140) |
|
OCI before reclassifications (3) |
|
18 |
|
|
12 |
|
|
— |
|
|
(208) |
|
(1) |
(178) |
|
Amounts reclassified to Net loss |
|
(19) |
|
|
(7) |
|
|
3 |
|
|
— |
|
|
(23) |
|
Net current-period OCI |
|
(1) |
|
|
5 |
|
|
3 |
|
|
(208) |
|
|
(201) |
|
Balance at December 31, 2024 |
|
$ |
56 |
|
|
$ |
— |
|
|
$ |
(180) |
|
|
$ |
(1,217) |
|
|
$ |
(1,341) |
|
|
|
|
|
|
|
|
|
|
|
|
(1)See Note 4 – Derivative Financial Instruments for gains (losses) relating to net investment hedges.
(2)The gain recognized in AOCI, net of tax from cross-currency swap contracts represents the amount excluded from effectiveness testing.
(3)The tax provision included in Net Cash Flow Hedge Gain (Loss), Cross-Currency Swap Contracts - Fair Value Hedge and Translation Adjustments are $5 million, $4 million, and $7 million, respectively.
THE ESTÉE LAUDER COMPANIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The following table represents the effects of reclassification adjustments from AOCI into net earnings (loss) for the three and six months ended December 31, 2024 and 2023:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amount Reclassified from AOCI |
|
|
|
|
|
Affected Line Item in Consolidated Statements of Earnings (Loss) |
|
|
Three Months Ended December 31, |
|
Six Months Ended December 31, |
|
|
|
(In millions) |
|
2024 |
|
2023 |
|
2024 |
|
2023 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gain on Cash Flow Hedges |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency forward contracts |
|
$ |
14 |
|
|
$ |
12 |
|
|
$ |
24 |
|
|
$ |
21 |
|
|
|
|
|
|
Net sales |
Interest rate contracts |
|
1 |
|
|
(1) |
|
|
1 |
|
|
(1) |
|
|
|
|
|
|
Interest expense |
Total gain on cash flow hedges, before tax |
|
15 |
|
|
11 |
|
|
25 |
|
|
20 |
|
|
|
|
|
|
|
Provision for income taxes |
|
(3) |
|
|
(2) |
|
|
(6) |
|
|
(4) |
|
|
|
|
|
|
Provision (benefit) for income taxes |
Total gain on cash flow hedges, net of tax |
|
12 |
|
|
9 |
|
|
19 |
|
|
16 |
|
|
|
|
|
|
Net earnings (loss) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cross-Currency Swap Contracts - Fair Value Hedge |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gain on cross-currency swap contracts, before tax |
|
5 |
|
|
4 |
|
|
9 |
|
|
9 |
|
|
|
|
|
|
Selling, general and administrative |
Provision for income taxes |
|
(1) |
|
|
(1) |
|
|
(2) |
|
|
(2) |
|
|
|
|
|
|
Provision (benefit) for income taxes |
Total gain on cross-currency swap contracts - fair value hedge, net of tax |
|
4 |
|
|
3 |
|
|
7 |
|
|
7 |
|
|
|
|
|
|
Net earnings (loss) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Retirement Plan and Other Retiree Benefit Adjustments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortization of prior service cost |
|
1 |
|
|
— |
|
|
3 |
|
|
— |
|
|
|
|
|
|
Other components of net periodic benefit cost |
Amortization of actuarial gain (loss) |
|
(3) |
|
|
1 |
|
|
(7) |
|
|
2 |
|
|
|
|
|
|
Other components of net periodic benefit cost |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total retirement plan and other retiree benefit adjustments, before tax |
|
(2) |
|
|
1 |
|
|
(4) |
|
|
2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Benefit (provision) for income taxes |
|
1 |
|
|
(1) |
|
|
1 |
|
|
(1) |
|
|
|
|
|
|
Provision (benefit) for income taxes |
Total retirement plan and other retiree benefit adjustments, net of tax |
|
(1) |
|
|
— |
|
|
(3) |
|
|
1 |
|
|
|
|
|
|
Net earnings (loss) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total reclassification adjustments, net of tax |
|
$ |
15 |
|
|
$ |
12 |
|
|
$ |
23 |
|
|
$ |
24 |
|
|
|
|
|
|
Net earnings (loss) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
THE ESTÉE LAUDER COMPANIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
NOTE 12 – STATEMENT OF CASH FLOWS
Supplemental cash flow information for the six months ended December 31, 2024 and 2023 is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions) |
|
2024 |
|
2023 |
Cash: |
|
|
|
|
Cash paid during the period for interest |
|
$ |
179 |
|
|
$ |
188 |
|
Cash paid during the period for income taxes |
|
$ |
327 |
|
|
$ |
263 |
|
|
|
|
|
|
Non-cash investing and financing activities: |
|
|
|
|
|
|
|
|
|
Property, plant and equipment accrued but unpaid |
|
$ |
24 |
|
|
$ |
41 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Right-of-use assets obtained in exchange for new/modified operating lease liabilities |
|
$ |
311 |
|
|
$ |
210 |
|
NOTE 13 – SEGMENT DATA AND RELATED INFORMATION
Reportable operating segments include components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker (the “Chief Executive”) in deciding how to allocate resources and in assessing performance. Although the Company operates in one business segment, beauty products, management also evaluates performance on a product category basis. Product category performance is measured based upon net sales before returns associated with restructuring and other activities, and operating income (loss) before charges associated with restructuring and other activities. Returns and charges associated with restructuring and other activities are not allocated to the Company's product categories or geographic regions because they are centrally directed and controlled, are not included in internal measures of product category or geographic region performance, and result from activities that are deemed Company-wide initiatives to redesign, resize and reorganize select areas of the business.
The accounting policies for the Company’s reportable segments are substantially the same as those for the consolidated financial statements, as described in the notes to consolidated financial statements in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2024. The assets and liabilities of the Company are managed centrally and are reported internally in the same manner as the consolidated financial statements; thus, no additional information is produced for the Chief Executive or included herein. There has been no significant variance in the total or long-lived asset values associated with the Company’s segment data since June 30, 2024.
THE ESTÉE LAUDER COMPANIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended December 31, |
|
|
|
Six Months Ended December 31, |
(In millions) |
|
2024 |
|
2023 |
|
|
|
|
|
2024 |
|
2023 |
PRODUCT CATEGORY DATA |
|
|
|
|
|
|
|
|
|
|
|
|
Net sales: |
|
|
|
|
|
|
|
|
|
|
|
|
Skin Care |
|
$ |
1,921 |
|
|
$ |
2,173 |
|
|
|
|
|
|
$ |
3,450 |
|
|
$ |
3,813 |
|
Makeup |
|
1,150 |
|
|
1,167 |
|
|
|
|
|
|
2,188 |
|
|
2,229 |
|
Fragrance |
|
744 |
|
|
737 |
|
|
|
|
|
|
1,374 |
|
|
1,373 |
|
Hair Care |
|
159 |
|
|
173 |
|
|
|
|
|
|
298 |
|
|
321 |
|
Other |
|
30 |
|
|
30 |
|
|
|
|
|
|
55 |
|
|
62 |
|
|
|
4,004 |
|
|
4,280 |
|
|
|
|
|
|
7,365 |
|
|
7,798 |
|
Returns associated with restructuring and other activities |
|
— |
|
|
(1) |
|
|
|
|
|
|
— |
|
|
(1) |
|
Net sales |
|
$ |
4,004 |
|
|
$ |
4,279 |
|
|
|
|
|
|
$ |
7,365 |
|
|
$ |
7,797 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income (loss) before charges associated with restructuring and other activities: |
|
|
|
|
|
|
|
|
|
|
|
|
Skin Care |
|
$ |
306 |
|
|
$ |
415 |
|
|
|
|
|
|
$ |
423 |
|
|
$ |
452 |
|
Makeup |
|
(211) |
|
|
30 |
|
|
|
|
|
|
(396) |
|
|
(10) |
|
Fragrance |
|
(446) |
|
|
131 |
|
|
|
|
|
|
(386) |
|
|
238 |
|
Hair Care |
|
(3) |
|
|
(3) |
|
|
|
|
|
|
(21) |
|
|
(25) |
|
Other |
|
(45) |
|
|
9 |
|
|
|
|
|
|
(34) |
|
|
27 |
|
|
|
(399) |
|
|
582 |
|
|
|
|
|
|
(414) |
|
|
682 |
|
Reconciliation: |
|
|
|
|
|
|
|
|
|
|
|
|
Charges associated with restructuring and other activities |
|
(181) |
|
|
(8) |
|
|
|
|
|
|
(287) |
|
|
(10) |
|
Interest expense |
|
(90) |
|
|
(98) |
|
|
|
|
|
|
(182) |
|
|
(193) |
|
Interest income and investment income, net |
|
23 |
|
|
40 |
|
|
|
|
|
|
58 |
|
|
81 |
|
Other components of net periodic benefit cost |
|
(3) |
|
|
3 |
|
|
|
|
|
|
(5) |
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings (loss) before income taxes |
|
$ |
(650) |
|
|
$ |
519 |
|
|
|
|
|
|
$ |
(830) |
|
|
$ |
565 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GEOGRAPHIC DATA(1) |
|
|
|
|
|
|
|
|
|
|
|
|
Net sales: |
|
|
|
|
|
|
|
|
|
|
|
|
The Americas |
|
$ |
1,223 |
|
|
$ |
1,242 |
|
|
|
|
|
|
$ |
2,410 |
|
|
$ |
2,450 |
|
Europe, the Middle East & Africa |
|
1,494 |
|
|
1,589 |
|
|
|
|
|
|
2,724 |
|
|
2,841 |
|
Asia/Pacific |
|
1,287 |
|
|
1,449 |
|
|
|
|
|
|
2,231 |
|
|
2,507 |
|
|
|
4,004 |
|
|
4,280 |
|
|
|
|
|
|
7,365 |
|
|
7,798 |
|
Returns associated with restructuring and other activities |
|
— |
|
|
(1) |
|
|
|
|
|
|
— |
|
|
(1) |
|
Net sales |
|
$ |
4,004 |
|
|
$ |
4,279 |
|
|
|
|
|
|
$ |
7,365 |
|
|
$ |
7,797 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income (loss): |
|
|
|
|
|
|
|
|
|
|
|
|
The Americas |
|
$ |
(823) |
|
|
$ |
(55) |
|
|
|
|
|
|
$ |
(991) |
|
|
$ |
(237) |
|
Europe, the Middle East & Africa |
|
316 |
|
|
379 |
|
|
|
|
|
|
406 |
|
|
523 |
|
Asia/Pacific |
|
108 |
|
|
258 |
|
|
|
|
|
|
171 |
|
|
396 |
|
|
|
(399) |
|
|
582 |
|
|
|
|
|
|
(414) |
|
|
682 |
|
Charges associated with restructuring and other activities |
|
(181) |
|
|
(8) |
|
|
|
|
|
|
(287) |
|
|
(10) |
|
Operating income (loss) |
|
$ |
(580) |
|
|
$ |
574 |
|
|
|
|
|
|
$ |
(701) |
|
|
$ |
672 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) The net sales from the Company's travel retail business are included in the Europe, the Middle East & Africa region, and operating income attributable to these net sales are included in that region and in The Americas. The exception is for net sales and operating income of Dr.Jart+ in the travel retail channel in Korea that are reflected in Korea in the Asia/Pacific region. During the fiscal 2025 second quarter, the Company exited Dr.Jart+ from the travel retail channel in Korea.
THE ESTÉE LAUDER COMPANIES INC.
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
RESULTS OF OPERATIONS
We manufacture, market and sell beauty products including those in the skin care, makeup, fragrance and hair care categories, which are distributed in approximately 150 countries and territories. The following table is a comparative summary of operating results for the three and six months ended December 31, 2024 and 2023, and reflects the basis of presentation described in Notes to Consolidated Financial Statements, Note 1 – Summary of Significant Accounting Policies for all periods presented. Products and services that do not meet our definition of skin care, makeup, fragrance and hair care have been included in the “other” category.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended December 31, |
|
Six Months Ended December 31, |
|
|
(In millions) |
|
2024 |
|
2023 |
|
2024 |
|
2023 |
|
|
|
|
NET SALES |
|
|
|
|
|
|
|
|
|
|
|
|
By Product Category: |
|
|
|
|
|
|
|
|
|
|
|
|
Skin Care |
|
$ |
1,921 |
|
|
$ |
2,173 |
|
|
$ |
3,450 |
|
|
$ |
3,813 |
|
|
|
|
|
Makeup |
|
1,150 |
|
|
1,167 |
|
|
2,188 |
|
|
2,229 |
|
|
|
|
|
Fragrance |
|
744 |
|
|
737 |
|
|
1,374 |
|
|
1,373 |
|
|
|
|
|
Hair Care |
|
159 |
|
|
173 |
|
|
298 |
|
|
321 |
|
|
|
|
|
Other |
|
30 |
|
|
30 |
|
|
55 |
|
|
62 |
|
|
|
|
|
|
|
4,004 |
|
|
4,280 |
|
|
7,365 |
|
|
7,798 |
|
|
|
|
|
Returns associated with restructuring and other activities |
|
— |
|
|
(1) |
|
|
— |
|
|
(1) |
|
|
|
|
|
Net sales |
|
$ |
4,004 |
|
|
$ |
4,279 |
|
|
$ |
7,365 |
|
|
$ |
7,797 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By Region(1): |
|
|
|
|
|
|
|
|
|
|
|
|
The Americas |
|
$ |
1,223 |
|
|
$ |
1,242 |
|
|
$ |
2,410 |
|
|
$ |
2,450 |
|
|
|
|
|
Europe, the Middle East & Africa |
|
1,494 |
|
|
1,589 |
|
|
2,724 |
|
|
2,841 |
|
|
|
|
|
Asia/Pacific |
|
1,287 |
|
|
1,449 |
|
|
2,231 |
|
|
2,507 |
|
|
|
|
|
|
|
4,004 |
|
|
4,280 |
|
|
7,365 |
|
|
7,798 |
|
|
|
|
|
Returns associated with restructuring and other activities |
|
— |
|
|
(1) |
|
|
— |
|
|
(1) |
|
|
|
|
|
Net sales |
|
$ |
4,004 |
|
|
$ |
4,279 |
|
|
$ |
7,365 |
|
|
$ |
7,797 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OPERATING INCOME (LOSS) |
|
|
|
|
|
|
|
|
|
|
|
|
By Product Category: |
|
|
|
|
|
|
|
|
|
|
|
|
Skin Care |
|
$ |
306 |
|
|
$ |
415 |
|
|
$ |
423 |
|
|
$ |
452 |
|
|
|
|
|
Makeup |
|
(211) |
|
|
30 |
|
|
(396) |
|
|
(10) |
|
|
|
|
|
Fragrance |
|
(446) |
|
|
131 |
|
|
(386) |
|
|
238 |
|
|
|
|
|
Hair Care |
|
(3) |
|
|
(3) |
|
|
(21) |
|
|
(25) |
|
|
|
|
|
Other |
|
(45) |
|
|
9 |
|
|
(34) |
|
|
27 |
|
|
|
|
|
|
|
(399) |
|
|
582 |
|
|
(414) |
|
|
682 |
|
|
|
|
|
Charges associated with restructuring and other activities |
|
(181) |
|
|
(8) |
|
|
(287) |
|
|
(10) |
|
|
|
|
|
Operating income (loss) |
|
$ |
(580) |
|
|
$ |
574 |
|
|
$ |
(701) |
|
|
$ |
672 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By Region(1): |
|
|
|
|
|
|
|
|
|
|
|
|
The Americas |
|
$ |
(823) |
|
|
$ |
(55) |
|
|
$ |
(991) |
|
|
$ |
(237) |
|
|
|
|
|
Europe, the Middle East & Africa |
|
316 |
|
|
379 |
|
|
406 |
|
|
523 |
|
|
|
|
|
Asia/Pacific |
|
108 |
|
|
258 |
|
|
171 |
|
|
396 |
|
|
|
|
|
|
|
(399) |
|
|
582 |
|
|
(414) |
|
|
682 |
|
|
|
|
|
Charges associated with restructuring and other activities |
|
(181) |
|
|
(8) |
|
|
(287) |
|
|
(10) |
|
|
|
|
|
Operating income (loss) |
|
$ |
(580) |
|
|
$ |
574 |
|
|
$ |
(701) |
|
|
$ |
672 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) The net sales from the Company's travel retail business are included in the Europe, the Middle East & Africa region, and operating income attributable to these net sales are included in that region and in The Americas. The exception is for net sales and operating income of Dr.Jart+ in the travel retail channel in Korea that are reflected in Korea in the Asia/Pacific region. During the fiscal 2025 second quarter, the Company exited Dr.Jart+ from the travel retail channel in Korea.
THE ESTÉE LAUDER COMPANIES INC.
The following table presents certain consolidated earnings (loss) data as a percentage of net sales:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended December 31, |
|
Six Months Ended December 31, |
|
|
|
|
2024 |
|
2023 |
|
2024 |
|
2023 |
|
|
|
|
Net sales |
|
100.0 |
% |
|
100.0 |
% |
|
100.0 |
% |
|
100.0 |
% |
|
|
|
|
Cost of sales |
|
23.9 |
|
|
27.0 |
|
|
25.6 |
|
|
28.5 |
|
|
|
|
|
Gross profit |
|
76.1 |
|
|
73.0 |
|
|
74.4 |
|
|
71.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative |
|
64.6 |
|
|
59.5 |
|
|
66.3 |
|
|
62.8 |
|
|
|
|
|
Restructuring and other charges |
|
4.5 |
|
|
0.2 |
|
|
3.8 |
|
|
0.1 |
|
|
|
|
|
Impairment of goodwill and other intangible assets |
|
21.5 |
|
|
— |
|
|
11.7 |
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Talcum litigation settlement agreements |
|
— |
|
|
— |
|
|
2.2 |
|
|
— |
|
|
|
|
|
Total operating expenses |
|
90.6 |
|
|
59.6 |
|
|
83.9 |
|
|
62.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income (loss) |
|
(14.5) |
|
|
13.4 |
|
|
(9.5) |
|
|
8.6 |
|
|
|
|
|
Interest expense |
|
2.2 |
|
|
2.3 |
|
|
2.5 |
|
|
2.5 |
|
|
|
|
|
Interest income and investment income, net |
|
0.6 |
|
|
0.9 |
|
|
0.8 |
|
|
1.0 |
|
|
|
|
|
Other components of net periodic benefit cost |
|
0.1 |
|
|
(0.1) |
|
|
0.1 |
|
|
(0.1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings (loss) before income taxes |
|
(16.2) |
|
|
12.1 |
|
|
(11.3) |
|
|
7.2 |
|
|
|
|
|
Provision (benefit) for income taxes |
|
(1.5) |
|
|
4.6 |
|
|
(1.1) |
|
|
2.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net earnings (loss) |
|
(14.7) |
|
|
7.6 |
|
|
(10.1) |
|
|
4.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net earnings attributable to redeemable noncontrolling interest |
|
— |
|
|
(0.3) |
|
|
— |
|
|
(0.2) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net earnings (loss) attributable to The Estée Lauder Companies Inc. |
|
(14.7) |
% |
|
7.3 |
% |
|
(10.1) |
% |
|
4.4 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Not adjusted for differences caused by rounding
Period-over-period changes in our net sales are generally attributable to the impacts from (i) pricing on our base portfolio, including changes in mix and those due to strategic pricing actions, (ii) volume, including changes driven by the impact of new product innovation, (iii) acquisitions and/or divestitures, and/or (iv) foreign currency translation. The percentages disclosed for these impacts are calculated on an individual basis.
The net sales impact from pricing consists of changes in list prices, due to strategic pricing actions, and mix shifts within and among product categories, geographic regions, brands and distribution channels. The prices at which we sell our products vary by brand, distribution channel (e.g., wholesale or direct-to-consumer) and may also vary by country. Our brands and products cover a broad array of pricing tiers. Prices of skin care and fragrance products are typically higher than makeup and hair care products.
THE ESTÉE LAUDER COMPANIES INC.
New product innovation includes the introduction of new products, as well as changes related to existing products or where they are sold, including reformulations, regional expansion, repackaging and sets. A product is considered "new innovation" for the twelve-month period following the initial shipment date. Our innovation is launched at different price points than existing products and value derived from innovation may vary from year-to-year. We continually introduce new products, support new and established products through advertising, merchandising and sampling and phase out existing products that no longer meet the needs of our consumers or our objectives. The economics of developing, producing, launching, supporting and discontinuing products impact our sales and operating performance each period. The introduction of new products often has some cannibalizing effect on sales of existing products, which we take into account in our business planning. The impact of new product introductions, including timing compared to introductions in prior periods, also affects our results.
Non-GAAP Financial Measures
We use certain non-GAAP financial measures, among other financial measures, to evaluate our operating performance, which represent the manner in which we conduct and view our business. Management believes that excluding certain items that are not comparable from period-to-period helps investors and others compare operating performance between periods. While we consider the non-GAAP measures useful in analyzing our results, they are not intended to replace, or act as a substitute for, any presentation included in the consolidated financial statements prepared in conformity with U.S. GAAP. See Reconciliations of Non-GAAP Financial Measures beginning on page 57 for reconciliations between non-GAAP financial measures and the most directly comparable U.S. GAAP measures.
We operate on a global basis, with the majority of our net sales generated outside the United States. Accordingly, fluctuations in foreign currency exchange rates affect our results of operations. Therefore, we present certain net sales, operating results and diluted net earnings per common share information excluding the effect of foreign currency rate fluctuations to provide a framework for assessing the performance of our underlying business outside the United States. Constant currency information compares results between periods as if exchange rates had remained constant period-over-period. We calculate constant currency information by translating current-period results using monthly average foreign currency exchange rates and adjusting for the period-over-period impact of foreign currency cash flow hedging activities.
Overview
We are a leader in prestige beauty, which combines the repeat purchase and relative affordability of consumer goods with high quality products and services. Within prestige beauty, we are diversified by product category, geography, brand, product sub-category, channel, consumer segment and price point. We also leverage consumer analytics and insights by deploying our brands to grow sales and pursue profitable opportunities. These analytics and insights, combined with our creativity, inform our innovation to provide a broad, locally-relevant and inclusive range of prestige products with the aim of competing effectively for a greater share of a consumer's beauty routine. Elements of our strategy are described below, as well as in the Overview on page 31 of our Annual Report on Form 10-K for the year ended June 30, 2024.
•Our skin care net sales decreased 12% for the three months ended December 31, 2024, primarily driven by lower net sales from Estée Lauder and La Mer. The decrease in net sales from Estée Lauder for the three months ended December 31, 2024 was primarily driven by declines in mainland China, as well as, to a lesser extent, declines in net sales in our Asia travel retail business and in Hong Kong SAR, reflecting the overall challenging retail environments, including ongoing pressure from subdued sentiment from Chinese consumers. Net sales from La Mer decreased, primarily driven by the aforementioned overall challenging retail environment within our Asia travel retail business.
•Our makeup net sales decreased 1% for the three months ended December 31, 2024, primarily reflecting lower net sales from M·A·C, TOM FORD, Smashbox and Bobbi Brown. The decrease in net sales from M·A·C was primarily driven by lower net sales in the eye and face subcategories. Net sales from TOM FORD decreased, primarily driven by lower net sales in mainland China and our Asia travel retail business, reflecting the overall challenging retail environments, including ongoing pressure from subdued sentiment from Chinese consumers, as well as lower net sales in Hong Kong SAR, driven by the eye subcategory. Net sales from Smashbox decreased, primarily driven by North America, reflecting lower net sales in the face subcategory. The decrease in net sales from Bobbi Brown was driven by lower net sales in the lip subcategory. Partially offsetting the decrease in makeup net sales were higher net sales from Clinique in all geographic regions, led by North America, reflecting the launch in Amazon's U.S. Premium Beauty store, as well as the success of hero products, and higher net sales from Estée Lauder, driven by growth in the face subcategory.
THE ESTÉE LAUDER COMPANIES INC.
•Our fragrance net sales increased 1% for the three months ended December 31, 2024, reflecting higher net sales from Le Labo, and to a lesser extent, Editions de Parfums Frédéric Malle. Net sales from Le Labo increased, primarily reflecting growth of hero products, targeted expanded consumer reach and new product launches. The increase in net sales from Editions de Parfums Frédéric Malle reflected growth across the product portfolio as well as targeted expanded consumer reach. Offsetting the reported fragrance net sales increase were lower net sales from Estée Lauder, Clinique and TOM FORD. Net sales from Estée Lauder decreased, primarily driven by lower net sales across its fragrance portfolio. The decrease in net sales from Clinique was primarily due to lower net sales from the Clinique Happy franchise line of products. Net sales from TOM FORD decreased, primarily driven by lower net sales in North America, reflecting softness in the brand's retail sales, resulting in lower replenishment orders, as well as the overall challenging retail environments in mainland China and Hong Kong SAR, including ongoing pressure from subdued sentiment from Chinese consumers.
•Our hair care net sales decreased 8% for the three months ended December 31, 2024, primarily attributable to lower net sales from Aveda, reflecting our softness in the North America and Europe, the Middle East & Africa salon channels, softness in our direct-to-consumer business, as well as the unfavorable impact of timing of shipments compared to the prior-year period.
Our global distribution capability and operations allow us to focus on targeted expanded consumer reach wherever consumer demographics and trends are attractive. Our regional organizations, and the expertise of our people there, enable our brands to be more locally and culturally relevant in both product assortment and communications. We are continually evolving the way we connect with our consumers in stores, online and where they travel, including by expanding our digital and social media presence and the engagement of global and local influencers to amplify brand or product stories. We tailor implementation of our strategy by market to drive consumer engagement, recruitment and loyalty. We strive to strengthen our presence in large, image-building core markets, while broadening our presence in emerging markets.
•Net sales in The Americas decreased 2% for the three months ended December 31, 2024, primarily reflecting lower net sales in North America and to Latin America distributors. Net sales in North America decreased, reflecting softness in our retail sales, including challenges with our distribution mix, skewed towards slower-growing channels. These challenges were largely offset by the launch of nine brands to-date in Amazon's U.S. Premium Beauty store. Net sales to Latin America distributors decreased, due in part, to lower net sales in fragrance, driven by Estée Lauder.
•Net sales in Europe, the Middle East & Africa decreased 6% for the three months ended December 31, 2024, primarily driven by lower net sales in our Asia travel retail business, reflecting the impacts from an overall challenging retail environment, including ongoing pressure from subdued sentiment from Chinese consumers.
•Net sales in Asia/Pacific decreased 11% for the three months ended December 31, 2024, primarily driven by lower net sales from mainland China, Korea, and Hong Kong SAR, reflecting the impacts from the overall challenging retail environments, including subdued consumer sentiment. The net sales decline in Korea also reflects the exit of Dr.Jart+ from the travel retail channel in Korea during the fiscal 2025 second quarter.
Outlook
We have experienced challenges within our business, including in our Asia travel retail business, and we expect volatility and uncertainty to continue, given the ongoing, subdued consumer sentiment in China and Korea, as well as pressures from changes in selling policies at several Korean retailers. In North America, we continue to underperform the industry. We are also monitoring evolving global geopolitical risks and tensions, including the imposition of tariffs. These challenges are collectively expected to impact net sales and profitability, including impacts to our effective tax rate from changes to our geographical mix of earnings.
THE ESTÉE LAUDER COMPANIES INC.
We continue to believe that the best way to increase long-term stockholder value is to provide superior products and services in the most efficient and effective manner while recognizing shifts in consumers’ behaviors and shopping practices. Accordingly, our long-term strategy has numerous initiatives across geographic regions, product categories, brands, channels of distribution and functions designed to grow our sales, provide cost efficiencies, leverage our strengths, such as our history of outstanding creativity and innovation, high quality products and services, and engaging communications, and make us more productive and profitable. With the transition of leadership announced in the second quarter of fiscal 2025, we have embarked on “Beauty Reimagined,” that aims to accelerate best-in-class consumer coverage, create transformative innovation, boost consumer-facing investments and enable growth through more efficiencies expected through the expansion of the Profit Recovery and Growth Plan ("PRGP"), as discussed below.
We continue to monitor the effects of the global macro environment, including the risk of recession; currency volatility; inflationary pressures; supply chain challenges; social and political issues; competitive pressures; legal and regulatory matters, including the imposition of tariffs and sanctions; geopolitical tensions; and global security issues. For example, any potential tariffs on imports into the United States and/or tariffs on imports into other countries could have a material adverse effect on our business, as could geopolitical tensions between the United States and other countries. We are also mindful of inflationary pressures on our cost base and are monitoring the impact on consumer preferences, and the impact of changes being made in the organization, including those related to the PRGP. We are also mindful of, and monitoring, the potential impact of changes expected to be made as part of the PRGP on suppliers, retailers and others, and challenges relating to successfully outsourcing select services. Declines in net sales and profitability have, and may continue to, adversely impact the goodwill and other intangible assets associated with our brands, as well as long-lived assets, potentially resulting in impairments.
Restructuring Program Component of the Profit Recovery and Growth Plan
As announced on November 1, 2023, we launched the PRGP to help progressively rebuild our profit margins in fiscal years 2025 and 2026.
The PRGP is focused on rebuilding stronger, more sustainable profitability, supporting sales growth acceleration and increasing speed and agility. The plan is designed to improve gross margin, lower the cost base and reduce overhead expenses, while increasing investments in key consumer-facing activities. Upon completion of this plan, we expect to have improved our gross margin and expense base to drive greater operating leverage for the future.
As a component of the PRGP, on February 5, 2024, we announced a two-year restructuring program. The restructuring program’s main focus included the reorganization and rightsizing of certain areas of our business as well as simplification and acceleration of processes. We committed to this course of action on February 1, 2024.
In connection with the restructuring program, we estimated a net reduction in the range of approximately 1,800 to 3,000 positions globally, which was about 3-5% of our positions including temporary and part-time employees as of June 30, 2023. This reduction took into account the elimination of some positions as well as retraining and redeployment of certain employees in select areas.
We planned to substantially complete specific initiatives under the restructuring program through fiscal 2026. We expected that the restructuring program would result in restructuring and other charges totaling between $500 million and $700 million, before taxes, consisting of employee-related costs, contract terminations, asset write-offs and other costs associated with implementing these initiatives.
After reviewing additional potential initiatives and the progress of previously approved initiatives, on February 3, 2025, we committed to the expansion of the PRGP, including an expansion of the restructuring program.
The expansion of the overall PRGP is focused on three key areas. First, we plan to adopt a more competitive approach to procurement, a key pillar of savings, by further consolidating spending and strategically re-evaluating key supplier relationships. Second, we plan to further improve efficiencies within our supply chain network through a zero-waste approach, aiming to improve demand forecasting and innovation planning to minimize excess inventory and product destruction. Third, we are outsourcing select services to proven global partners.
THE ESTÉE LAUDER COMPANIES INC.
The expanded component of the restructuring program will begin during our fiscal 2025 third quarter with all initiatives to be approved by the end of fiscal 2026. Specific initiatives under the expanded component of the restructuring program are expected to be substantially completed by the end of fiscal 2027. The focus of the now expanded restructuring program (now, collectively the “Restructuring Program”) includes (i) reorganization and rightsizing of certain areas and (ii) simplification and acceleration of processes, along with the newly added focus on (i) outsourcing of select services and (ii) evolution of go-to-market footprint and selling models.
In connection with the Restructuring Program, we now estimate a net reduction in the range of approximately 5,800 to 7,000 positions globally, which is about 9-11% of our positions including temporary and part-time employees as of June 30, 2023. This net reduction takes into account the elimination of positions after retraining and redeployment of certain employees in select areas.
We now expect that the Restructuring Program will result in restructuring and other charges totaling between $1,200 million and $1,600 million, before taxes, consisting of employee-related costs, contract terminations, asset write-offs and other costs associated with implementing these initiatives, which other than the non-cash charges, are expected to result in future cash expenditures funded from cash provided by operations.
Once fully implemented, we now expect the Restructuring Program to yield annual target gross benefits of between $800 million and $1,000 million, before taxes, a portion of which is expected to be reinvested in consumer-facing activities. The net benefits of the PRGP, which includes the Restructuring Program, are expected to enable a return to a double-digit operating margin over the next few years.
Further information about the Restructuring Program Component of the Profit Recovery and Growth Plan, is described in Notes to Consolidated Financial Statements, Note 3 – Charges Associated with Restructuring and Other Activities herein.
Talcum Litigation Settlement Agreements
From the end of August 2024 through October 2024, we reached agreements with certain plaintiff law firms (collectively, the “talcum litigation settlement agreements”) for: (i) the resolution of pending cosmetic talcum powder matters handled by those firms as well as (ii) a process for resolving potential future cosmetic talcum powder claims expected to be brought on behalf of plaintiffs by those firms from January 1, 2025 through December 31, 2029, with annual capped amounts per year for each participating law firm. To account for the talcum litigation settlement agreements, we recorded a charge of $159 million during the fiscal 2025 first quarter for the amount agreed to settle the current claims and an estimated amount for potential future claims. Further information about the talcum litigation settlement agreements, is described in Notes to Consolidated Financial Statements, Note 8 – Commitments and Contingencies herein.
THE ESTÉE LAUDER COMPANIES INC.
Impairment Analysis During the Six Months Ended December 31, 2024
During the fiscal 2025 second quarter, the TOM FORD brand experienced lower-than-expected growth within key geographic regions and channels, including in mainland China, Asia travel retail and Hong Kong SAR. Also during the fiscal 2025 second quarter, the Too Faced reporting unit experienced lower-than-expected results in key geographic regions and channels. As a result, we made revisions to the internal forecasts relating to our TOM FORD brand and Too Faced reporting unit. Additionally, there were increases in the weighted average cost of capital for both the TOM FORD brand and Too Faced reporting unit as compared to the prior-year annual goodwill and other indefinite-lived intangible asset impairment testing as of April 1, 2024.
We concluded that the changes in circumstances in the TOM FORD brand and Too Faced reporting unit, along with increases in the weighted average cost of capital, triggered the need for interim impairment reviews of the TOM FORD trademark and the Too Faced trademark and goodwill. These changes in circumstances were also an indicator that the carrying amounts of Too Faced’s long-lived assets, including customer lists, may not be recoverable. Accordingly, we performed interim impairment tests for the TOM FORD and Too Faced trademarks and Too Faced goodwill as well as a recoverability test for the Too Faced long-lived assets as of December 31, 2024. We concluded that the carrying value of the trademark intangible assets exceeded their estimated fair values, which were determined utilizing the relief-from-royalty method, and recorded an impairment charge of $773 million for TOM FORD and $75 million for Too Faced. We concluded that the carrying amounts of the long-lived assets for Too Faced were recoverable. Additionally, as a result of the interim impairment review, the remaining carrying value of Too Faced’s goodwill was not recoverable and we recorded an impairment charge of $13 million, reducing the carrying value to zero. The significant assumptions used in the relief-from-royalty method include revenue growth rates and profit margins, terminal values, weighted-average cost of capital used to discount future cash flows and royalty rates. The most significant unobservable input used to estimate the fair value of the TOM FORD and Too Faced trademark intangible assets was the weighted average cost of capital, which was 11.5% and 14%, respectively.
A summary of the impairment charges for the three and six months ended December 31, 2024 and the remaining trademark and goodwill carrying values as of December 31, 2024, for the TOM FORD brand and Too Faced reporting unit, are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Impairment Charges(1) |
|
Carrying Value |
(In millions) |
|
|
|
|
|
Three and Six Months Ended
December 31, 2024
|
|
As of December 31, 2024 |
Brand/Reporting Unit |
|
Geographic Region |
|
|
|
|
|
Trademark |
|
Goodwill |
|
Trademark(2) |
|
Goodwill |
TOM FORD |
|
The Americas |
|
|
|
|
|
$ |
773 |
|
|
$ |
— |
|
|
$ |
1,805 |
|
|
$ |
— |
|
Too Faced |
|
The Americas |
|
|
|
|
|
75 |
|
|
13 |
|
|
112 |
|
|
— |
|
Total |
|
|
|
|
|
|
|
$ |
848 |
|
|
$ |
13 |
|
|
$ |
1,917 |
|
|
$ |
— |
|
(1)The date of the fair value measurement for the TOM FORD and Too Faced trademark intangible assets and Too Faced reporting unit was December 31, 2024.
(2)The carrying values of the trademark intangible assets, subsequent to the impairment charges, are equal to their fair values.
The impairment charge related to the TOM FORD trademark intangible asset for the three and six months ended December 31, 2024 of $773 million was reflected in the fragrance, makeup and other product categories of $549 million, $170 million and $54 million, respectively. The trademark and goodwill impairment charges related to Too Faced were reflected in the makeup product category.
The fair value of the TOM FORD and Too Faced trademarks were equal to their carrying values subsequent to the impairment charges taken as of December 31, 2024. The key assumptions used to determine the estimated fair value of the trademarks are primarily predicated on the success of future new product launches, the ability to secure strategic price increases, the achievement of distribution expansion plans, and the realization of cost reduction and other efficiency efforts. If such plans do not materialize, or if there are further challenges in the business environments in which the TOM FORD brand or Too Faced reporting unit operates, resulting changes in the key assumptions could have negative impacts on the estimated fair value of the trademarks, and it is possible we could recognize additional impairment charges in the future.
THE ESTÉE LAUDER COMPANIES INC.
NET SALES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended December 31, |
|
|
|
Six Months Ended December 31, |
($ in millions) |
|
2024 |
|
2023 |
|
|
|
|
|
2024 |
|
2023 |
As Reported: |
|
|
|
|
|
|
|
|
|
|
|
|
Net sales |
|
$ |
4,004 |
|
|
$ |
4,279 |
|
|
|
|
|
|
$ |
7,365 |
|
|
$ |
7,797 |
|
$ Change from prior-year period |
|
(275) |
|
|
|
|
|
|
|
|
(432) |
|
|
|
% Change from prior-year period |
|
(6) |
% |
|
|
|
|
|
|
|
(6) |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP Financial Measure(1): |
|
|
|
|
|
|
|
|
|
|
|
|
% Change from prior-year period in constant currency |
|
(6) |
% |
|
|
|
|
|
|
|
(6) |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)See “Reconciliations of Non-GAAP Financial Measures” beginning on page 57 for reconciliations between non-GAAP financial measures and the most directly comparable U.S. GAAP measures.
Reported net sales decreased for the three and six months ended December 31, 2024, primarily driven by a decrease in skin care and, to a lesser extent, makeup and hair care. The decrease in skin care net sales in both periods was primarily driven by lower net sales from Estée Lauder and La Mer.
By geographic region, reported net sales decreased for the three and six months ended December 31, 2024, reflecting lower net sales across all geographic regions, primarily driven by Asia/Pacific and Europe, the Middle East & Africa. The decrease in net sales in Asia/Pacific was primarily driven by lower net sales from mainland China, Korea and Hong Kong SAR. For the three and six months ended December 31, 2024, the decrease in net sales in Europe, the Middle East & Africa was primarily driven by lower net sales in our travel retail business.
Reported net sales decreased 6% for the three months ended December 31, 2024, driven by the decrease from volume of 11%. Partially offsetting this decrease was an increase from pricing of 4% due to the favorable impact from strategic pricing actions, partially offset by changes in mix.
Reported net sales decreased 6% for the six months ended December 31, 2024, driven by the decrease from volume of 9%. Partially offsetting this decrease was an increase from pricing of 4% due to the favorable impact from strategic pricing actions, partially offset by changes in mix.
Returns associated with restructuring and other activities are not allocated to our product categories or geographic regions because they are centrally directed and controlled, are not included in internal measures of product category or geographic region performance and result from activities that are deemed Company-wide initiatives to redesign, resize and reorganize select areas of the business. For the three and six months ended December 31, 2024, there were no returns associated with restructuring and other activities, and for each of the three and six months ended December 31, 2023, there were $1 million in returns associated with restructuring and other activities.
THE ESTÉE LAUDER COMPANIES INC.
Product Categories
Skin Care
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended December 31, |
|
Six Months Ended December 31, |
($ in millions) |
|
2024 |
|
2023 |
|
2024 |
|
2023 |
As Reported: |
|
|
|
|
|
|
|
|
Net sales |
|
$ |
1,921 |
|
|
$ |
2,173 |
|
|
$ |
3,450 |
|
|
$ |
3,813 |
|
$ Change from prior-year period |
|
(252) |
|
|
|
|
(363) |
|
|
|
% Change from prior-year period |
|
(12) |
% |
|
|
|
(10) |
% |
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP Financial Measure(1): |
|
|
|
|
|
|
|
|
% Change from prior-year period in constant currency |
|
(12) |
% |
|
|
|
(10) |
% |
|
|
|
|
|
|
|
|
|
|
|
(1)See “Reconciliations of Non-GAAP Financial Measures” beginning on page 57 for reconciliations between non-GAAP financial measures and the most directly comparable U.S. GAAP measures.
Reported skin care net sales decreased for the three and six months ended December 31, 2024, reflecting lower net sales from Estée Lauder and La Mer, combined, of approximately $201 million and $318 million, respectively.
The decrease in net sales from Estée Lauder for the three and six months ended December 31, 2024 was primarily driven by declines in mainland China, as well as, to a lesser extent, declines in net sales in our Asia travel retail business and in Hong Kong SAR, reflecting the overall challenging retail environments, including ongoing pressure from subdued sentiment from Chinese consumers.
For the three and six months ended December 31, 2024, net sales from La Mer decreased, primarily driven by the aforementioned overall challenging retail environment within our Asia travel retail business.
Skin care net sales were impacted by approximately $2 million of unfavorable and $11 million of favorable foreign currency translation for the three and six months ended December 31, 2024, respectively.
Reported skin care net sales decreased 12% for the three months ended December 31, 2024, driven by the decrease from volume of 15%. Partially offsetting this decrease was an increase from pricing of 4% due to the favorable impact from strategic pricing actions, partially offset by changes in mix.
Reported skin care net sales decreased 10% for the six months ended December 31, 2024, driven by the decrease from volume of 12%. Partially offsetting this decrease was an increase from pricing of 2% due to the favorable impact from strategic pricing actions, partially offset by changes in mix.
Makeup
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended December 31, |
|
Six Months Ended December 31, |
($ in millions) |
|
|
2024 |
|
2023 |
|
2024 |
|
2023 |
As Reported: |
|
|
|
|
|
|
|
|
|
Net sales |
|
|
$ |
1,150 |
|
|
$ |
1,167 |
|
|
$ |
2,188 |
|
|
$ |
2,229 |
|
$ Change from prior-year period |
|
|
(17) |
|
|
|
|
(41) |
|
|
|
% Change from prior-year period |
|
|
(1) |
% |
|
|
|
(2) |
% |
|
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP Financial Measure(1): |
|
|
|
|
|
|
|
|
|
% Change from prior-year period in constant currency |
|
|
(1) |
% |
|
|
|
(1) |
% |
|
|
|
|
|
|
|
|
|
|
|
|
(1)See “Reconciliations of Non-GAAP Financial Measures” beginning on page 57 for reconciliations between non-GAAP financial measures and the most directly comparable U.S. GAAP measures.
THE ESTÉE LAUDER COMPANIES INC.
Reported makeup net sales decreased slightly for the three months ended December 31, 2024, primarily driven by lower net sales from M·A·C, TOM FORD, Smashbox and Bobbi Brown, combined, of approximately $30 million. The decrease in net sales from M·A·C was primarily driven by lower net sales in the eye and face subcategories. Net sales from TOM FORD decreased, primarily driven by lower net sales in mainland China and our Asia travel retail business, reflecting the overall challenging retail environments, including ongoing pressure from subdued sentiment from Chinese consumers, as well as lower net sales in Hong Kong SAR, driven by the eye subcategory. Net sales from Smashbox decreased, primarily driven by North America, reflecting lower net sales in the face subcategory. The decrease in net sales from Bobbi Brown was driven by lower net sales in the lip subcategory.
Reported makeup net sales decreased for the six months ended December 31, 2024, reflecting lower net sales from M·A·C, and to a lesser extent, Smashbox, Too Faced and TOM FORD, combined, of approximately $84 million. The decrease in net sales from M·A·C was primarily driven by lower net sales in the face and eye subcategories and reflected softness in the brand's retail sales in North America. Net sales from Smashbox decreased, primarily reflecting lower net sales in the face and eye subcategories. The decrease in net sales from Too Faced was primarily driven by North America, reflecting lower net sales in the face and lip subcategories. Net sales from TOM FORD decreased, primarily driven by lower net sales in mainland China, reflecting the overall challenging retail environment, including ongoing pressure from subdued sentiment from Chinese consumers, as well as lower net sales in Hong Kong SAR, driven by the eye subcategory.
Partially offsetting the makeup net sales decreases for the three and six months ended December 31, 2024 were higher net sales from Clinique and Estée Lauder, combined, of approximately $18 million and $52 million, respectively. Net sales from Clinique increased across all geographic regions, led by North America, reflecting the launch in Amazon's U.S. Premium Beauty store, as well as the success of hero products. Net sales from Estée Lauder increased, primarily driven by growth in the face subcategory.
Makeup net sales were impacted by approximately $11 million and $9 million of unfavorable foreign currency translation for the three and six months ended December 31, 2024, respectively.
Reported makeup net sales decreased 1% for the three months ended December 31, 2024, driven by the decrease from volume of 7% and the unfavorable impact from foreign currency translation of 1%. Partially offsetting these decreases was an increase from pricing of 6% due to the favorable impact from strategic pricing actions and changes in mix.
Reported makeup net sales decreased 2% for the six months ended December 31, 2024, driven by the decrease from volume of 8%. Partially offsetting this decrease was an increase from pricing of 6% due to the favorable impact from strategic pricing actions and changes in mix.
Fragrance
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended December 31, |
|
Six Months Ended December 31, |
($ in millions) |
|
2024 |
|
2023 |
|
2024 |
|
2023 |
As Reported: |
|
|
|
|
|
|
|
|
Net sales |
|
$ |
744 |
|
|
$ |
737 |
|
|
$ |
1,374 |
|
|
$ |
1,373 |
|
$ Change from prior-year period |
|
7 |
|
|
|
|
1 |
|
|
|
% Change from prior-year period |
|
1 |
% |
|
|
|
— |
% |
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP Financial Measure(1): |
|
|
|
|
|
|
|
|
% Change from prior-year period in constant currency |
|
2 |
% |
|
|
|
— |
% |
|
|
|
|
|
|
|
|
|
|
|
(1)See “Reconciliations of Non-GAAP Financial Measures” beginning on page 57 for reconciliations between non-GAAP financial measures and the most directly comparable U.S. GAAP measures.
Reported fragrance net sales increased slightly for the three months ended December 31, 2024, reflecting higher net sales from Le Labo, and to a lesser extent, Editions de Parfums Frédéric Malle, combined, of approximately $26 million. Net sales from Le Labo increased, primarily reflecting growth of hero products, targeted expanded consumer reach and new product launches. The increase in net sales from Editions de Parfums Frédéric Malle reflected growth across the product portfolio as well as targeted expanded consumer reach.
THE ESTÉE LAUDER COMPANIES INC.
Reported fragrance net sales remained virtually flat for the six months ended December 31, 2024, reflecting higher net sales from Le Labo, and to a lesser extent, Kilian Paris, Editions de Parfums Frédéric Malle and incremental net sales associated with the fiscal 2025 first quarter launch of BALMAIN Beauty, combined, of approximately $50 million. Net sales from Le Labo increased, primarily reflecting targeted expanded consumer reach, growth of hero products and new product launches. The increase in net sales from Kilian Paris reflected the success of new product launches. The increase in net sales from Editions de Parfums Frédéric Malle reflected growth across the product portfolio as well as targeted expanded consumer reach.
Offsetting the reported fragrance net sales increase for the three and six months ended December 31, 2024 were lower net sales from Estée Lauder, Clinique and TOM FORD, combined, of approximately $25 million and $54 million, respectively. Net sales from Estée Lauder decreased in both periods, primarily driven by lower net sales across its fragrance portfolio. The decrease in net sales from Clinique in both periods was primarily due to lower net sales from the Clinique Happy franchise line of products. Net sales from TOM FORD decreased in both periods, primarily driven by lower net sales in North America, reflecting softness in the brand's retail sales, resulting in lower replenishment orders, as well as the overall challenging retail environments in mainland China and Hong Kong SAR, including ongoing pressure from subdued sentiment from Chinese consumers.
Fragrance net sales were impacted by approximately $5 million and $2 million of unfavorable foreign currency translation for the three and six months ended December 31, 2024, respectively.
Reported fragrance net sales increased 1% for the three months ended December 31, 2024, driven by an increase from pricing of 7%, due to the favorable impact from strategic pricing actions and changes in mix. Partially offsetting this increase was the decrease from volume of 5% and the unfavorable impact from foreign currency translation of 1%.
Reported fragrance net sales were virtually flat for the six months ended December 31, 2024, driven by an increase from pricing of 6%, due to the favorable impact from strategic pricing actions and changes in mix, offset by the decrease from volume of 6%.
Hair Care
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended December 31, |
|
Six Months Ended December 31, |
($ in millions) |
|
2024 |
|
2023 |
|
2024 |
|
2023 |
As Reported: |
|
|
|
|
|
|
|
|
Net sales |
|
$ |
159 |
|
|
$ |
173 |
|
|
$ |
298 |
|
|
$ |
321 |
|
$ Change from prior-year period |
|
(14) |
|
|
|
|
(23) |
|
|
|
% Change from prior-year period |
|
(8) |
% |
|
|
|
(7) |
% |
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP Financial Measure(1): |
|
|
|
|
|
|
|
|
% Change from prior-year period in constant currency |
|
(8) |
% |
|
|
|
(7) |
% |
|
|
|
|
|
|
|
|
|
|
|
(1)See “Reconciliations of Non-GAAP Financial Measures” beginning on page 57 for reconciliations between non-GAAP financial measures and the most directly comparable U.S. GAAP measures.
Reported hair care net sales decreased for the three and six months ended December 31, 2024, driven by lower net sales from Aveda, primarily driven by our softness in the North America and Europe, the Middle East & Africa salon channels, softness in our direct-to-consumer business, as well as the unfavorable impact of timing of shipments compared to the prior-year periods.
Reported hair care net sales decreased 8% for the three months ended December 31, 2024, driven by the decrease from volume of 6% and a decrease from pricing of 2%, due to changes in mix, partially offset by the favorable impact from strategic pricing actions.
Reported hair care net sales decreased 7% for the six months ended December 31, 2024, driven by the decrease from volume of 6% and a decrease from pricing of 2%, due to changes in mix, partially offset by the favorable impact from strategic pricing actions.
THE ESTÉE LAUDER COMPANIES INC.
Geographic Regions
The Americas
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended December 31, |
|
Six Months Ended December 31, |
($ in millions) |
|
2024 |
|
2023 |
|
2024 |
|
2023 |
As Reported: |
|
|
|
|
|
|
|
|
Net sales |
|
$ |
1,223 |
|
|
$ |
1,242 |
|
|
$ |
2,410 |
|
|
$ |
2,450 |
|
$ Change from prior-year period |
|
(19) |
|
|
|
|
(40) |
|
|
|
% Change from prior-year period |
|
(2) |
% |
|
|
|
(2) |
% |
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP Financial Measure(1): |
|
|
|
|
|
|
|
|
% Change from prior-year period in constant currency |
|
— |
% |
|
|
|
(1) |
% |
|
|
|
|
|
|
|
|
|
|
|
(1)See “Reconciliations of Non-GAAP Financial Measures” beginning on page 57 for reconciliations between non-GAAP financial measures and the most directly comparable U.S. GAAP measures.
Reported net sales in The Americas decreased for the three months ended December 31, 2024, primarily reflecting lower net sales in North America, and to Latin America distributors, combined, of approximately $12 million. Net sales in North America decreased, reflecting softness in our retail sales, including challenges with our distribution mix, skewed toward slower-growing channels. These challenges were largely offset by the launch of nine brands to-date in Amazon's U.S. Premium Beauty store. Net sales to Latin America distributors decreased for the three months ended December 31, 2024, due in part, to lower net sales in fragrance, driven by Estée Lauder.
Reported net sales in The Americas decreased for the six months ended December 31, 2024, primarily reflecting lower net sales in North America, to Latin America distributors and in Mexico, combined, of approximately $31 million. The decrease in net sales from North America reflected softness in our retail sales, including challenges with our distribution mix, skewed towards slower-growing channels. These challenges were largely offset by the launch of nine brands to-date in Amazon's U.S. Premium Beauty store. Net sales to Latin America distributors decreased, due in part, to lower net sales in fragrance, driven by Estée Lauder. The decrease in net sales in Mexico was primarily driven by the unfavorable impact of foreign currency translation.
Net sales in The Americas were impacted by approximately $13 million and $24 million of unfavorable foreign currency translation for the three and six months ended December 31, 2024, respectively.
Reported net sales in The Americas decreased 2% for the three months ended December 31, 2024, driven by the decrease from volume of 11% and the unfavorable impact from foreign currency translation of 1%. These decreases were partially offset by an increase from pricing of 11%, due to the favorable impact of strategic pricing actions and changes in mix.
Reported net sales in The Americas decreased 2% for the six months ended December 31, 2024, driven by the decrease from volume of 9% and the unfavorable impact from foreign currency translation of 1%. These decreases were partially offset by an increase from pricing of 8%, due to the favorable impact of strategic pricing actions and changes in mix.
THE ESTÉE LAUDER COMPANIES INC.
Europe, the Middle East & Africa
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended December 31, |
|
Six Months Ended December 31, |
($ in millions) |
|
2024 |
|
2023 |
|
2024 |
|
2023 |
As Reported: |
|
|
|
|
|
|
|
|
Net sales |
|
$ |
1,494 |
|
|
$ |
1,589 |
|
|
$ |
2,724 |
|
|
$ |
2,841 |
|
$ Change from prior-year period |
|
(95) |
|
|
|
|
(117) |
|
|
|
% Change from prior-year period |
|
(6) |
% |
|
|
|
(4) |
% |
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP Financial Measure(1): |
|
|
|
|
|
|
|
|
% Change from prior-year period in constant currency |
|
(6) |
% |
|
|
|
(5) |
% |
|
|
|
|
|
|
|
|
|
|
|
(1)See “Reconciliations of Non-GAAP Financial Measures” beginning on page 57 for reconciliations between non-GAAP financial measures and the most directly comparable U.S. GAAP measures.
Reported net sales decreased in Europe, the Middle East & Africa for the three and six months ended December 31, 2024, primarily driven by lower net sales in our Asia travel retail business, reflecting the impacts from an overall challenging retail environment, including ongoing pressure from subdued sentiment from Chinese consumers.
Partially offsetting the decrease in reported net sales in Europe, the Middle East & Africa for the six months ended December 31, 2024 were higher net sales from Israel and Turkey, combined, of approximately $21 million. Net sales in Israel increased, reflecting business disruption in the prior-year period, including the closure of stores which have since reopened. Net sales from Turkey increased, primarily driven by growth in makeup, led by higher net sales from M·A·C, and growth in skin care, led by higher net sales from Estée Lauder.
Net sales in Europe, the Middle East & Africa were impacted by approximately $4 million of unfavorable and $19 million of favorable foreign currency translation for the three and six months ended December 31, 2024, respectively.
Reported net sales in Europe, the Middle East & Africa decreased 6% for the three months ended December 31, 2024, driven by the decrease from volume of 5%. The impact of pricing was flat period-over-period.
Reported net sales in Europe, the Middle East & Africa decreased 4% for the six months ended December 31, 2024, driven by the decrease from volume of 5%, partially offset by the favorable impact from foreign currency translation of 1%. The impact of pricing was flat period-over-period.
Asia/Pacific
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended December 31, |
|
Six Months Ended December 31, |
($ in millions) |
|
2024 |
|
2023 |
|
2024 |
|
2023 |
As Reported: |
|
|
|
|
|
|
|
|
Net sales |
|
$ |
1,287 |
|
|
$ |
1,449 |
|
|
$ |
2,231 |
|
|
$ |
2,507 |
|
$ Change from prior-year period |
|
(162) |
|
|
|
|
(276) |
|
|
|
% Change from prior-year period |
|
(11) |
% |
|
|
|
(11) |
% |
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP Financial Measure(1): |
|
|
|
|
|
|
|
|
% Change from prior-year period in constant currency |
|
(11) |
% |
|
|
|
(11) |
% |
|
|
|
|
|
|
|
|
|
|
|
(1)See “Reconciliations of Non-GAAP Financial Measures” beginning on page 57 for reconciliations between non-GAAP financial measures and the most directly comparable U.S. GAAP measures.
THE ESTÉE LAUDER COMPANIES INC.
Reported net sales decreased in Asia/Pacific for the three and six months ended December 31, 2024, primarily driven by lower net sales from mainland China, Korea, and Hong Kong SAR, combined, of approximately $166 million and $285 million, respectively, reflecting the impacts from the overall challenging retail environments, including subdued consumer sentiment. The net sales decline in Korea in both periods also reflects the exit of Dr.Jart+ from the travel retail channel in Korea during the fiscal 2025 second quarter.
Net sales in Asia/Pacific were impacted by approximately $1 million of unfavorable and $5 million of favorable foreign currency translation for the three and six months ended December 31, 2024, respectively.
Reported net sales in Asia/Pacific decreased 11% for the three months ended December 31, 2024, driven by the decrease from volume of 16%. Partially offsetting this decrease was an increase from pricing of 4% due to the favorable impact from strategic pricing actions, partially offset by changes in mix.
Reported net sales in Asia/Pacific decreased 11% for the six months ended December 31, 2024, driven by the decrease from volume of 15%. Partially offsetting this decrease was an increase from pricing of 4% due to the favorable impact from strategic pricing actions, partially offset by changes in mix.
GROSS MARGIN
Gross margin increased to 76.1% and 74.4% for the three and six months ended December 31, 2024, as compared with 73.0% and 71.5% in the prior-year periods.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Favorable (Unfavorable) Basis Points |
|
|
|
|
December 31, 2024 |
|
|
|
|
Three Months Ended |
|
Six Months Ended |
|
|
As Reported: |
|
|
|
|
|
|
Mix of business |
|
55 |
|
|
35 |
|
|
|
Obsolescence charges |
|
155 |
|
|
170 |
|
|
|
Manufacturing costs and other |
|
110 |
|
|
105 |
|
|
|
Foreign exchange transactions |
|
(10) |
|
|
(10) |
|
|
|
|
|
|
|
|
|
|
Charges associated with restructuring and other activities |
|
— |
|
|
(10) |
|
|
|
As Reported Gross Margin Basis Point Variance |
|
310 |
|
|
290 |
|
|
|
|
|
|
|
|
|
|
Non-GAAP Financial Measure Adjustments |
|
|
|
|
|
|
Charges associated with restructuring and other activities |
|
— |
|
|
10 |
|
|
|
Non-GAAP Gross Margin Basis Point Variance |
|
310 |
|
|
300 |
|
|
|
The increase in gross margin for the three and six months ended December 31, 2024 was driven by lower obsolescence charges, due to a reduction in excess inventory. Also contributing to the increase in gross margin was the favorable impact from manufacturing costs and other, reflecting favorability in cost efficiencies within our global supply chain network, the impact in both periods of the recognition of manufacturing variances associated with reduced manufacturing volumes on our standard cost within cost of sales in the second half of fiscal 2024, partially offset by the impact of inflation on our costs. Additionally, there was a favorable impact from our mix of business, reflecting the benefit of net strategic pricing actions, partially offset by the impact of lower net sales.
THE ESTÉE LAUDER COMPANIES INC.
OPERATING EXPENSES
Operating expenses as a percentage of net sales were 90.6% and 83.9% for the three and six months ended December 31, 2024, as compared with 59.6% and 62.9% in the prior-year periods.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Favorable (Unfavorable) Basis Points |
|
|
|
|
December 31, 2024 |
|
|
|
|
Three Months Ended |
|
Six Months Ended |
|
|
As Reported: |
|
|
|
|
|
|
General and administrative expenses |
|
(200) |
|
|
(140) |
|
|
|
Advertising, merchandising, sampling and product development |
|
(210) |
|
|
(120) |
|
|
|
Selling |
|
(130) |
|
|
(120) |
|
|
|
Shipping |
|
30 |
|
|
20 |
|
|
|
Store operating costs |
|
(20) |
|
|
(20) |
|
|
|
Stock-based compensation |
|
(10) |
|
|
10 |
|
|
|
Foreign exchange transactions |
|
30 |
|
|
20 |
|
|
|
Charges associated with restructuring and other activities |
|
(430) |
|
|
(370) |
|
|
|
Goodwill and other intangible asset impairments |
|
(2,150) |
|
|
(1,170) |
|
|
|
Talcum litigation settlement agreements |
|
— |
|
|
(220) |
|
|
|
|
|
|
|
|
|
|
Changes in fair value of DECIEM acquisition-related stock options |
|
(10) |
|
|
10 |
|
|
|
As Reported Operating Expense Margin Basis Point Variance |
|
(3,100) |
|
|
(2,100) |
|
|
|
|
|
|
|
|
|
|
Non-GAAP Financial Measure Adjustments: |
|
|
|
|
|
|
Impact of restructuring and other activities |
|
440 |
|
|
360 |
|
|
|
Goodwill and other intangible asset impairments |
|
2,150 |
|
|
1,170 |
|
|
|
Talcum litigation settlement agreements |
|
— |
|
|
220 |
|
|
|
Changes in fair value of DECIEM acquisition-related stock options |
|
10 |
|
|
(10) |
|
|
|
Non-GAAP Operating Expense Margin Basis Point Variance |
|
(500) |
|
|
(360) |
|
|
|
The unfavorable change in operating expense margin for the three and six months ended December 31, 2024 reflects the impact of the decrease in net sales, as well as higher general and administrative and selling expenses, and for the three months ended December 31, 2024, also reflects higher advertising, merchandising, sampling and product development expenses. The increase in general and administrative expenses in both periods primarily reflected the year-over-year unfavorable impact of a change in policy related to local government subsidies in China. Selling expenses increased in both periods as we continue to invest in our business, reflecting higher staffing costs to support sales, targeted expanded consumer reach and key campaigns.
The increase in advertising, merchandising, sampling and product development expenses for the three months ended December 31, 2024 reflected investments to support sales, including through key campaigns and launches, as well as the year-over-year timing of expenses.
THE ESTÉE LAUDER COMPANIES INC.
OPERATING RESULTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended December 31, |
|
Six Months Ended December 31, |
($ in millions) |
|
2024 |
|
2023 |
|
2024 |
|
2023 |
As Reported: |
|
|
|
|
|
|
|
|
Operating income (loss) |
|
$ |
(580) |
|
|
$ |
574 |
|
|
$ |
(701) |
|
|
$ |
672 |
|
$ Change from prior-year period |
|
(1,154) |
|
|
|
|
(1,373) |
|
|
|
% Change from prior-year period |
|
(100+)% |
|
|
|
(100+)% |
|
|
|
|
|
|
|
|
|
|
|
Operating margin |
|
(14.5) |
% |
|
13.4 |
% |
|
(9.5) |
% |
|
8.6 |
% |
|
|
|
|
|
|
|
|
|
Non-GAAP Financial Measure(1): |
|
|
|
|
|
|
|
|
% Change in operating income from the prior-year period adjusting for the impact of charges associated with restructuring and other activities, the impact of goodwill and other intangible asset impairments, talcum litigation settlement agreements and the change in fair value of DECIEM acquisition-related stock options |
|
(20) |
% |
|
|
|
(12) |
% |
|
|
|
|
|
|
|
|
|
|
|
(1)See “Reconciliations of Non-GAAP Financial Measures” beginning on page 57 for reconciliations between non-GAAP financial measures and the most directly comparable U.S. GAAP measures.
The decrease in reported operating margin for the three and six months ended December 31, 2024 primarily reflects an increase in operating expense margin, driven by goodwill and other intangible asset impairments relating to TOM FORD and Too Faced, combined, of $861 million, included in the makeup, fragrance and other product categories, and a decrease in net sales, partially offset by an increase in gross margin, as discussed above.
Charges associated with restructuring and other activities are not allocated to our product categories or geographic regions because they are centrally directed and controlled, are not included in internal measures of product category or geographic region performance and result from activities that are deemed Company-wide initiatives to redesign, resize and reorganize select areas of the business. Accordingly, the following discussions of Operating income (loss) by Product Categories and Geographic Regions exclude the impact of charges associated with restructuring and other activities for the three months ended December 31, 2024 and 2023 of $181 million and $8 million, respectively, and for the six months ended December 31, 2024 and 2023 of $287 million and $10 million, respectively.
THE ESTÉE LAUDER COMPANIES INC.
Product Categories
Skin Care
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended December 31, |
|
Six Months Ended December 31, |
($ in millions) |
|
2024 |
|
2023 |
|
2024 |
|
2023 |
As Reported: |
|
|
|
|
|
|
|
|
Operating income |
|
$ |
306 |
|
|
$ |
415 |
|
|
$ |
423 |
|
|
$ |
452 |
|
$ Change from prior-year period |
|
(109) |
|
|
|
|
(29) |
|
|
|
% Change from prior-year period |
|
(26) |
% |
|
|
|
(6) |
% |
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP Financial Measure(1): |
|
|
|
|
|
|
|
|
% Change in operating income from the prior-year period adjusting for the change in fair value of DECIEM acquisition-related stock options |
|
(25) |
% |
|
|
|
(7) |
% |
|
|
|
|
|
|
|
|
|
|
|
(1)See “Reconciliations of Non-GAAP Financial Measures” beginning on page 57 for reconciliations between non-GAAP financial measures and the most directly comparable U.S. GAAP measures.
Reported skin care operating income decreased for the three and six months ended December 31, 2024, primarily driven by lower operating results from La Mer, and to a lesser extent, The Ordinary and Estée Lauder, combined, of approximately $132 million and $192 million, respectively. Operating results from La Mer decreased in both periods, primarily driven by a decrease in net sales and an increase in advertising and promotional activities to support key shopping moments and new product launches, partially offset by lower cost of sales. The decrease in operating results from The Ordinary in both periods was primarily driven by higher advertising and promotional expenses due to the timing of advertising and promotional activities compared to the prior-year period and higher cost of sales due to changes in product mix. Operating results from Estée Lauder decreased in both periods, primarily driven by a decrease in net sales, partially offset by lower cost of sales and reflecting disciplined advertising and promotional expense management. Partially offsetting the decline in skin care operating income for the product category overall was lower cost of sales.
Makeup
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended December 31, |
|
Six Months Ended December 31, |
($ in millions) |
|
2024 |
|
2023 |
|
2024 |
|
2023 |
As Reported: |
|
|
|
|
|
|
|
|
Operating income (loss) |
|
$ |
(211) |
|
|
$ |
30 |
|
|
$ |
(396) |
|
$ |
(10) |
|
$ Change from prior-year period |
|
(241) |
|
|
|
|
(386) |
|
|
% Change from prior-year period |
|
(100+)% |
|
|
|
(100+)% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP Financial Measure(1): |
|
|
|
|
|
|
|
|
% Change in operating income (loss) from the prior-year period adjusting for the the impact of goodwill and other intangible asset impairments and talcum litigation settlement agreements |
|
57 |
% |
|
|
|
100+% |
|
|
|
|
|
|
|
|
|
|
|
(1)See “Reconciliations of Non-GAAP Financial Measures” beginning on page 57 for reconciliations between non-GAAP financial measures and the most directly comparable U.S. GAAP measures.
THE ESTÉE LAUDER COMPANIES INC.
Reported makeup operating results decreased for the three and six months ended December 31, 2024, primarily driven by the unfavorable year-over-year impacts of other intangible asset impairment charges relating to TOM FORD and Too Faced, combined, of $245 million and a goodwill impairment charge relating to Too Faced of $13 million, as well as lower net sales, partially offset by lower cost of sales. Also contributing to the decrease in makeup operating results for the six months ended December 31, 2024 was the charge in the fiscal 2025 first quarter associated with the talcum litigation settlement agreements of $159 million.
Fragrance
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended December 31, |
|
Six Months Ended December 31, |
($ in millions) |
|
2024 |
|
2023 |
|
2024 |
|
2023 |
As Reported: |
|
|
|
|
|
|
|
|
Operating income (loss) |
|
$ |
(446) |
|
|
$ |
131 |
|
|
$ |
(386) |
|
|
$ |
238 |
|
$ Change from prior-year period |
|
(577) |
|
|
|
|
(624) |
|
|
|
% Change from prior-year period |
|
(100+)% |
|
|
|
(100+)% |
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP Financial Measure(1): |
|
|
|
|
|
|
|
|
% Change in operating income from the prior-year period adjusting for the impact of other intangible asset impairments |
|
(21) |
% |
|
|
|
(32) |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)See “Reconciliations of Non-GAAP Financial Measures” beginning on page 57 for reconciliations between non-GAAP financial measures and the most directly comparable U.S. GAAP measures.
Reported fragrance operating income decreased for the three and six months ended December 31, 2024, primarily driven by lower operating results from TOM FORD, and to a lesser extent, Jo Malone London, combined, of approximately $571 million and $603 million, respectively. The decrease in operating results from TOM FORD in both periods was primarily driven by an unfavorable year-over-year impact of the other intangible asset impairment charge of $549 million. Also contributing to the decrease in operating results from TOM FORD for the six months ended December 31, 2024 was a decline in net sales, an increase in selling expenses to support the growth of the business and an increase in advertising and promotional activities to support new product launches. The decrease in operating results from Jo Malone London in both periods was due to higher advertising and promotional activities and selling expenses to support key campaigns, partially offset by lower cost of sales. Also contributing to the decrease in operating results from Jo Malone London for the six months ended December 31, 2024 was higher store operating costs to support targeted expanded consumer reach.
Hair Care
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended December 31, |
|
Six Months Ended December 31, |
($ in millions) |
|
2024 |
|
2023 |
|
2024 |
|
2023 |
As Reported: |
|
|
|
|
|
|
|
|
Operating loss |
|
$ |
(3) |
|
|
$ |
(3) |
|
|
$ |
(21) |
|
|
$ |
(25) |
|
$ Change from prior-year period |
|
— |
|
|
|
|
4 |
|
|
|
% Change from prior-year period |
|
— |
% |
|
|
|
16 |
% |
|
|
Reported hair care operating results were flat for the three months ended December 31, 2024 and increased slightly for the six months ended December 31, 2024, primarily reflecting a decrease in operating expenses and lower cost of sales, partially offset by a decrease in net sales.
THE ESTÉE LAUDER COMPANIES INC.
Geographic Regions
The Americas
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended December 31, |
|
Six Months Ended December 31, |
($ in millions) |
|
2024 |
|
2023 |
|
2024 |
|
2023 |
As Reported: |
|
|
|
|
|
|
|
|
Operating loss |
|
$ |
(823) |
|
$ |
(55) |
|
|
$ |
(991) |
|
$ |
(237) |
|
$ Change from prior-year period |
|
(768) |
|
|
|
(754) |
|
|
% Change from prior-year period |
|
(100+)% |
|
|
|
(100+)% |
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP Financial Measure(1): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
% Change in operating loss from the prior-year period adjusting for the impact of goodwill and other intangible asset impairments, talcum litigation settlement agreements and change in fair value of DECIEM acquisition-related stock options |
|
100+% |
|
|
|
100+% |
|
|
|
|
|
|
|
|
|
|
|
(1)See “Reconciliations of Non-GAAP Financial Measures” beginning on page 57 for reconciliations between non-GAAP financial measures and the most directly comparable U.S. GAAP measures.
Reported operating loss in The Americas increased for the three and six months ended December 31, 2024, primarily reflecting lower operating results in North America of approximately $764 million and $744 million, respectively. The lower operating results were primarily driven by the unfavorable year-over-year impacts of other intangible asset impairment charges relating to TOM FORD and Too Faced of $848 million and a goodwill impairment charge relating to Too Faced of $13 million, partially offset by lower cost of sales, including lower obsolescence charges compared to the prior-year period due to a reduction in excess inventory, and the favorable year-over-year impact relating to net intercompany activity. Also contributing to the decrease in operating results in North America for the six months ended December 31, 2024 was the charge in the fiscal 2025 first quarter associated with the talcum litigation settlement agreements of $159 million.
Europe, the Middle East & Africa
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended December 31, |
|
Six Months Ended December 31, |
($ in millions) |
|
2024 |
|
2023 |
|
2024 |
|
2023 |
As Reported: |
|
|
|
|
|
|
|
|
Operating income |
|
$ |
316 |
|
|
$ |
379 |
|
|
$ |
406 |
|
|
$ |
523 |
|
$ Change from prior-year period |
|
(63) |
|
|
|
|
(117) |
|
|
|
% Change from prior-year period |
|
(17) |
% |
|
|
|
(22) |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reported operating income decreased in Europe, the Middle East & Africa for the three and six months ended December 31, 2024, primarily driven by lower results from our travel retail business, reflecting a decrease in net sales and the unfavorable year-over-year impact of net intercompany activity, partially offset by lower cost of sales and disciplined advertising and promotional expense management.
THE ESTÉE LAUDER COMPANIES INC.
Asia/Pacific
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended December 31, |
|
Six Months Ended December 31, |
($ in millions) |
|
2024 |
|
2023 |
|
2024 |
|
2023 |
As Reported: |
|
|
|
|
|
|
|
|
Operating income |
|
$ |
108 |
|
|
$ |
258 |
|
|
$ |
171 |
|
|
$ |
396 |
|
$ Change from prior-year period |
|
(150) |
|
|
|
|
(225) |
|
|
|
% Change from prior-year period |
|
(58) |
% |
|
|
|
(57) |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reported operating income decreased in Asia/Pacific for the three and six months ended December 31, 2024, primarily driven by lower results in mainland China, Hong Kong SAR and Korea, combined, of approximately $131 million and $189 million, respectively. The decrease in operating results from mainland China in both periods was primarily driven by a decrease in net sales and the year-over-year unfavorable impact of a change in policy related to local government subsidies in China, partially offset by disciplined advertising and promotional expense management and lower cost of sales. Hong Kong SAR operating results decreased in both periods, primarily driven by a decrease in net sales. Operating results in Korea decreased in both periods, primarily driven by a decrease in net sales, partially offset by lower store operating costs relating to the exit of Dr.Jart+ from the travel retail channel during the fiscal 2025 second quarter as well as lower cost of sales.
INTEREST AND INVESTMENT INCOME
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended December 31, |
|
Six Months Ended December 31, |
(In millions) |
|
2024 |
|
2023 |
|
2024 |
|
2023 |
Interest expense |
|
$ |
90 |
|
|
$ |
98 |
|
|
$ |
182 |
|
|
$ |
193 |
|
Interest income and investment income, net |
|
$ |
23 |
|
|
$ |
40 |
|
|
$ |
58 |
|
|
$ |
81 |
|
Interest expense decreased for the three and six months ended December 31, 2024, primarily reflecting a lower average debt balance compared to the prior-year periods. Interest income and investment income, net decreased for the three months ended December 31, 2024, primarily reflecting a lower average cash balance and lower interest rates compared to the prior-year period. For the six months ended December 31, 2024, interest income and investment income decreased, primarily reflecting a lower average cash balance compared to the prior-year period, partially offset by higher interest rates compared to the prior-year period.
PROVISION FOR INCOME TAXES
The provision or benefit for income taxes represents U.S. federal, foreign, state and local income taxes. The effective rate differs from the federal statutory rate primarily due to the effect of state and local income taxes, the tax impact of stock-based compensation, the taxation of foreign income and income tax reserve adjustments, which represent changes in our net liability for unrecognized tax benefits including tax settlements and lapses of the applicable statutes of limitations. Our effective tax rate will change from quarter-to-quarter based on recurring and non-recurring factors including the geographical mix of earnings, enacted tax legislation, state and local income taxes, tax reserve adjustments, the tax impact of stock-based compensation, the interaction of various global tax strategies and the impact from certain acquisitions. In addition, changes in judgment from the evaluation of new information resulting in the recognition, derecognition or remeasurement of a tax position taken in a prior annual period are recognized separately in the quarter of change.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended December 31, |
|
Six Months Ended December 31, |
|
2024 |
|
2023 |
|
2024 |
|
2023 |
Effective rate for income taxes |
9.2 |
% |
|
37.6 |
% |
|
10.1 |
% |
|
36.3 |
% |
Basis-point change from the prior-year period |
(2,840) |
|
|
|
|
(2,620) |
|
|
|
For the three months ended December 31, 2024, the decrease in the effective tax rate was primarily attributable to the impact of the discrete treatment of charges associated with restructuring and other activities, the impairment of goodwill and other intangible assets, as well as an unfavorable impact associated with previously issued stock-based compensation.
THE ESTÉE LAUDER COMPANIES INC.
For the six months ended December 31, 2024, the decrease in the effective tax rate was primarily attributable to the impact of the discrete treatment of charges associated with restructuring and other activities, the impairment of goodwill and other intangible assets, the charge associated with the talcum litigation settlement agreements (See Note 8 - Commitments and Contingencies for further discussion) and an unfavorable impact associated with previously issued stock-based compensation.
NET EARNINGS (LOSS) ATTRIBUTABLE TO THE ESTÉE LAUDER COMPANIES INC.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended December 31, |
|
Six Months Ended December 31, |
($ in millions, except per share data) |
|
2024 |
|
2023 |
|
2024 |
|
2023 |
As Reported: |
|
|
|
|
|
|
|
|
Net earnings (loss) attributable to The Estée Lauder Companies Inc. |
|
$ |
(590) |
|
|
$ |
313 |
|
|
$ |
(746) |
|
|
$ |
344 |
|
$ Change from prior-year period |
|
(903) |
|
|
|
|
(1,090) |
|
|
|
% Change from prior-year period |
|
(100+)% |
|
|
|
(100+)% |
|
|
Diluted net earnings (loss) per common share |
|
$ |
(1.64) |
|
|
$ |
.87 |
|
|
$ |
(2.07) |
|
|
$ |
.95 |
|
% Change from prior-year period |
|
(100+)% |
|
|
|
(100+)% |
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP Financial Measure(1): |
|
|
|
|
|
|
|
|
% Change in diluted net earnings per common share from the prior-year period adjusting for the impact of charges associated with restructuring and other activities, goodwill and other intangible asset impairments, talcum litigation settlement agreements and the change in fair value of DECIEM acquisition-related stock options |
|
(29) |
% |
|
|
|
(22) |
% |
|
|
|
|
|
|
|
|
|
|
|
(1)See “Reconciliations of Non-GAAP Financial Measures” below for reconciliations between non-GAAP financial measures and the most directly comparable U.S. GAAP measures.
RECONCILIATIONS OF NON-GAAP FINANCIAL MEASURES
We use certain non-GAAP financial measures, among other financial measures, to evaluate our operating performance, which represent the manner in which we conduct and view our business. Management believes that excluding certain items that are not comparable from period-to-period, or do not reflect the Company’s underlying ongoing business, provides transparency for such items and helps investors and others compare and analyze our operating performance from period-to-period. In the future, we expect to incur charges or adjustments similar in nature to those presented below; however, the impact to the Company’s results in a given period may be highly variable and difficult to predict. Our non-GAAP financial measures may not be comparable to similarly titled measures used by, or determined in a manner consistent with, other companies. While we consider the non-GAAP measures useful in analyzing our results, they are not intended to replace, or act as a substitute for, any presentation included in the consolidated financial statements prepared in conformity with U.S. GAAP. The following tables present Net sales, Operating income and Diluted net earnings per common share adjusted to exclude the impact of charges associated with restructuring and other activities; goodwill and other intangible asset impairments; talcum litigation settlement agreements; the change in fair value of DECIEM acquisition-related stock options; and the effects of foreign currency translation.
The following tables provide reconciliations between these non-GAAP financial measures and the most directly comparable U.S. GAAP measures.
THE ESTÉE LAUDER COMPANIES INC.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
($ in millions, except per share data) |
|
Three Months Ended
December 31,
|
|
Variance |
|
% Change |
|
% Change
in
constant currency
|
|
2024 |
|
2023 |
|
|
|
Net sales, as reported |
|
$ |
4,004 |
|
|
$ |
4,279 |
|
|
$ |
(275) |
|
|
(6) |
% |
|
(6) |
% |
Returns associated with restructuring and other activities |
|
— |
|
|
1 |
|
|
(1) |
|
|
|
|
|
Net sales, as adjusted |
|
$ |
4,004 |
|
|
$ |
4,280 |
|
|
$ |
(276) |
|
|
(6) |
% |
|
(6) |
% |
|
|
|
|
|
|
|
|
|
|
|
Operating income (loss), as reported |
|
$ |
(580) |
|
|
$ |
574 |
|
|
$ |
(1,154) |
|
|
(100+)% |
|
(100+)% |
Charges associated with restructuring and other activities |
|
181 |
|
|
8 |
|
|
173 |
|
|
|
|
|
Goodwill and other intangible asset impairments |
|
861 |
|
|
— |
|
|
861 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in fair value of DECIEM acquisition-related stock options |
|
— |
|
|
(5) |
|
|
5 |
|
|
|
|
|
Operating income, as adjusted |
|
$ |
462 |
|
|
$ |
577 |
|
|
$ |
(115) |
|
|
(20) |
% |
|
(19) |
% |
|
|
|
|
|
|
|
|
|
|
|
Diluted net earnings (loss) per common share, as reported |
|
$ |
(1.64) |
|
|
$ |
.87 |
|
|
$ |
(2.51) |
|
|
(100+)% |
|
(100+)% |
Charges associated with restructuring and other activities |
|
.39 |
|
|
.02 |
|
|
.37 |
|
|
|
|
|
Goodwill and other intangible asset impairments |
|
1.87 |
|
|
— |
|
|
1.87 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in fair value of DECIEM acquisition-related stock options (less portion attributable to redeemable noncontrolling interest) |
|
— |
|
|
(.01) |
|
|
.01 |
|
|
|
|
|
Diluted net earnings per common share, as adjusted |
|
$ |
.62 |
|
|
$ |
.88 |
|
|
$ |
(.26) |
|
|
(29) |
% |
|
(27) |
% |
THE ESTÉE LAUDER COMPANIES INC.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
($ in millions, except per share data) |
|
Six Months Ended
December 31,
|
|
Variance |
|
% Change |
|
% Change
in
constant currency
|
|
2024 |
|
2023 |
|
|
|
Net sales, as reported |
|
$ |
7,365 |
|
|
$ |
7,797 |
|
|
$ |
(432) |
|
|
(6) |
% |
|
(6) |
% |
Returns associated with restructuring and other activities |
|
— |
|
|
1 |
|
|
(1) |
|
|
|
|
|
Net sales, as adjusted |
|
$ |
7,365 |
|
|
$ |
7,798 |
|
|
$ |
(433) |
|
|
(6) |
% |
|
(6) |
% |
|
|
|
|
|
|
|
|
|
|
|
Operating income (loss), as reported |
|
$ |
(701) |
|
|
$ |
672 |
|
|
$ |
(1,373) |
|
|
(100+)% |
|
(100+)% |
Charges associated with restructuring and other activities |
|
287 |
|
|
10 |
|
|
277 |
|
|
|
|
|
Goodwill and other intangible asset impairments |
|
861 |
|
|
— |
|
|
861 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Talcum litigation settlement agreements |
|
159 |
|
— |
|
|
159 |
|
|
|
|
|
Change in fair value of DECIEM acquisition-related stock options |
|
— |
|
|
3 |
|
|
(3) |
|
|
|
|
|
Operating income, as adjusted |
|
$ |
606 |
|
|
$ |
685 |
|
|
$ |
(79) |
|
|
(12) |
% |
|
(12) |
% |
|
|
|
|
|
|
|
|
|
|
|
Diluted net earnings (loss) per common share, as reported |
|
$ |
(2.07) |
|
|
$ |
.95 |
|
|
$ |
(3.02) |
|
|
(100+)% |
|
(100+)% |
Charges associated with restructuring and other activities |
|
.63 |
|
|
.02 |
|
|
.61 |
|
|
|
|
|
Goodwill and other intangible asset impairments |
|
1.87 |
|
|
— |
|
|
1.87 |
|
|
|
|
|
Talcum litigation settlement agreements |
|
.34 |
|
|
— |
|
|
.34 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in fair value of DECIEM acquisition-related stock options (less portion attributable to redeemable noncontrolling interest) |
|
— |
|
|
.01 |
|
|
(.01) |
|
|
|
|
|
Diluted net earnings per common share, as adjusted |
|
$ |
.77 |
|
|
$ |
.98 |
|
|
$ |
(.21) |
|
|
(22) |
% |
|
(23) |
% |
As diluted net earnings per common share, as adjusted, is used as a measure of the Company’s performance, we consider the impact of current and deferred income taxes when calculating the per-share impact of each of the reconciling items.
THE ESTÉE LAUDER COMPANIES INC.
The following tables reconcile the change in net sales by product category and geographic region, as reported, to the change in net sales excluding the effects of foreign currency translation:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As Reported |
|
Impact of foreign currency translation |
|
Variance, in constant currency |
|
% Change, as reported |
|
% Change, in constant currency |
|
|
Three Months Ended
December 31,
|
|
|
|
|
|
|
($ in millions) |
|
2024 |
|
2023 |
|
Variance |
|
|
|
|
By Product Category: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Skin Care |
|
$ |
1,921 |
|
|
$ |
2,173 |
|
|
$ |
(252) |
|
|
$ |
2 |
|
|
$ |
(250) |
|
|
(12) |
% |
|
(12) |
% |
Makeup |
|
1,150 |
|
|
1,167 |
|
|
(17) |
|
|
11 |
|
|
(6) |
|
|
(1) |
|
|
(1) |
|
Fragrance |
|
744 |
|
|
737 |
|
|
7 |
|
|
5 |
|
|
12 |
|
|
1 |
|
|
2 |
|
Hair Care |
|
159 |
|
|
173 |
|
|
(14) |
|
|
— |
|
|
(14) |
|
|
(8) |
|
|
(8) |
|
Other |
|
30 |
|
|
30 |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
|
4,004 |
|
|
4,280 |
|
|
(276) |
|
|
18 |
|
|
(258) |
|
|
(6) |
|
|
(6) |
|
Returns associated with restructuring and other activities |
|
— |
|
|
(1) |
|
|
1 |
|
|
— |
|
|
1 |
|
|
|
|
|
Total |
|
$ |
4,004 |
|
|
$ |
4,279 |
|
|
$ |
(275) |
|
|
$ |
18 |
|
|
$ |
(257) |
|
|
(6) |
% |
|
(6) |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By Region: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The Americas |
|
$ |
1,223 |
|
|
$ |
1,242 |
|
|
$ |
(19) |
|
|
$ |
13 |
|
|
$ |
(6) |
|
|
(2) |
% |
|
— |
% |
Europe, the Middle East & Africa |
|
1,494 |
|
|
1,589 |
|
|
(95) |
|
|
4 |
|
|
(91) |
|
|
(6) |
|
|
(6) |
|
Asia/Pacific |
|
1,287 |
|
|
1,449 |
|
|
(162) |
|
|
1 |
|
|
(161) |
|
|
(11) |
|
|
(11) |
|
|
|
4,004 |
|
|
4,280 |
|
|
(276) |
|
|
18 |
|
|
(258) |
|
|
(6) |
|
|
(6) |
|
Returns associated with restructuring and other activities |
|
— |
|
|
(1) |
|
|
1 |
|
|
— |
|
|
1 |
|
|
|
|
|
Total |
|
$ |
4,004 |
|
|
$ |
4,279 |
|
|
$ |
(275) |
|
|
$ |
18 |
|
|
$ |
(257) |
|
|
(6) |
% |
|
(6) |
% |
THE ESTÉE LAUDER COMPANIES INC.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As Reported |
|
Impact of foreign currency translation |
|
Variance, in constant currency |
|
% Change, as reported |
|
% Change, in constant currency |
|
|
Six Months Ended December 31, |
|
|
|
|
|
|
($ in millions) |
|
2024 |
|
2023 |
|
Variance |
|
|
|
|
By Product Category: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Skin Care |
|
$ |
3,450 |
|
|
$ |
3,813 |
|
|
$ |
(363) |
|
|
$ |
(11) |
|
|
$ |
(374) |
|
|
(10) |
% |
|
(10) |
% |
Makeup |
|
2,188 |
|
|
2,229 |
|
|
(41) |
|
|
9 |
|
|
(32) |
|
|
(2) |
|
|
(1) |
|
Fragrance |
|
1,374 |
|
|
1,373 |
|
|
1 |
|
|
2 |
|
|
3 |
|
|
— |
|
|
0 |
|
Hair Care |
|
298 |
|
|
321 |
|
|
(23) |
|
|
— |
|
|
(23) |
|
|
(7) |
|
|
(7) |
|
Other |
|
55 |
|
|
62 |
|
|
(7) |
|
|
— |
|
|
(7) |
|
|
(11) |
|
|
(11) |
|
|
|
7,365 |
|
|
7,798 |
|
|
(433) |
|
|
— |
|
|
(433) |
|
|
(6) |
|
|
(6) |
|
Returns associated with restructuring and other activities |
|
— |
|
|
(1) |
|
|
1 |
|
|
— |
|
|
1 |
|
|
|
|
|
Total |
|
$ |
7,365 |
|
|
$ |
7,797 |
|
|
$ |
(432) |
|
|
$ |
— |
|
|
$ |
(432) |
|
|
(6) |
% |
|
(6) |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By Region: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The Americas |
|
$ |
2,410 |
|
|
$ |
2,450 |
|
|
$ |
(40) |
|
|
$ |
24 |
|
|
$ |
(16) |
|
|
(2) |
% |
|
(1) |
% |
Europe, the Middle East & Africa |
|
2,724 |
|
|
2,841 |
|
|
(117) |
|
|
(19) |
|
|
(136) |
|
|
(4) |
|
|
(5) |
|
Asia/Pacific |
|
2,231 |
|
|
2,507 |
|
|
(276) |
|
|
(5) |
|
|
(281) |
|
|
(11) |
|
|
(11) |
|
|
|
7,365 |
|
|
7,798 |
|
|
(433) |
|
|
— |
|
|
(433) |
|
|
(6) |
|
|
(6) |
|
Returns associated with restructuring and other activities |
|
— |
|
|
(1) |
|
|
1 |
|
|
— |
|
|
1 |
|
|
|
|
|
Total |
|
$ |
7,365 |
|
|
$ |
7,797 |
|
|
$ |
(432) |
|
|
$ |
— |
|
|
$ |
(432) |
|
|
(6) |
% |
|
(6) |
% |
THE ESTÉE LAUDER COMPANIES INC.
The following tables reconcile the change in operating results by product category and geographic region, as reported, to the change in operating income excluding the impact of goodwill and other intangible asset impairments and the change in fair value of DECIEM acquisition-related stock options, as well as the talcum litigation settlement agreements for the six months ended December 31, 2024:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As Reported |
|
Add:
Changes in
goodwill and other intangible asset impairments
|
|
|
|
|
|
Add:
Change in fair value of DECIEM acquisition-related stock options
|
|
Variance, as adjusted |
|
% Change, as reported |
|
% Change, as adjusted |
|
|
Three Months Ended
December 31
|
|
|
|
|
|
|
|
|
|
($ in millions) |
|
2024 |
|
2023 |
|
Variance |
|
|
|
|
|
|
|
By Product Category: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Skin Care |
|
$ |
306 |
|
|
$ |
415 |
|
|
$ |
(109) |
|
|
$ |
— |
|
|
|
|
|
|
$ |
5 |
|
|
$ |
(104) |
|
|
(26) |
% |
|
(25) |
% |
Makeup |
|
(211) |
|
|
30 |
|
|
(241) |
|
|
258 |
|
|
|
|
|
|
— |
|
|
17 |
|
|
(100+) |
|
57 |
|
Fragrance |
|
(446) |
|
|
131 |
|
|
(577) |
|
|
549 |
|
|
|
|
|
|
— |
|
|
(28) |
|
|
(100+) |
|
(21) |
|
Hair Care |
|
(3) |
|
|
(3) |
|
|
— |
|
|
— |
|
|
|
|
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
Other |
|
(45) |
|
|
9 |
|
|
(54) |
|
|
54 |
|
|
|
|
|
|
— |
|
|
— |
|
|
(100+) |
|
— |
|
|
|
(399) |
|
|
582 |
|
|
(981) |
|
|
$ |
861 |
|
|
|
|
|
|
$ |
5 |
|
|
$ |
(115) |
|
|
(100+)% |
|
(20) |
% |
Charges associated with restructuring and other activities |
|
(181) |
|
|
(8) |
|
|
(173) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
(580) |
|
|
$ |
574 |
|
|
$ |
(1,154) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By Region: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The Americas |
|
$ |
(823) |
|
|
$ |
(55) |
|
|
$ |
(768) |
|
|
$ |
861 |
|
|
|
|
|
|
$ |
5 |
|
|
$ |
98 |
|
|
(100+)% |
|
100+% |
Europe, the Middle East & Africa |
|
316 |
|
|
379 |
|
|
(63) |
|
|
— |
|
|
|
|
|
|
— |
|
|
(63) |
|
|
(17) |
|
|
(17) |
|
Asia/Pacific |
|
108 |
|
|
258 |
|
|
(150) |
|
|
— |
|
|
|
|
|
|
— |
|
|
(150) |
|
|
(58) |
|
|
(58) |
|
|
|
(399) |
|
|
582 |
|
|
(981) |
|
|
$ |
861 |
|
|
|
|
|
|
$ |
5 |
|
|
$ |
(115) |
|
|
(100+)% |
|
(20) |
% |
Charges associated with restructuring and other activities |
|
(181) |
|
|
(8) |
|
|
(173) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
(580) |
|
|
$ |
574 |
|
|
$ |
(1,154) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
THE ESTÉE LAUDER COMPANIES INC.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As Reported |
|
Add:
Changes in
goodwill and other intangible asset impairments
|
|
|
|
Add:
Talcum litigation settlement agreements
|
|
Add:
Change in fair value of DECIEM acquisition-related stock options
|
|
Variance, as adjusted |
|
% Change, as reported |
|
% Change, as adjusted |
|
|
Six Months Ended
December 31
|
|
|
|
|
|
|
|
|
|
($ in millions) |
|
2024 |
|
2023 |
|
Variance |
|
|
|
|
|
|
|
By Product Category: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Skin Care |
|
$ |
423 |
|
|
$ |
452 |
|
|
$ |
(29) |
|
|
$ |
— |
|
|
|
|
$ |
— |
|
|
$ |
(3) |
|
|
$ |
(32) |
|
|
(6) |
% |
|
(7) |
% |
Makeup |
|
(396) |
|
|
(10) |
|
|
(386) |
|
|
258 |
|
|
|
|
159 |
|
|
— |
|
|
31 |
|
|
(100+) |
|
100+% |
Fragrance |
|
(386) |
|
|
238 |
|
|
(624) |
|
|
549 |
|
|
|
|
— |
|
|
— |
|
|
(75) |
|
|
(100+) |
|
(32) |
|
Hair Care |
|
(21) |
|
|
(25) |
|
|
4 |
|
|
— |
|
|
|
|
— |
|
|
— |
|
|
4 |
|
|
16 |
|
|
16 |
|
Other |
|
(34) |
|
|
27 |
|
|
(61) |
|
|
54 |
|
|
|
|
— |
|
|
— |
|
|
(7) |
|
|
(100+) |
|
(26) |
|
|
|
(414) |
|
|
682 |
|
|
(1,096) |
|
|
$ |
861 |
|
|
|
|
$ |
159 |
|
|
$ |
(3) |
|
|
$ |
(79) |
|
|
(100+)% |
|
(12) |
% |
Charges associated with restructuring and other activities |
|
(287) |
|
|
(10) |
|
|
(277) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
(701) |
|
|
$ |
672 |
|
|
$ |
(1,373) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By Region: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The Americas |
|
$ |
(991) |
|
|
$ |
(237) |
|
|
$ |
(754) |
|
|
$ |
861 |
|
|
|
|
$ |
159 |
|
|
$ |
(3) |
|
|
$ |
263 |
|
|
(100+)% |
|
100+% |
Europe, the Middle East & Africa |
|
406 |
|
|
523 |
|
|
(117) |
|
|
— |
|
|
|
|
— |
|
|
— |
|
|
(117) |
|
|
(22) |
|
|
(22) |
|
Asia/Pacific |
|
171 |
|
|
396 |
|
|
(225) |
|
|
— |
|
|
|
|
— |
|
|
— |
|
|
(225) |
|
|
(57) |
|
|
(57) |
|
|
|
(414) |
|
|
682 |
|
|
(1,096) |
|
|
$ |
861 |
|
|
|
|
$ |
159 |
|
|
$ |
(3) |
|
|
$ |
(79) |
|
|
(100+)% |
|
(12) |
% |
Charges associated with restructuring and other activities |
|
(287) |
|
|
(10) |
|
|
(277) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
(701) |
|
|
$ |
672 |
|
|
$ |
(1,373) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
FINANCIAL CONDITION
LIQUIDITY AND CAPITAL RESOURCES
Overview
Our principal sources of funds historically have been cash flows from operations, borrowings pursuant to our commercial paper program, borrowings from the issuance of long-term debt and committed and uncommitted credit lines provided by banks and other lenders in the United States and abroad. At December 31, 2024, we had cash and cash equivalents of $2,586 million compared with $3,395 million at June 30, 2024. Our cash and cash equivalents are maintained at a number of financial institutions. To mitigate the risk of uninsured balances, we select financial institutions based on their credit ratings and financial strength, and we perform ongoing evaluations of these institutions to limit our concentration risk exposure.
Based on past performance and current expectations, we believe that cash on hand, cash generated from operations, available credit lines and access to credit markets will be adequate to support seasonal working capital needs, currently planned business operations, information technology enhancements, capital expenditures, acquisitions, dividends, stock repurchases, restructuring initiatives, commitments and other contractual obligations on both a near-term and long-term basis.
The Tax Cuts and Jobs Act resulted in the Transition Tax on unrepatriated earnings of our foreign subsidiaries and changed the tax law in ways that present opportunities to repatriate cash without additional U.S. federal income tax. We continue to analyze the indefinite reinvestment assertion on our applicable foreign earnings. We do not believe continuing to reinvest these applicable foreign earnings impairs our ability to meet our domestic debt or working capital obligations. If these reinvested earnings were repatriated into the United States as dividends, we would be subject to state income taxes and applicable foreign taxes in certain jurisdictions.
Inflation impacted our overall operating results in the fiscal 2025 second quarter and we expect it to continue. Generally, we have plans to introduce new products at higher prices, increase prices and implement other operating efficiencies which we expect to offset some of these cost increases.
THE ESTÉE LAUDER COMPANIES INC.
Credit Ratings
Changes in our credit ratings will likely result in changes in our borrowing costs. Our credit ratings also impact the cost of our revolving credit facility. Downgrades in our credit ratings may reduce our ability to issue commercial paper and/or long-term debt and would likely increase the relative costs of borrowing. A credit rating is not a recommendation to buy, sell, or hold securities, is subject to revision or withdrawal at any time by the assigning rating organization, and should be evaluated independently of any other rating. As of January 28, 2025, our long-term debt is rated A with a negative watch by Standard & Poor’s and A2 with a negative outlook by Moody’s.
THE ESTÉE LAUDER COMPANIES INC.
Debt
At December 31, 2024, our outstanding borrowings were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
($ in millions) |
|
Long-term Debt |
|
Current Debt |
|
Total Debt |
5.150% Senior Notes, due May 15, 2053 ("2053 Senior Notes") (1), (15) |
|
$ |
591 |
|
|
$ |
— |
|
|
$ |
591 |
|
3.125% Senior Notes, due December 1, 2049 (“2049 Senior Notes”) (2), (15) |
|
637 |
|
|
— |
|
|
637 |
|
4.150% Senior Notes, due March 15, 2047 (“2047 Senior Notes”) (3), (15) |
|
494 |
|
|
— |
|
|
494 |
|
4.375% Senior Notes, due June 15, 2045 (“2045 Senior Notes”) (4), (15) |
|
454 |
|
|
— |
|
|
454 |
|
3.700% Senior Notes, due August 15, 2042 (“2042 Senior Notes”) (5), (15) |
|
247 |
|
|
— |
|
|
247 |
|
6.000% Senior Notes, due May 15, 2037 (“2037 Senior Notes”) (6), (15) |
|
295 |
|
|
— |
|
|
295 |
|
5.000% Senior Notes, due February 14, 2034 ("2034 Senior Notes) (7), (15) |
|
644 |
|
|
— |
|
|
644 |
|
5.75% Senior Notes, due October 15, 2033 (“October 2033 Senior Notes”) (8), (15) |
|
198 |
|
|
— |
|
|
198 |
|
4.650% Senior Notes, due May 15, 2033 ("May 2033 Senior Notes") (9), (15) |
|
696 |
|
|
— |
|
|
696 |
|
1.950% Senior Notes, due March 15, 2031 ("2031 Senior Notes") (10), (15) |
|
552 |
|
|
— |
|
|
552 |
|
2.600% Senior Notes, due April 15, 2030 ("2030 Senior Notes") (11), (15) |
|
601 |
|
|
— |
|
|
601 |
|
2.375% Senior Notes, due December 1, 2029 (“2029 Senior Notes”) (12), (15) |
|
645 |
|
|
— |
|
|
645 |
|
4.375% Senior Notes, due May 15, 2028 ("2028 Senior Notes") (13), (15) |
|
697 |
|
|
— |
|
|
697 |
|
3.150% Senior Notes, due March 15, 2027 (“2027 Senior Notes”) (14), (15) |
|
499 |
|
|
— |
|
|
499 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other long-term borrowings |
|
26 |
|
|
— |
|
|
26 |
|
Other current borrowings |
|
— |
|
|
4 |
|
|
4 |
|
|
|
|
|
|
|
|
|
|
$ |
7,276 |
|
|
$ |
4 |
|
|
$ |
7,280 |
|
|
|
|
|
|
|
|
(1)Consists of $600 million principal, unamortized debt discount of $3 million and debt issuance costs of $6 million.
(2)Consists of $650 million principal, unamortized debt discount of $7 million and debt issuance costs of $6 million.
(3)Consists of $500 million principal, unamortized debt discount of $1 million and debt issuance costs of $5 million.
(4)Consists of $450 million principal, net unamortized debt premium of $8 million and debt issuance costs of $4 million.
(5)Consists of $250 million principal, unamortized debt discount of $1 million and debt issuance costs of $2 million.
(6)Consists of $300 million principal, unamortized debt discount of $2 million and debt issuance costs of $3 million.
(7)Consists of $650 million principal, unamortized debt discount of $2 million and debt issuance costs of $4 million.
(8)Consists of $200 million principal, unamortized debt discount of $1 million and debt issuance costs of $1 million.
(9)Consists of $700 million principal, unamortized debt discount of $1 million and debt issuance costs of $3 million.
(10)Consists of $600 million principal, unamortized debt discount of $3 million, debt issuance costs of $2 million and a $43 million loss to reflect the fair value of interest rate swaps.
(11)Consists of $700 million principal, unamortized debt discount of $1 million, debt issuance costs of $3 million and a $95 million loss to reflect the fair value of interest rate swaps.
(12)Consists of $650 million principal, unamortized debt discount of $3 million and debt issuance costs of $2 million.
(13)Consists of $700 million principal, debt issuance costs of $3 million.
(14)Consists of $500 million principal and debt issuance costs of $1 million.
(15)The Senior Notes contain certain customary covenants, including limitations on indebtedness secured by liens.
In December 2024, the Company repaid the outstanding principal balance of its $500 million, 2.000% Senior Notes at maturity with cash from operations.
Total debt as a percent of total capitalization was 64% and 59% at December 31, 2024 and June 30, 2024, respectively.
THE ESTÉE LAUDER COMPANIES INC.
Cash Flows
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended December 31, |
(In millions) |
|
2024 |
|
2023 |
Net cash flows provided by operating activities |
|
$ |
387 |
|
|
$ |
937 |
|
Net cash flows used for investing activities |
|
$ |
(294) |
|
|
$ |
(557) |
|
Net cash flows used for financing activities |
|
$ |
(878) |
|
|
$ |
(489) |
|
The change in net cash flows provided by operating activities was primarily driven by lower earnings for the six months ended December 31, 2024, excluding non-cash items, and an unfavorable change in operating assets and liabilities variances, including the impact from the significant reduction in inventory in the prior-year period, as compared to the reduction in inventory in the current-year period.
The change in net cash flows used for investing activities was primarily driven by a favorable year-over-year impact from capital expenditure payments made relating to the manufacturing facility in Japan, near Tokyo, in the prior-year period.
The change in net cash flows used for financing activities primarily reflected an increase in repayments of long-term debt due to the repayment of the outstanding principal balance of our $500 million, 2.000% Senior Notes that matured during the fiscal 2025 second quarter, partially offset by a decrease in dividends paid to stockholders.
Dividends
For a summary of quarterly cash dividends declared per share on our Class A and Class B Common Stock during the six months ended December 31, 2024, see Notes to Consolidated Financial Statements, Note 11 – Equity and Redeemable Noncontrolling Interest.
Pension and Post-retirement Plan Funding
There have been no significant changes to our pension and post-retirement funding as discussed in our Annual Report on Form 10-K for the fiscal year ended June 30, 2024.
Commitments, Contractual Obligations and Contingencies
There have been no significant changes to our commitments and contractual obligations as discussed in our Annual Report on Form 10-K for the fiscal year ended June 30, 2024. For a discussion of contingencies, see Notes to Consolidated Financial Statements, Note 8 – Commitments and Contingencies.
Derivative Financial Instruments and Hedging Activities
For a discussion of our derivative financial instruments and hedging activities, see Notes to Consolidated Financial Statements, Note 4 – Derivative Financial Instruments.
Foreign Exchange Risk Management
For a discussion of foreign exchange risk management, see Notes to Consolidated Financial Statements, Note 4 – Derivative Financial Instruments (Fair Value Hedges, Cash Flow Hedges and Net Investment Hedges).
Credit Risk
For a discussion of credit risk, see Notes to Consolidated Financial Statements, Note 4 – Derivative Financial Instruments (Credit Risk).
Market Risk
We address certain financial exposures through a controlled program of market risk management that includes the use of foreign currency forward contracts to reduce the effects of fluctuating foreign currency exchange rates and to mitigate the change in fair value of specific assets and liabilities on the balance sheet. To perform a sensitivity analysis of our foreign currency forward contracts, we assess the change in fair values from the impact of hypothetical changes in foreign currency exchange rates. A hypothetical 10% weakening of the U.S. dollar against the foreign exchange rates for the currencies in our portfolio would have resulted in a net decrease in the fair value of our portfolio of approximately $299 million and $371 million as of December 31, 2024 and June 30, 2024, respectively. This potential change does not consider our underlying foreign currency exposures.
THE ESTÉE LAUDER COMPANIES INC.
We also enter into cross-currency swap contracts to hedge the impact of foreign currency changes on certain intercompany foreign currency denominated debt and to hedge a portion of the net investment in certain foreign operations. A hypothetical 10% weakening of the U.S. dollar against the foreign exchange rates for the currencies in our cross-currency swap contracts would have resulted in a net decrease in the fair value of our cross-currency swap contracts of approximately $85 million and $49 million as of December 31, 2024 and June 30, 2024, respectively.
In addition, we enter into interest rate derivatives to manage the effects of interest rate movements on our aggregate liability portfolio, including future debt issuances. Based on a hypothetical 100 basis point increase in interest rates, the estimated fair value of our interest rate derivatives would decrease by approximately $45 million and $48 million as of December 31, 2024 and June 30, 2024, respectively.
Our sensitivity analysis represents an estimate of reasonably possible net losses that would be recognized on our portfolio of derivative financial instruments assuming hypothetical movements in future market rates and is not necessarily indicative of actual results, which may or may not occur. It does not represent the maximum possible loss or any expected loss that may occur, since actual future gains and losses will differ from those estimated, based upon actual fluctuations in market rates, operating exposures, and the timing thereof, and changes in our portfolio of derivative financial instruments during the year. We believe, however, that any such loss incurred would be offset by the effects of market rate movements on the respective underlying transactions for which the derivative financial instrument was intended.
OFF-BALANCE SHEET ARRANGEMENTS
We do not maintain any off-balance sheet arrangements, transactions, obligations or other relationships with unconsolidated entities that would be expected to have a material current or future effect upon our financial condition or results of operations.
CRITICAL ACCOUNTING POLICIES
As disclosed in our Annual Report on Form 10-K for the fiscal year ended June 30, 2024, the discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in conformity with U.S. GAAP. The preparation of these financial statements requires us to make estimates and assumptions that affect the amounts of assets, liabilities, revenues and expenses reported in those financial statements. These estimates and assumptions can be subjective and complex, and consequently, actual results could differ from those estimates. Our most critical accounting policies relate to goodwill and other indefinite-lived intangible assets - impairment assessment and income taxes. Since June 30, 2024, there have been no significant changes to the assumptions and estimates related to our critical accounting policies, except as disclosed within the Impairment Analysis During the Six Months Ended December 31, 2024 section in Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations on page 43.
RECENTLY ISSUED ACCOUNTING STANDARDS
For a discussion regarding the impact of accounting standards that were recently issued but not yet effective, on the Company’s consolidated financial statements, see Notes to Consolidated Financial Statements, Note 1 – Summary of Significant Accounting Policies.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION
We and our representatives from time to time make written or oral forward-looking statements, including in this and other filings with the Securities and Exchange Commission, in our press releases and in our reports to stockholders, which may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may address our expectations regarding sales, earnings or other future financial performance and liquidity, other performance measures, product introductions, entry into new geographic regions, information technology initiatives, new methods of sale, our long-term strategy, restructuring and other charges and resulting cost savings, and future operations or operating results. These statements may contain words like “expect,” “will,” “will likely result,” “would,” “believe,” “estimate,” “planned,” “plans,” “intends,” “may,” “should,” “could,” “anticipate,” “estimate,” “project,” “projected,” “forecast,” and “forecasted” or similar expressions. Although we believe that our expectations are based on reasonable assumptions within the bounds of our knowledge of our business and operations, actual results may differ materially from our expectations. Factors that could cause actual results to differ from expectations include, without limitation:
THE ESTÉE LAUDER COMPANIES INC.
(1)increased competitive activity from companies in the skin care, makeup, fragrance and hair care businesses;
(2)our ability to develop, produce and market new products on which future operating results may depend and to successfully address challenges in our business;
(3)consolidations, restructurings, bankruptcies and reorganizations in the retail industry causing a decrease in the number of stores that sell our products, an increase in the ownership concentration within the retail industry, ownership of retailers by our competitors or ownership of competitors by our customers that are retailers and our inability to collect receivables;
(4)destocking and tighter working capital management by retailers;
(5)the success, or changes in timing or scope, of new product launches and the success, or changes in timing or scope, of advertising, sampling and merchandising programs;
(6)shifts in the preferences of consumers as to how they perceive value and where and how they shop;
(7)social, political and economic risks to our foreign or domestic manufacturing, distribution and retail operations, including changes in foreign investment and trade policies and regulations of the host countries and of the United States;
(8)changes in the laws, regulations and policies (including the interpretations and enforcement thereof) that affect, or will affect, our business, including those relating to our products or distribution networks, changes in accounting standards, tax laws and regulations, environmental or climate change laws, regulations or accords, trade rules and customs regulations, and the outcome and expense of legal or regulatory proceedings, and any action we may take as a result;
(9)foreign currency fluctuations affecting our results of operations and the value of our foreign assets, the relative prices at which we and our foreign competitors sell products in the same markets and our operating and manufacturing costs outside of the United States;
(10)changes in global or local conditions, including those due to volatility in the global credit and equity markets, government economic policies, natural or man-made disasters, real or perceived epidemics, supply chain challenges, inflation, or increased energy costs, that could affect consumer purchasing, the willingness or ability of consumers to travel and/or purchase our products while traveling, the financial strength of our customers, suppliers or other contract counterparties, our operations, the cost and availability of capital which we may need for new equipment, facilities or acquisitions, the returns that we are able to generate on our pension assets and the resulting impact on funding obligations, the cost and availability of raw materials and the assumptions underlying our critical accounting estimates;
(11)shipment delays, commodity pricing, depletion of inventory and increased production costs resulting from disruptions of operations at any of the facilities that manufacture our products or at our distribution or inventory centers, including disruptions that may be caused by the implementation of information technology initiatives, or by restructurings;
(12)real estate rates and availability, which may affect our ability to increase or maintain the number of retail locations at which we sell our products and the costs associated with our other facilities;
(13)changes in product mix to products which are less profitable;
(14)our ability to acquire, develop or implement new information technology, including operational technology and websites, on a timely basis and within our cost estimates; to maintain continuous operations of our new and existing information technology; and to secure the data and other information that may be stored in such technologies or other systems or media;
(15)our ability to capitalize on opportunities for improved efficiency, such as publicly-announced strategies and restructuring and cost-savings initiatives, and to integrate acquired businesses and realize value therefrom;
(16)consequences attributable to local or international conflicts around the world, as well as from any terrorist action, retaliation and the threat of further action or retaliation;
THE ESTÉE LAUDER COMPANIES INC.
(17)the timing and impact of acquisitions, investments and divestitures; and
(18)additional factors as described in our filings with the Securities and Exchange Commission, including the Annual Report on Form 10-K for the fiscal year ended June 30, 2024.
We assume no responsibility to update forward-looking statements made herein or otherwise.
Item 3. Quantitative and Qualitative Disclosures About Market Risk.
The information required by this item is set forth in Item 2 of this Quarterly Report on Form 10-Q under the caption Liquidity and Capital Resources - Market Risk and is incorporated herein by reference.
Item 4. Controls and Procedures.
Our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) are designed to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission and to ensure that information required to be disclosed is accumulated and communicated to management, including our principal executive and financial officers, to allow timely decisions regarding disclosure. The Chief Executive Officer and the Chief Financial Officer, with assistance from other members of management, have reviewed the effectiveness of our disclosure controls and procedures as of December 31, 2024 and, based on their evaluation, have concluded that the disclosure controls and procedures were effective as of such date.
As part of our review of internal control over financial reporting, we make changes to systems and processes to improve such controls and increase efficiencies, while ensuring that we maintain an effective internal control environment. There have been no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) that occurred during the second quarter of fiscal 2025 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
PART II. OTHER INFORMATION
Item 1. Legal Proceedings.
For a discussion of legal proceedings, see Notes to Consolidated Financial Statements, Note 8 – Commitments and Contingencies.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
Share Repurchase Program
We are authorized by the Board of Directors to repurchase shares of our Class A Common Stock in the open market or in privately negotiated transactions, depending on market conditions and other factors. The following table provides information relating to our repurchase of Class A Common Stock during the referenced periods:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Period |
|
Total Number
of Shares
Purchased(1)
|
|
Average Price Paid Per Share |
|
Total Number of Shares Purchased as Part of Publicly Announced Program |
|
Maximum
Number of Shares
that May Yet Be
Purchased Under
the Program(2)
|
October 2024 |
|
— |
|
$ |
— |
|
|
— |
|
25,073,242 |
November 2024 |
|
364,194 |
|
67.76 |
|
|
— |
|
25,073,242 |
December 2024 |
|
— |
|
— |
|
|
— |
|
25,073,242 |
|
|
364,194 |
|
67.76 |
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
(1)Reflects shares that were repurchased by the Company to satisfy tax withholding obligations upon the payout of certain stock-based compensation arrangements.
(2)The Board of Directors has authorized the current repurchase program for up to 256.0 million shares. The total amount was last increased by the Board on October 31, 2018. Our repurchase program does not have an expiration date.
THE ESTÉE LAUDER COMPANIES INC.
Beginning in December 2022, we suspended the repurchase of shares of our Class A Common Stock under our publicly announced program. We may resume repurchases in the future.
Item 5. Other Information.
Trading Arrangements
During the fiscal 2025 second quarter, none of the Company’s directors or officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” each as defined in Item 408(a) of Regulation S-K under the Exchange Act.
Item 6. Exhibits.
|
|
|
|
|
|
|
|
|
Exhibit Number |
|
Description |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.1 |
|
|
|
|
|
10.2 |
|
|
|
|
|
10.3 |
|
|
|
|
|
10.4 |
|
|
|
|
|
10.5 |
|
|
|
|
|
31.1 |
|
|
|
|
|
31.2 |
|
|
|
|
|
32.1 |
|
|
|
|
|
32.2 |
|
|
|
|
|
101.1 |
|
The following materials from The Estée Lauder Companies Inc.’s Quarterly Report on Form 10-Q for the quarterly period ended December 31, 2024 are formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) the Consolidated Statements of Earnings (Loss), (ii) the Consolidated Statements of Comprehensive Income (Loss), (iii) the Consolidated Balance Sheets, (iv) the Consolidated Statements of Cash Flows and (v) Notes to Consolidated Financial Statements |
|
|
|
104 |
|
The cover page from The Estée Lauder Companies Inc.’s Quarterly Report on Form 10-Q for the quarterly period ended December 31, 2024 is formatted in iXBRL |
|
|
|
|
|
† Exhibit is a management contract or compensatory plan or arrangement.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
THE ESTÉE LAUDER COMPANIES INC. |
|
|
|
|
By: |
/s/ AKHIL SHRIVASTAVA |
Date: February 4, 2025 |
|
Akhil Shrivastava |
|
|
Executive Vice President and Chief Financial Officer |
|
|
(Principal Financial and Accounting Officer) |
EX-10.1
2
exhibit101_secondamendme.htm
EX-10.1
exhibit101_secondamendme
I1 | P a g e Exhibit 10.1 EXECUTION COPY SECOND AMENDMENT TO EMPLOYMENT AGREEMENT THIS SECOND AMENDMENT (“Second Amendment”) dated October 29, 2024 amends the terms of the February 9, 2011 EMPLOYMENT AGREEMENT and the February 25, 2013 Amendment to Employment Agreement and Stock Options Agreements (collectively “Agreement”) between THE ESTÉE LAUDER COMPANIES INC., a Delaware corporation (the “Company”), and FABRIZIO FREDA, a resident of New York, New York (the “Executive” or “you”). The Agreement is amended as follows: 1. Employment Term Paragraph 1 is replaced in its entirety with the following: The Executive will remain employed through June 30, 2026 (the “Term of Employment”). 2. Duties and Extent of Services Paragraph 2(a) is replaced in its entirety with the following: (a) During the Term of Employment and until such time as the Company appoints his successor to begin in role (“Successor Appointment”), the Executive shall serve as (i) President and Chief Executive Officer, reporting to the Chair subject to the control of the Board of Directors, and (ii) a member of the Board of Directors. In such capacities, the Executive shall render such executive, managerial, administrative and other services as customarily are associated with and incident to such positions, and as the Company may, from time to time, reasonably require of him consistent with such positions. Subject to the roles described in the first sentence of Section 2(c), until the Successor Appointment, Executive shall be a full-time employee of the Company and shall exclusively devote all his business time and efforts faithfully and competently to the Company and shall diligently perform to the best of his ability all of the duties required of him as President and Chief Executive Officer, and in the other positions or offices of the Company or its subsidiaries or affiliates commensurate with this status as President and Chief Executive Officer assigned to him hereunder. Paragraph 2(b) is replaced in its entirety with the following: (b) Following the Successor Appointment, the Executive will serve as a Special Advisor to the Company, reporting to the Chair until his retirement on June 30, 2026 (“Special Advisor Period”). As Special Advisor, the Executive will no longer serve as President and Chief Executive Officer; will no longer be a Section 16 Officer; and will no longer serve as a member of the Board of Directors. As Special Advisor, you will faithfully and diligently perform services requested by the Chair as well as reasonably assist in the transition of all your areas of responsibility including any board service, with such Special Advisor responsibilities taking no less than 20% of your time.
I2 | P a g e Paragraph 2(c) is replaced in its entirety with the following: The Executive currently serves on the board of directors for BlackRock and Patrinvest, which the Company has previously approved. The parties agree that until June 30, 2025, the Executive will not serve on any additional external company boards, in advisory roles or operational roles for other organizations (collectively “external roles”) unless such roles are approved in advance by the Company through the EVP, Global Human Resources, EVP & General Counsel, and the Chair of the Compensation Committee of the Board of Directors. During the remainder of the Special Advisor Period, from July 1, 2025 through June 30, 2026, the Executive may serve in external roles, provided such roles: (1) are not competitive to the Company; (2) do not interfere with the Executive’s commitments to the Company; and (3) do not otherwise create a conflict of interest, unless such roles are approved in advance by the Company through the EVP, Global Human Resources, EVP & General Counsel, and the Chair of the Compensation Committee of the Board of Directors. With respect to the approval process, the parties agree that any such request to the Company must be made in writing and if such request is not responded to within 30 days of receipt, the external role will be considered approved. Paragraph 3(a) is replaced in its entirety with the following: 3(a) Base Salary. From the date of this Second Amendment until the end of the Term of Employment, the Executive shall be paid an annual Base Salary of $2,100,000. Subject to Section 6(j) of this Agreement, which has been renumbered 6(g) herein, all amounts of Base Salary provided for hereunder shall be payable in accordance with the regular payroll policies of the Company in effect from time to time. For purposes of clarity, the Executive shall not be entitled to any separation pay or severance after the conclusion of the Term of Employment. Paragraph 3(b) is replaced in its entirety with the following: 3(b) Incentive Bonus Compensation. The Executive shall be eligible to participate in the Company’s Executive Annual Incentive Plan or any subsequent Bonus Plan for executives (the “Bonus Plan”), with aggregate target bonus opportunities to be reviewed by the Compensation Committee from time to time. For FY2025 and FY2026, the aggregate target bonus opportunity each year shall be equal to $5,775,000 and shall be subject to Company performance and otherwise subject the terms and conditions of the Bonus Plan, which are incorporated herein by reference; provided, however, that the bonus payout with respect to any fiscal year shall be paid to Executive no later than the 15th day of the third month following the end of such fiscal year and the individual performance component of the bonus payout for FY2026 shall be based solely on his personal performance as Special Advisor.
I3 | P a g e Paragraph 4(b) is replaced in its entirety with the following: 4(b) Equity-Based Compensation – PRGP Incentive Plan The Executive shall be eligible to participate in the Company’s Profit Recovery and Growth plan incentive program for Fiscal 2025 only at a target of $3,125,000. If program metrics are achieved and there is a payout under this plan, the Executive shall receive an RSU grant in August of 2025. This grant will have a two-year cliff vesting, subject to terms of plan and approval by the Compensation Committee. Participation in this plan requires the Executive to be employed by ELC on the grant date of the award. Paragraph 4(c) is replaced in its entirety with the following: 4(c) Equity-Based Compensation – Annual Awards. The Executive has already received an equity grant for FY2025. For FY2026, the Executive will receive an annual equity-based compensation award under the Share Incentive Plan, (x) the terms of which will be consistent with the grants that other Company executive officers receive and (y) which will be consistent with the combination of RSUs, PSUs and/or options that other Company executive officers receive, with a value at the time of grant of $12,500,000, with the number of shares determined in accordance with procedures generally utilized by the Company for its financial reporting at the time of grant; provided, that, the grant will not be subject to an IP percentage adjustment; provided, however, at no time shall the aggregate grants during a fiscal year exceed or be in respect of more than 500,000 shares of Class A Common Stock, as outlined in the Agreement (“shares limitation”). For purposes of this calculation, shares underlying performance share units and other performance-based awards shall be at target performance, which means that that above-target performance payouts on performance share units or any other form of performance-based awards shall not be subject to this limitation). Executive will not be eligible for any equity grants after the FY2026 grant other than the PRGP Incentive Plan for FY2025 outlined in Paragraph 4(b) above. Paragraph 5(b) is modified as follows: The terms of 5(b) Perquisite Reimbursement; Financial Counseling remain in effect during the Employment Term and the reimbursements will apply to calendar year 2025 and 2026. Following his retirement on June 30, 2026, the Company will provide the financial counseling described in this section of up to $5,000 per year for calendar years 2027, 2028 and 2029. Paragraph 5 (c) is replaced in its entirety with the following: 5(c) Executive Auto. You have the option of either returning the car to the company or purchasing it at the value it is worth at the time it is returned, to be returned no later than the end of the Term of Employment. If you return the car before the end of the Term of Employment, the Executive may receive an automobile allowance in the gross monthly amount of $1,100.00 for the remainder of the Term of Employment. The Executive acknowledges that this will result in the receipt by him of additional taxable income.
I4 | P a g e Paragraph 5 (d) is replaced in its entirety with the following: Travel & Expenses. The Company agrees to reimburse the Executive for all reasonable and necessary travel (inclusive of first-class air and private air travel consistent with past practice), business entertainment and other business out-of-pocket expenses incurred or expended by him in connection with the performance of his duties hereunder upon presentation of proper expense statements or vouchers or such other supporting information as the Company may reasonably require of the Executive. The timing of payment of such reimbursements and presentation by the Executive of expenses incurred shall be in accordance with the rules described in Section 5(b). The Company agrees that during the Special Advisor Period, the Executive’s travel plans and means of travel (e.g. private plane, first class air travel) will be subject to the approval of the Chair. Paragraph 5 (e) is replaced in its entirety with the following: 5(e) Spousal/Companion Travel. For FY2025 and FY2026, the Executive may upon prior approval of the Chair arrange for his spouse/companion or domestic partner to accompany him on up to two (2) business related travel itineraries per fiscal year, on a reasonable basis, at Company expense. Any reimbursement for such travel shall require presentation of proper expense statements or vouchers or such other supporting information as the Company may reasonably require of the Executive and shall be payable within seventy-five (75) days after the end of the calendar year of presentment. The Executive acknowledges that participation in this program will result in the receipt by him of additional taxable income. Paragraph 5 (g) is replaced in its entirety with the following: Modification of Benefits. Notwithstanding anything to the contrary contained herein, the Company reserves the right with respect to any benefit set forth in this Section 5 to modify its plans or policies applicable to such benefit, including not to provide such benefit, provided any such changes are not made solely to deprive Executive of an agreed upon benefit and were also made to all other Executive Officers of the Company and shall be subject to approval of the Compensation Committee. Paragraph 5(h) is a new section: 5(h) is a new section. 5(h) Administrative Support. During your Employment Term, the Company will continue to provide you with your existing administrative assistant support team (collectively “Admin. Team”) at the Company’s expense until June 30, 2025; from July 1, 2025 through December 31, 2025, the Company will provide you with your two most senior members of the Admin. Team; and from January 1, 2026 until March 31, 2026, the Company will provide you with one senior member of the Admin. Team, unless an earlier date is requested by the Executive. Nothing in this Second Amendment will prevent the Admin. Team from seeking alternate employment within the Company or externally or participating in the Company restructuring, provided that the Company shall use commercially reasonable efforts not to take affirmative actions to transfer the Admin. Team within
I5 | P a g e the Company during the applicable time periods above. Beginning in October 2025 and until June 30, 2028, or at an earlier date if requested by the Executive, the Company will also provide you with one dedicated administrative assistant in Milan and an office in Milan at a Company facility at the Company’s expense. Paragraph 5(i) is a new section. 5(i) My Next Season. The Company agrees to provide you with access to My Next Season transition support which must be commenced within one year of June 30, 2026. Paragraph 5(j) is a new section. 5(j) Company Driver and Security. The Company agrees to provide you with a Company driver and security services as are currently in place through December 31, 2025 and the Company shall use commercially reasonable efforts not to take affirmative actions to change the current driver until December 31, 2025. Paragraph 5(k) is a new section. 5(k) Immigration Support. The Company agrees to provide you and your family with immigration support as needed through December 31, 2027. Paragraph 5(l) is a new section. 5(l) Gratis. You will be eligible for lifetime Gratis. An annual amount of $1,280 will be available at the beginning of each year. The Retiree Gratis Pass will be mailed shortly following your retirement and purchases can be made on Beauty Perks or at the Company Store. Paragraph 5(m) is a new section. 5(m) BlackCloak. The Company will provide you and your family with coverage under the BlackCloak (or similar) program for 3 years post separation through June 30, 2029 to the extent such program continues to be offered to other Executive Officers within the Company. Section 6. Termination is modified as set forth below: A new sentence is added before 6(a) to state the following: The parties acknowledge and agree that the Executive’s retirement and transition to Special Advisor do not constitute Termination for Cause, Termination Without Cause or Termination by Executive for Material Breach under the Agreement. For purposes of clarity, the Executive shall not be entitled to any separation pay or severance after the conclusion of the Term of Employment.
I6 | P a g e Through the end of the Term of Employment, the Termination provisions in Section 6 will apply as modified below. The parties acknowledge and agree that unless otherwise specified below, if the Executive’s employment is terminated before the end of the Term of Employment, the Executive will be paid or provided any remaining compensation or benefits, subject to the terms of applicable plans and this Agreement (other than any terms that require the continued employment as a condition to receiving or retaining any such compensation or benefits), that would have been owed but have not yet been paid to the Executive under this Agreement and Second Amendment. The timing of any such payments will be made in compliance with Code section 409A. Paragraph 6(a) is replaced in its entirety with the following: 6(a) Permanent Disability. In the event of the “permanent disability” (as hereinafter defined) of the Executive during the Term of Employment, the Company shall have the right, upon written notice to the Executive, to terminate the Executive’s employment hereunder, effective upon the giving of such notice (or such later date as shall be specified in such notice). In the event of such termination, the Executive will be paid or provided any remaining compensation or benefits, subject to the terms of applicable plans and this Agreement (other than any terms that require the continued employment as a condition to receiving or retaining any such compensation or benefits), that would have been owed but have not yet been paid to the Executive under this Second Amendment, provided, however, that the Company shall only be required to pay that amount of the Executive’s Base Salary which shall not be covered by short-term disability payments or benefits or long-term disability payments or benefits, if any, to the Executive under any Company plan or arrangement. In addition, upon termination for permanent disability, the Executive shall continue to participate, to the extent permitted by applicable law and regulations and the applicable benefit plan, program or arrangement, in any and all healthcare, life insurance and accidental death and dismemberment insurance benefit plans, programs or arrangements of the Company during the Disability Continuation Period (disregarding any required delay in payments under Section 6(g)). Thereafter, the Executive’s rights to participate in such programs and plans, or to receive similar coverage, if any, shall be as determined under such programs. The timing of any such payments will be made in compliance with Code section 409A. For purposes of this Section 6(a), “permanent disability” means any disability as defined under the Company’s applicable disability insurance policy or, if no such policy is available, any physical or mental disability or incapacity that renders the Executive incapable of performing the services required of him in accordance with his obligations under Section 2 hereof for a period of six (6) consecutive months or for shorter periods aggregating six (6) months during any twelve-month period. In the event of “permanent disability” after the Term of Employment ends, the Company shall have no further obligations under this Agreement, except that the Executive will be paid or provided any remaining compensation or benefits, subject to the terms of applicable plans and this Agreement, that would have been owed but have not yet been paid to the Executive under this Second Amendment. The timing of any such payments will be made in compliance with Code section 409A. Paragraph 6(b) is replaced in its entirety with the following: 6(b) Death. In the event of the death of the Executive during the Term of Employment, Executive’s
I7 | P a g e employment and this Agreement shall automatically terminate. In the event of Executive’s death during the Term of Employment, the Company shall provide Executive’s estate with the payments and benefits described in this Agreement, subject to the terms of applicable plans and this Agreement (other than any terms that require the continued employment as a condition to receiving or retaining any such compensation or benefits), that would have been owed but have not yet been paid to the Executive under this Second Amendment. In the event of death after the Term of Employment ends, the Company shall have no further obligations under this Agreement, except that the Executive’s estate will be paid or provided any remaining compensation or benefits, subject to the terms of applicable plans and this Agreement, that would have been owed but have not yet been paid to the Executive under this Second Amendment. The timing of any such payments will be made in compliance with Code section 409A. 6(c) Termination Without Cause is deleted in its entirety. Section 6(d) Termination With Cause is renumbered as 6(c) and otherwise remains unchanged. Section 6(e) Termination by Executive is renumbered as 6(d) and otherwise remains unchanged except that if Executive resigns before June 30, 2025, Executive shall also receive the benefits described in Section 5(h) for a transition period of 3 months following such termination. If Executive remains employed through June 30, 2025, he shall receive the benefits described in Section 5(h) for the entirety of the periods set forth in Section 5(h); provided, however, that if Executive becomes reemployed after June 30, 2025 and has administrative support in his new role, the Executive will adjust the Company’s admin support to what the Executive believes is reasonably necessary for transition support from the Company. Section 6(f) Termination by Executive for Material Breach is deleted in its entirety. Section 6(g) Change in Control is deleted in its entirety. Section 6(h) Certain Limitations is renumbered as 6(e) and otherwise remains unchanged. Section 6(i) Effect of Termination is renumbered as 6(f). The first sentence is modified to delete reference to the former subparagraph 6(c) (which has been deleted from the Agreement) and otherwise remains unchanged. Section 6(j) Section 409A of the Code is renumbered as 6(g) and otherwise remains unchanged. Subparagraph (i) is modified to delete reference to Section 6(c)(iv)(A) given the former subparagraph 6(c) was deleted from the Agreement and deletes the following language “any bonus payments under Section 6(c) (iv)(B) shall be paid in a single lump sum payment on the first business day following the expiration of such six-month period” given the former subparagraph 6(c) was deleted from the Agreement but otherwise remains unchanged. Paragraph 6 (k) is renumbered 6(h) and is replaced in its entirety with the following: Section 6(h) Relocation. Unless the Executive is terminated for “cause” under this Agreement, the Company will reimburse the Executive for the actual cost of relocating Executive and his family from the New York City area to Milan, Italy. Such reimbursement shall be subject to the Executive actually undertaking relocation by June 30, 2027. The relocation will be executed in accordance with the
I8 | P a g e Company’s current relocation policy with the following exceptions: (1) temporary housing will be increased from 30 days to 6 months; (2) storage of household goods increased from 60 days to 6 months; (3) shipment of household goods may be shipped to more than one location upon request of the Executive; and (4) the Executive and his family will be permitted to travel via first class for the relocation. Section 6(l) Release of Claims is renumbered as 6(i) and is replaced in its entirety with the following: Release of Claims. As a condition precedent to the receipt of payments (other than accrued but unpaid amounts) and benefits pursuant to this Second Amendment, the Executive, or in the case of his death or Disability that prevents the Executive from performing his obligation under this Section 6(i), his personal representative, or his beneficiary, if applicable, and the Company will execute an effective general release of claims (in a form satisfactory to the Company against the Company and its subsidiaries and affiliates and their respective directors, officers, employees, attorneys and agents; provided, however, that such effective release will not affect any right that the Executive, or in the event of his death, his personal representative or beneficiary, otherwise has to any vested benefits the Executive may have in any employee benefit plan of Company or any of its subsidiaries or affiliates. Section 6(m) Modification of Severance Payments and Benefit is deleted in its entirety. Section 8 Covenant Not to Compete is superseded in its entirety and replaced with the following: 8. Covenant Not to Compete. The Executive agrees that during the Employment Term, the Executive shall not, directly or indirectly, without the prior written consent of the Company: (a) solicit, entice, persuade or induce any employee, consultant, agent or independent contractor of the Company or of any of its subsidiaries or affiliates to terminate his, her or its employment with the Company or such subsidiary or affiliate, to become employed by any person, firm or corporation other than the Company or such subsidiary or affiliate or approach any such employee, consultant, agent or independent contractor for any of the foregoing purposes, or authorize or assist in the taking of any such actions by any third party (for purposes of this Section 8 (a), the terms “employee,” “consultant,” “agent” and “independent contractor” shall include any persons with such status at any time during the six (6) months preceding any solicitation in question). These non-solicitation provisions will remain in effect for a period of 1 year from the termination of the Executive’s employment for any reason; or (b) other than with the consent of the EVP, Global Human Resources, EVP & General Counsel, and the Chair of the Compensation Committee of the Board of Directors, directly or indirectly engage, participate, or make any financial investment in, or become employed by or render consulting, advisory or other services to or for any person, firm, corporation or other business enterprise, wherever located, which is engaged, directly or indirectly, in competition with the Business or any business of the Company or any of its subsidiaries or affiliates as conducted or any business proposed to be conducted at the time of the expiration or termination of the Executive’s employment with the Company and its subsidiaries and affiliates; provided, however, that nothing in this Section 8(b) shall be construed to preclude the Executive from making any investments in the securities of any business enterprise whether or not engaged in competition with the Company or any of its subsidiaries or
I9 | P a g e affiliates, to the extent that such securities construed to preclude the Executive from making any investments in the securities of any business enterprise whether or not engaged in competition with the Company or any of its subsidiaries or affiliates, to the extent that such securities are actively traded on a national securities exchange or in the over-the-counter market in the United States or on any foreign securities exchange and represent, at the time of acquisition, not more than 3% of the aggregate voting power of such business enterprise. These non-compete provisions will remain in effect for a period of 1 year from the termination of the Executive’s employment for any reason. Note that nothing is intended to modify the provisions of the applicable Option Agreement(s), Performance Share Unit Agreement(s) and Restricted Stock Unit Agreement(s) which shall remain in full force and effect and such equity agreements have provisions that impact equity upon undertaking competitive employment. Paragraph 11 is replaced in its entirety with the following: 11. Entire Agreement. This Agreement and Second Amendment constitute an integrated agreement, containing the entire understanding of the Parties with respect to the matters addressed herein and, except as set forth in the Agreement and this Second Amendment, no representations, warranties or promises have been made or relied on by the Parties. The Agreement and this Second Amendment shall prevail over any prior communications between the Parties or their representations relative to matters addressed herein. Paragraph 19 is replaced in its entirety with the following: 19. Additional Agreements: (a) Cooperation. The Executive agrees that, both during and after your employment with the Company, you shall reasonably cooperate with the Company in the defense or prosecution of any claims or actions now in existence or which may be brought in the future against or on behalf of the Company which relate to events or occurrences that transpired while you were employed by the Company. During and after your employment, you also agree to reasonably cooperate with the Company in connection with any investigation or review of any federal, state or local regulatory authority, or internal investigation by the Company, in each case as any such investigation or review relates to events or occurrences that transpired while you were employed by the Company. Your reasonable cooperation in connection with such claims, actions and investigations shall include, but not be limited to: (i) being available to the Company upon reasonable notice, at mutually convenient times, to meet with counsel for interviews and factual investigations; (ii) being available to the Company upon reasonable notice, at mutually convenient times, to meet with counsel to prepare for discovery or trial; (iii) appearing at the Company’s request to give testimony without requiring service of a subpoena or other legal process; and (iv) providing to the Company all pertinent information and turning over to the Company all relevant documents which are or may come into your possession. The Company shall reimburse you for any reasonable out-of- pocket expenses incurred in connection with your performance of obligations pursuant to this Section (including without limitation any travel and lodging expenses which shall be provided on the same basis as when Executive was Chief Executive Officer of the Company, including obtaining prior approval as appropriate); and (b) Confidential Information/Return of Company Property. In accordance with Section 7 of the Agreement, Executive confirms that on or before June 30 2026, you will return or delete all confidential information in the Executive’s possession that is not on Company premises and will return any Company equipment or other property. The Executive will be permitted to transfer or access your personal contact information in Outlook and/or on your cell
I10 | P a g e phone. The Company agrees to transfer your current cell phone number to you. The parties agree that should the Executive wish to use or disclose Company owned information in connection with teaching or publishing opportunities, the Executive must vet the specific information at issue and obtain approval in advance by the Company through the EVP, Global Human Resources, EVP & General Counsel and the Chair. IN WITNESS WHEREOF, the parties hereto have duly executed this Agreement as of the date first written above. THE ESTĒE LAUDER COMPANIES INC. Fabrizio Freda By: /s/Michael O’Hare /s/ Fabrizio Freda Michael O’Hare Executive Vice President, Global Human Resources Date: Oct 29th, 2024 Date: Oct 28, 2024
EX-10.2
3
exhibit102_amendedandres.htm
EX-10.2
exhibit102_amendedandres
Page | 1 EXECUTION COPY Exhibit 10.2 EMPLOYMENT AGREEMENT THIS AGREEMENT (“Agreement”) dated October 29, 2024, amends and restates the terms of the January 30, 2023 Agreement (“2023 Agreement”) between THE ESTÉE LAUDER COMPANIES INC., a Delaware corporation (the “Company”), and Stéphane de La Faverie, a resident of New York, New York (the “Executive” or “you”). W I T N E S S E TH: WHEREAS, the Company and its subsidiaries are principally engaged in the business of manufacturing, marketing and/or selling skin care, makeup, fragrance, home, bath and body, and hair care products and related services (the “Business”); and WHEREAS, the Executive became an Executive Officer of the Company on November 18, 2022, with his former title of Executive Group President; and WHEREAS, the Company desires to retain the services of the Executive as the President and Chief Executive Officer and/or any subsequent title or role agreed upon by the parties, and the Executive desires to provide services in such capacity to the Company, upon the terms and subject to the conditions hereinafter set forth; and WHEREAS, the Compensation Committee of the Board of Directors of the Company (the “Compensation Committee”) and the Stock Plan Subcommittee of the Compensation Committee have approved the terms of this Agreement on October 28, 2024. NOW, THEREFORE, in consideration of the foregoing and of the mutual covenants and obligations hereinafter set forth, the parties hereto, intending to be legally bound, hereby agree as follows: 1. Employment Term; Effectiveness The parties agree that the terms of the 2023 Agreement remain in effect until January 1, 2025, the effective date of this Agreement (the “Effective Date”). The Company hereby agrees to continue to employ the Executive, and the Executive hereby agrees to enter into employment, as President and Chief Executive Officer of the Company as of January 1, 2025, subject to termination pursuant to the terms of this Agreement. The period from January 1, 2025, through the date of termination of Executive’s employment with the Company shall be the “Term of Employment”. 2. Duties and Extent of Services. (a) During the Term of Employment, the Executive shall serve as: (i) President and Chief Executive Officer, reporting to Board of Directors; and (ii) while serving as President and Chief Executive Officer, a member of the Board of Directors. In such capacities, the Executive shall render such executive, managerial, administrative and other services as customarily are associated with and incident to such positions, and as the Company may, from time to time, reasonably require of the Executive consistent with such positions.
Page | 2 (b) The Executive shall also hold such other positions and executive offices of the Company and/or of any of the Company’s subsidiaries or affiliates as may from time to time be agreed by the Executive or assigned by the Board of Directors, provided that each such position shall be commensurate with the Executive’s standing in the business community as President and Chief Executive Officer of the Company. The Executive shall not be entitled to any compensation other than the compensation provided for herein for serving during the Term of Employment in any other office or position of the Company or any of its subsidiaries or affiliates, unless the Board of Directors of the Company or the appropriate committee thereof shall specifically approve such additional compensation. (c) The Executive shall be a full-time “at will” employee of the Company and shall exclusively devote all their business time and efforts faithfully and competently to the Company and shall diligently perform to the best of their ability all of the duties required of them as President and Chief Executive Officer and in the other positions or offices of the Company or its subsidiaries or affiliates assigned to their hereunder. Notwithstanding the foregoing provisions of this section, the Executive may serve as a non-management director of such business corporations (or in a like capacity in other for-profit or not-for-profit organizations) subject to the Company’s Policy for employees serving on boards. (d) The Executive shall comply with the Company's stock ownership guidelines applicable to the Executive as they may be implemented and/or amended by the Board of Directors or the Compensation Committee of the Board of Directors. 3. Cash Compensation (a) Base Salary. As compensation for all services to be rendered pursuant to this Agreement and as payment for the rights and interests granted by Executive hereunder, the Company shall pay or cause any of its subsidiaries to pay the Executive a base salary (the “Base Salary”) during the Term of Employment subject to the provisions of this Agreement. Your annual Base Salary effective January 1, 2025, shall be $1,500,000. Subject to the terms of this Agreement, all amounts of Base Salary provided for hereunder shall be periodically reviewed and, where appropriate in conjunction with the Company’s compensation policies, adjusted and payable in accordance with the regular payroll policies of the Company in effect from time to time. Notwithstanding the foregoing, Base Salary may not be reduced during the Term of Employment, except as otherwise agreed to by Executive or as a result of a proportionate, across- the-board reduction of base salaries payable to similarly situated executives at the Company. Executive’s Base Salary shall be paid in equal installments according to the Company’s normal payroll schedule and practices. (b) Incentive Bonus Compensation. The Executive shall be eligible to participate in the Company’s Executive Annual Incentive Plan or any subsequent Bonus Plan for executives that is approved by the stockholders of the Company (the “Bonus Plan”), with aggregate target bonus opportunities to be reviewed by the Compensation Committee from time to time. Effective January 1, 2025, the Executive’s aggregate target bonus opportunity shall be equal to $3,000,000, which for FY2025 will be prorated based on time in the President and Chief Executive Officer role. The remainder of the prorated bonus opportunity for FY2025 will be based on the target bonus opportunity while Executive was in the Executive Group President role. Any target bonus opportunities granted to the Executive shall be reviewed for adjustment, as appropriate, but not set lower than $3,000,000 in accordance with regular policies of the Company in effect from time to time, subject to the terms and conditions of the Bonus Plan, which are incorporated herein by reference; provided, however, that the bonus payout with respect to any fiscal year shall be paid to the Executive on or about the 15th day of the third month following the end of such fiscal
Page | 3 year. In the event of any conflict(s) between the terms of the Bonus Plan and this Agreement, the Bonus Plan will control with respect to such conflict(s). (c) Deferral. (i) Deferral Elections—In General. During the Term of Employment, the Executive may elect to defer payment of all or any part of any salary or incentive compensation payable under this Section by making an election, in a manner prescribed by the Company, on or before December 31 of the calendar year before the fiscal year begins (or such earlier date as may be necessary to comply with the applicable tax laws and regulations). (ii) Deferral Elections—Performance-Based Compensation. For any incentive bonus compensation that qualifies as performance-based compensation under Treas. Reg. Section 1.409A-1(e) and is based upon a performance period of at least twelve (12) months, the Executive may make a deferral election at any time before the date that is six (6) months before the applicable performance period ends, but only if (i) the incentive bonus compensation is not readily ascertainable when the election is made and (ii) the service provider has performed services continuously from the later of the beginning of the performance period or the date the performance criteria are established. (iii) Credit on Amounts Deferred. Any amounts deferred by Executive will be credited to a bookkeeping account in the name of the Executive as of the date scheduled for payment (the “Deferred Compensation Account”). The Deferred Compensation Account will be credited with interest as of each June 30 during the term of deferral, compounded annually, at an annual rate equal to the annual rate of interest announced by Citibank N.A. in New York, New York as its base rate in effect on such June 30, but limited to a maximum annual rate of 9%. (iv) Payment of Amounts Deferred and Vested. Subject to the terms of this Agreement, amounts credited to the Executive’s Deferred Compensation Account will be paid to the Executive (or the Executive’s designated beneficiary if the Executive dies before payment), subject to applicable withholding taxes on, or as soon as practicable after, the date the Executive separates from service with the Company (as defined in Treas. Reg. section 1.409A-1(h)) but in no event later than the end of the calendar year in which Executive separates from service or, if later, the 15th day of the third month following the date the Executive separates from service. The Company, in its sole discretion, may provide an investment facility for all or a portion of such deferred amounts, but is not required to do so. (d) One-Time Payment. The Executive shall receive a one-time payment of $25,000 as soon as practicable following the date on which this Agreement is signed by the parties, but no later than 45 days following such date. 4. Equity-Based Compensation (a) General. During the Term of Employment, the Executive shall be eligible to participate in the Amended and Restated Fiscal 2002 Share Incentive Plan or such other share incentive plan that is approved by the stockholders of the Company (the “Share Incentive Plan”). Any awards or opportunities granted to the Executive shall be subject to the terms and conditions of the Share Incentive Plan, which are incorporated herein by reference. The specific equity-based compensation awards shall be set forth in separate grant agreements approved by the Stock Plan Subcommittee of the Compensation Committee and applied to similar equity-based compensation awards granted to Executive Officers of the Company. (b) Annual Awards. As of the Effective Date, the Executive’s annual equity-based
Page | 4 compensation award target opportunity under the Share Incentive Plan shall be of a value at the time of grant of no less than $10,000,000. For FY2025, the target opportunity will be prorated based on time in the President and Chief Executive Officer role, with the remainder of the prorated target opportunity for FY2025 based on the target opportunity while Executive was in the Executive Group President role. For purposes of clarity, the Executive will receive an additional grant with a value of $3,259,500, which, including the equity grant receiving in August 2024, makes his total prorated grant value for FY2025 $6,740,500. This is expected to be provided in February 2025, subject to approval by the Stock Plan Subcommittee pursuant to its usual procedures. Annual grants will be made based on the assessment of your performance (subject to the appropriate grant date approvals). Thereafter, the equity-based compensation target opportunity shall be reviewed by the Compensation Committee for adjustment, as appropriate, in accordance with regular policies of the Company in effect from time to time, subject to the terms and conditions of the Share Incentive Plan. The number of underlying shares granted will be determined in accordance with procedures generally utilized by the Company for its financial reporting at the time of grant; provided, however, at no time shall the aggregate annual grants (excluding any grants made pursuant to the PRGP (as defined below)) during a fiscal year exceed or be in respect of more than the equivalent of 333,333 full-value shares of Class A Common Stock (not taking into account any stock splits or similar capitalization events). For purposes of this calculation, shares underlying performance share units and other performance-based awards shall be at target performance, which means that above- target performance payouts on performance share units or any other form of performance-based awards shall not be subject to this limitation. (c) .Equity-Based Compensation - PRGP IP. The Executive shall be eligible to participate in the Company’s Profit Recovery and Growth Plan incentive program for FY2025 and FY2026 at a target opportunity of 25% of Executive’s annual equity based compensation award target opportunity, up to a maximum of 50%. This amount will not be prorated for Executive’s time in roles. If program metrics are achieved and there is a payout under this plan, the Executive shall receive an RSU grant in August of 2025 and August 2026. This grant will have a two-year cliff vesting, subject to the terms of the plan and approval by the Compensation Committee. Participation in this plan requires the Executive to be employed by the Company on the grant date of the award. (d) Certain Conditions. Executive acknowledges and agrees that any grant of equity- based compensation shall be effective as provided only to the extent permitted by the Share Incentive Plan, and this Agreement shall not obligate the Company to adopt any successor plan providing for the grant of equity-based compensation. If authority over the Company’s equity compensation programs is changed from the Stock Plan Subcommittee to the Compensation Committee (or other committee), then after such change, references herein to the Stock Plan Subcommittee shall be to the appropriate committee. 5. Recoupment Policy. Compensation paid to Executive, including certain incentive and equity compensation, shall be subject to any recoupment policy adopted by the Company as it exists from time to time. 6. Benefits. (a) Standard Benefits. During the Term of Employment, the Executive shall be entitled to participate in all pension and retirement savings, fringe benefit and welfare plans, including group term life insurance, medical, health and accident, disability, and vacation plans and programs maintained by the Company from time to time for employees. During the Term of Employment, the Executive shall also be entitled to participate in additional benefits and programs as described in this Section for senior executives at a level commensurate with their position. The Executive acknowledges
Page | 5 that participation in such programs may result in the receipt of additional taxable income. (b) Perquisite Reimbursement; Financial Counseling. During the Term of Employment, the Company shall reimburse the Executive for the actual expenses incurred in connection with their professional standing, in accordance with the guidelines set out in the Company’s Senior Executive Compensation Program Perquisite Plan and upon presentation of proper expense statements or vouchers or such other supporting information as the Company may reasonably require of the Executive. Such reimbursement shall generally occur within seventy-five (75) days after the end of the calendar year of presentment, provided that such presentment occurs within ninety (90) days after the date the related expenses were incurred. Notwithstanding the above, to the extent that the expenses were incurred in one calendar year and presentment occurs in the following calendar year, such reimbursement shall occur by the end of the calendar year in which the presentment occurs. In no event shall the gross amount of such reimbursements be greater than $25,000 in respect of expenses incurred during any calendar year, nor shall amounts that are not reimbursed in one calendar year up to the $25,000 per year limitation be able to be used in another calendar year or otherwise be made available to the Executive. Additionally, the Company will pay directly to the service provider following presentment of invoice(s) reasonably acceptable to the Company up to $5,000 per year for reasonable financial counseling services for the Executive, and in no event shall amounts up to the $5,000 per year limitation that are not paid in one calendar year be able to be used in another calendar year or otherwise be made available to the Executive. The Executive acknowledges that participation in such programs will result in the receipt of additional taxable income. (c) Executive Auto. During the Term of Employment, the Executive will participate in the Executive Automobile Program of the Company will receive a monthly automobile allowance in accordance with the terms of said program. The Executive acknowledges that participation in this program will result in the receipt of additional taxable income. (d) Expenses. During the Term of Employment, the Company agrees to reimburse the Executive for all reasonable and necessary travel (inclusive of first-class air travel), business entertainment and other business out-of-pocket expenses incurred or expended in connection with the performance of the Executive’s duties hereunder upon presentation of proper expense statements or vouchers or such other supporting information as the Company may reasonably require of the Executive. The timing of payment of such reimbursements and presentation by the Executive of expenses incurred shall be in accordance with the rules described in this Section. (e) Spousal/Companion Travel. During the Term of Employment, the Executive may upon prior approval of the President and Chief Executive Officer or his respective designee(s), arrange for spouse/companion or domestic partner to accompany the Executive on up to two (2) business related travel itineraries per fiscal year, on a reasonable basis, at Company expense. Any reimbursement for such travel shall require presentation of proper expense statements or vouchers or such other supporting information as the Company may reasonably require of the Executive and shall be payable within seventy-five (75) days after the end of the calendar year of presentment. The Executive acknowledges that participation in this program will result in the receipt of additional taxable income. (f) Executive Term Life Insurance. During the Term of Employment, the Company shall pay premiums on a term life insurance policy or successor life insurance policy with a face amount of $5,000,000. Such obligation to pay premiums is subject to standard underwriting conditions. The Executive acknowledges that this coverage will result in the receipt of additional taxable income. (g) Modification of Benefits. Notwithstanding anything to the contrary contained herein, the Company reserves the right with respect to any benefit set forth in this Section or in Section
Page | 6 3(c) above to modify such benefit or not to provide such benefit, provided that no such action will apply to the Executive unless it applies across-the-board to the Company’s other Executive Officers. Changes in any benefit provided solely to Executive Officers of the Company shall be subject to approval of the Compensation Committee. 7. Termination. (a) Permanent Disability. In the event of the “permanent disability” (as hereinafter defined) of the Executive during the Term of Employment, the Company shall have the right, upon written notice to the Executive, to terminate the Executive’s employment hereunder, effective upon the giving of such notice (or such later date as shall be specified in such notice). In the event of such termination, the Company shall have no further obligations hereunder, except that the Executive shall be entitled to receive (i) any accrued but unpaid salary and other amounts to which the Executive otherwise is entitled hereunder prior to the date of their termination of employment, in accordance with the terms of this Agreement (including any reimbursable business or perquisite expenses incurred but not yet submitted for reimbursement prior to the date of termination of employment), plus all benefits under the employee benefit programs and plans of the Company (including the Share Incentive Plan and the Deferred Compensation Account) as determined under such programs and plans upon and as of such a termination, including, if applicable, accrued but unused vacation (collectively, the “Accrued Benefits”); (ii) bonus compensation earned but not paid under this Agreement that relates to any fiscal year ended prior to the date of their termination of employment; (iii) a pro-rata portion of the annual bonus payout that the Executive would have been entitled to receive had the Executive remained in employment through the end of the fiscal year during which termination due to permanent disability occurred, based on the portion of the fiscal year that has elapsed prior to such termination, and paid in accordance with Section 3(b) hereof (provided, that such payment shall not be made prior to the sixtieth (60th) day following the Executive’s date of termination); (iv) reimbursement for financial counseling services under Section 6(b) hereof for a period of one (1) year from the date of termination, paid in accordance with Section 6(b) hereof (provided, that no such payment shall be made prior to the sixtieth (60th) day following the Executive’s date of termination); and (v) their Base Salary at a rate equal to the highest rate during the past twelve (12) months for a period of one (1) year from the date of termination as a result of permanent disability, paid in accordance with Section 3(a) hereof (the “Disability Continuation Period”), and Section 7(j)(i) hereof (provided, that such payments shall not commence prior to the sixtieth (60th) day following the Executive’s date of termination); provided, however, that the Company shall only be required to pay that amount of the Executive’s Base Salary which shall not be covered by short-term disability payments or benefits or long-term disability payments or benefits, if any, to the Executive under any Company plan or arrangement. In addition, upon termination for permanent disability, the Executive shall continue to participate, to the extent permitted by applicable law and regulations and the applicable benefit plan, program or arrangement, in any and all healthcare, life insurance and accidental death and dismemberment insurance benefit plans, programs or arrangements of the Company during the Disability Continuation Period (disregarding any required delay in payments under this Section). Thereafter, the Executive’s rights to participate in such programs and plans, or to receive similar coverage, if any, shall be as determined under such programs. Because continued participation in any qualified pension and qualified retirement savings plans of the Company is not permitted during the Disability Continuation Period, the Company shall provide to the Executive, subject to the terms of this Section, a lump sum cash payment, within 60 days of the end of the Disability Continuation Period, equal to the sum of (x) the maximum qualified defined contribution retirement savings plan match for pre-tax and after-tax contributions allowable by the plan and by applicable laws and regulations for each year during the Disability Continuation Period (or other period as expressly provided herein), and (y) the excess of the benefit that would have been received by the Executive had they
Page | 7 been credited with additional years of age and service equal to the Disability Continuation Period (or other period as expressly provided herein) over the actual benefit to which the Executive is entitled, in each case, under any and all qualified and non-qualified defined benefit pension plans and qualified defined contribution retirement savings plans in which the Executive participates as of the date of termination of employment, calculated as of and based upon the Executive’s date of termination (such sum the “Pension Replacement Payment”). Notwithstanding the above, any amounts payable under this Section that are separation pay as described under Treas. Reg. §1.409A-1(b)(9)(iii)(A) shall be paid no later than December 31 of the second calendar year following the year in which the Executive’s termination for permanent disability occurs; any amounts payable under this Section that are not otherwise exempt from Code section 409A are subject to, and payable in accordance with, Section 7(j) of this Agreement. Except as otherwise provided in this Section 7(a), the Company will have no further obligations under Sections 3, 4 and 6 hereof or otherwise. For purposes of this Section 7(a), “permanent disability” means any disability as defined under the Company’s applicable disability insurance policy or, if no such policy is available, any physical or mental disability or incapacity that renders the Executive incapable of performing the services required of the Executive in accordance with their obligations under Section 2 hereof for a period of six (6) consecutive months or for shorter periods aggregating six (6) months during any twelve-month period. (b) Death. In the event of the death of the Executive during the Term of Employment, Executive’s employment and this Agreement shall automatically terminate. In the event of such termination the Company shall have no further obligations hereunder, except to pay or provide to the Executive’s beneficiary or legal representative (i) the Accrued Benefits; (ii) bonus compensation earned but not paid under Section 3(b) hereof that relates to any fiscal year ended prior to the date of death, paid in accordance with Section 3(b) hereof; (iii) a pro-rata portion of the annual bonus payout the Executive would have been entitled to receive had they remained in the employ of the Company through the end of the fiscal year during which termination due to their death occurred, based on the portion of the fiscal year that has elapsed prior to such termination, and paid in accordance with Section 3(b) hereof (provided, that such payment shall not be made prior to the sixtieth (60th) day following the Executive’s date of termination); (iv) reimbursement for financial counseling services under Section 6(b) hereof for a period of one (1) year from the date of termination, paid in accordance with Section 6(b) hereof (provided, that no such payment shall be made prior to the sixtieth (60th) day following the Executive’s date of termination); and (v) for a period of one (1) year from the date of death, the Executive’s Base Salary as established under Section 3(a) hereof as of the date of death, paid in accordance with Section 3(a) hereof (provided, that such payments shall not commence prior to the sixtieth (60th) day following the Executive’s date of termination); further provided, however, that, except as otherwise provided in this Section, the Company will have no further obligations under Sections 3, 4 and 6 hereof or otherwise. (c) Termination Without Cause. The Company shall have the right, upon ninety (90) days’ prior written notice given to the Executive, to terminate the Executive’s employment for any reason whatsoever (except for Cause (as defined below)). In the event of such termination, the Company shall have no further obligations hereunder, except that the Executive shall be entitled to (i) receive the Accrued Benefits; (ii) receive bonus compensation earned but not paid that relates to any fiscal year ended prior to the date of termination without Cause, paid in accordance with the terms of this Agreement; (iii) receive a pro-rata portion of the annual bonus payout that the Executive would have been entitled to receive had they remained in employment through the end of the fiscal year during which the termination without Cause occurred, based on the portion of the fiscal year that has elapsed prior to such termination, and paid in accordance with the terms of this Agreement (provided, that such payment shall not be made prior to the sixtieth (60th) day following the Executive’s date of termination); (iv) receive the following post- termination payments and benefits: A) for a period ending on a date two (2) years from the date of termination without Cause, in accordance with the regular payroll policies of the Company in effect from time to time, their Base Salary as established under and paid in accordance with the terms of this Agreement
Page | 8 and (B) bonus compensation equal to fifty percent (50%) of the average of the actual annual bonuses (or target bonus, if the Executive has not yet received an actual bonus) paid or payable to the Executive under the Bonus Plan during the past two (2) completed fiscal years paid in accordance with the terms of this Agreement (provided, that such payment shall not be made prior to the sixtieth (60th) day following the Executive’s date of termination); (v) receive reimbursement for financial counseling services under Section 6(b) hereof for a period of two (2) years from the date of termination, paid in accordance with the terms of this Agreement (provided, that no such payment shall be made prior to the sixtieth (60th) day following the Executive’s date of termination); and (vi) participate for a period ending on a date two (2) years from the date of termination without Cause (the “Without Cause Continuation Period”), to the extent permitted by applicable law and regulations and the applicable benefit plan, program or arrangement, in any and all qualified and non-qualified pension and qualified retirement savings, healthcare, life insurance and accidental death and dismemberment insurance benefit plans, programs or arrangements, on terms identical to those applicable to full-term senior officers of the Company. Because continued participation in any qualified pension and qualified retirement savings plans of the Company is not permitted during the Without Cause Continuation Period, the Company shall provide to the Executive, subject to this Section, a lump sum cash payment, to be paid within 60 days after the end of the Without Cause Continuation Period, equal to the Pension Replacement Payment (provided, that such payments shall not commence prior to the sixtieth (60th) day following the Executive’s date of termination). Notwithstanding the above, any amounts payable under this Section that are separation pay as described under Treas. Reg. §1.409A- 1(b)(9)(iii)(A) shall be paid no later than December 31 of the second calendar year following the year in which the Executive’s termination pursuant to this Section occurs; any amounts payable under this Section that are not otherwise exempt from Code section 409A are subject to, and payable in accordance with, Section 7(j) of this Agreement. Except as otherwise provided in this Section, the Company will have no further obligations under Sections 3, 4 and 6 hereof or otherwise. In the event of termination without Cause, the Executive shall not be required to mitigate damages hereunder. (d) Cause. The Company shall have the right, upon notice to the Executive, to immediately terminate the Executive’s employment under this Agreement for “Cause” (as defined below), effective upon the Executive’s receipt of such notice (or such later date as shall be specified in such notice), and the Company shall have no further obligations hereunder, except to pay the Executive the Accrued Benefits. Except as otherwise provided in this Section 7(d), the Company will have no further obligations under Sections 3, 4 and 6 hereof or otherwise. For purposes of this Agreement, “Cause” means: (i) a material breach of, or the willful failure or refusal by the Executive to perform and discharge duties or obligations they have agreed to perform or assume under this Agreement (other than by reason of disability or death) that, if capable of correction, is not corrected within ten (10) business days following notice thereof to the Executive by the Company, such notice to state with specificity the nature of the breach, failure or refusal; (ii) willful misconduct by the Executive, unrelated to the Company or any of its subsidiaries or affiliates, that could reasonably be anticipated to have a material adverse effect on the Company or any of its subsidiaries or affiliates (the determination of Cause to be made by the Company’s Board of Directors in their reasonable judgment); (iii) the Executive’s gross negligence, whether related or unrelated to the business of the Company or any of its subsidiaries or affiliates which could
Page | 9 reasonably be anticipated to have a material adverse effect on the Company or any of its subsidiaries or affiliates that, if capable of correction, is not corrected within ten (10) business days following notice thereof to the Executive by the Company, such notice to state with specificity the nature of the conduct complained of (the determination of Cause to be made by the Company’s Board of Directors in their reasonable judgment); (iv) the Executive’s failure to follow a material lawful directive of the Chair or the Board of the Directors of the Company that is within the scope of the Executive’s duties for a period of ten (10) business days after notice from the Board of Directors of the Company specifying the performance required; (v) any violation by the Executive of a policy contained in the Code of Conduct of the Company (the determination of Cause to be made by the Company’s Board of Directors in their reasonable judgment); (vi) drug or alcohol abuse by the Executive that materially affects the Executive’s performance of their duties under this Agreement; or (vii) conviction of, or the entry of a plea of guilty or nolo contendere by the Executive for, any felony. (e) Termination by Executive. The Executive shall have the right, exercisable at any time during the Term of Employment, to terminate their employment for any reason whatsoever, upon ninety (90) days’ prior written notice to the Company or, if less, a notice period as otherwise agreed to by the Company. Upon such termination, the Company shall have no further obligations hereunder other than to (i) pay the Executive the Accrued Benefits; and (ii) provide bonus compensation, if any, earned but not paid that relates to any fiscal year ended prior to the date of such a termination by the Executive, in accordance with the terms of this Agreement. Except as otherwise provided in this Section 7(e), the Company will have no further obligations under Sections 3, 4 and 6 hereof or otherwise. For the purpose of this Agreement, retirement by the Executive will be deemed “Termination by Executive” in accordance with this section. (f) Termination by Executive for Material Breach. The Executive shall have the right, exercisable by notice to the Company, to terminate their employment effective ninety (90) days after the giving of such notice, if, at any time during the Term of Employment, the Company shall be in material breach of its obligations hereunder; provided, however, that such notice must be provided to the Company within thirty (30) days of the date on which the Executive obtains knowledge or reasonably should obtain knowledge of such material breach; and provided further, that such termination will not become effective if within thirty (30) days after receiving the notice the Company shall have cured all such material breaches of its obligations hereunder. For purposes of this Section 7(f), a material breach shall only be (i) a material reduction in the Executive’s authority, functions, duties, responsibilities or title provided in Section 2 hereof, (ii) a material reduction in the Executive’s total aggregate target compensation, as set pursuant to Sections 3(a) and (b) and Section 4(b) hereof, but in no event if the reduction is occasioned as result of similar, commensurate reductions to executive officers and/or employees generally, or (iii) the Company's failure to pay any award that the Executive is entitled to receive pursuant to the terms of this Agreement. Such termination shall be deemed to be a termination without Cause, the Executive will be entitled to the amounts set forth in Section 7(c) above, and except as otherwise provided in this Section 7(f), the Company will have no further obligations under Sections 3, 4 and 6 hereof or otherwise.
Page | 10 (g) Termination for Good Reason following Change of Control. Within two (2) years after the occurrence of a Change of Control, the Executive may terminate employment for Good Reason. Such termination shall be deemed to be a termination without Cause, the Executive will be entitled to the amounts set forth in Section 7(c) above, and except as otherwise provided in this Section 7(g), the Company will have no further obligations under Sections 3, 4 and 6 hereof or otherwise. (i) Definitions. For purposes of this Agreement, (A) a “Change of Control” shall be deemed to have occurred upon any of the following events: (1) a change in control of a nature that would be required to be reported in response to Item 6(e) of Schedule 14A of Regulation 14(A) promulgated under the Securities Exchange Act of 1934, as amended; or (2) during any period of two (2) consecutive years, the individuals who at the beginning of such period constitute the Company’s Board of Directors or any individuals who would be “Continuing Directors” (as defined below) cease for any reason to constitute a majority thereof; or (3) the Company’s Class A Common Stock shall cease to be publicly traded; or (4) the Company’s Board of Directors shall approve a sale of all or substantially all of the assets of the Company, and such transaction shall have been consummated; or (5) the Company’s Board of Directors shall approve any merger, exchange, consolidation, or like business combination or reorganization of the Company, the consummation of which would result in the occurrence of any event described in Section 7(g)(i)(A)(2) or (3) above, and such transaction shall have been consummated. Notwithstanding the foregoing, (X) changes in the relative beneficial ownership among members of the Lauder family and family-controlled entities shall not, by itself, constitute a Change of Control of the Company, (Y) any spin-off of a division or subsidiary of the Company to its stockholders shall not constitute a Change of Control of the Company. (B) “Continuing Directors” shall mean (1) the directors in office on the date hereof and (2) any successor to such directors and any additional director who after the date hereof was nominated or selected by a majority of the Continuing Directors in office at the time of his or her nomination or selection.
Page | 11 (C) “Good Reason” means the occurrence of any of the following, without the express written consent of the Executive, within two (2) years after the occurrence of a Change in Control: (1) (a) the assignment to the Executive of any duties inconsistent in any material adverse respect with the Executive’s position, authority or responsibilities as contemplated by this Agreement, or (b) other material adverse change in such position, including title, authority or responsibilities; (2) any failure by the Company to comply with any provisions of Section 3, 4 or 6 hereof or a material reduction of the overall amounts set by the Compensation Committee or the Stock Plan Subcommittee and in effect within twelve (12) months prior to the Change in Control, other than an insubstantial or inadvertent failure remedied by the Company promptly after receipt of notice thereof given by the Executive; (3) the Company’s requiring the Executive to be based at any office or location more than fifty (50) miles from that location at which they performed their services specified under this Agreement immediately prior to the Change in Control, except for travel reasonably required in the performance of the Executive’s responsibilities; or (4) any failure by the Company to obtain the assumption and agreement to perform this Agreement by a successor as contemplated by this Agreement, unless such assumption occurs by operation of law. (h) Certain Limitations. (i) (A) a “Payment” means any payment or distribution in the nature of compensation to or for the benefit of the Executive, whether paid or payable pursuant to this Agreement or otherwise; (B) “Net After-Tax Receipt” shall mean the Present Value of a Payment net of all taxes imposed on the Executive with respect thereto under Sections 1 and 4999 of the Code and under applicable state and local laws, determined by applying the highest marginal rate under Section 1 of the Code and under state and local laws which applied to the Executive’s taxable income for the immediately preceding taxable year, or such other rate(s) as the Executive shall certify, in the Executive’s sole discretion, as likely to apply to the Executive in the relevant tax year(s); (C) “Present Value” shall mean such value determined in accordance with Sections 280G(b)(2)(A)(ii) and 280G(d)(4) of Code; (D) “Reduced Amount” shall mean the amount that (1) has a Present Value that is less than the Present Value of all Payments (without application of this Section 7(h)) and (2) results in aggregate Net After-Tax Receipts for all such Payments (after application of this Section 7(h)) that are greater than the Net After-Tax Receipts for all such Payments would have been made if this Section 7(h) were not applied; and (E) “Code” shall mean the Internal Revenue Code of 1986, as amended.
Page | 12 (ii) Anything in the Agreement to the contrary notwithstanding, in the event that a nationally recognized certified public accounting firm (other than the firm serving as the Company’s independent auditor) as may be designated by the Executive (the “Accountants”) determine that receipt of all Payments would subject the Executive to tax under Section 4999 of the Code, the Accountants shall determine whether some amount of Payments meets the definition of “Reduced Amount.” If the Accountants determine that there is a Reduced Amount, then the aggregate Payments shall be reduced to such Reduced Amount. (iii) If the Accountants determine that aggregate Payments should be reduced to the Reduced Amount, the Company shall reduce the Payments in the following order: (1) by reducing amounts payable pursuant to Section 7(c)(v) of the Agreement, then (2) by reducing amounts payable pursuant to Section 7(c)(vi) of the Agreement, then (3) by reducing amounts payable pursuant to Section 7(c)(iv) of the Agreement, then (4) by reducing the amount payable pursuant to Section 7(c)(iii) of the Agreement, and then (5) by not applying any vesting acceleration applicable to the Executive’s awards pursuant to the Share Incentive Plan, and any award agreement thereunder by and between the Executive and the Company. For the purposes of applying the ordering in the immediately preceding sentence, the Payments in each of clauses (1) through (4) will be reduced in reverse chronological order of scheduled payment, and any accelerated vesting that is not applied pursuant to clause (5) will be effective first with respect to any Payments that are not subject to Treas. Reg. § 1.280G-1 Q/A 24(c), and will be effective last with respect to any Payments that are subject to Treas. Reg. § 1.280G-1 Q/A 24(c). All determinations made by the Accountants under this Section shall be binding upon the Company and the Executive and shall be made within sixty (60) days of a termination of employment of the Executive. As promptly as practicable following such determination, the Company shall pay to or distribute for the benefit of the Executive such Payments as are then due to the Executive and shall promptly pay to or distribute for the benefit of the Executive in the future such Payments as become due to the Executive. (iv) As a result of the uncertainty in the application of Section 4999 of the Code at the time of the initial determination by the Accountants hereunder, it is possible that amounts will have been paid or distributed by the Company to or for the benefit of the Executive pursuant to this Agreement which should not have been so paid or distributed (“Overpayment”) or that additional amounts which will have not been paid or distributed by the Company to or for the benefit of the Executive pursuant to this Agreement could have been so paid or distributed (“Underpayment”), in each case, consistent with the calculation of the Reduced Amount hereunder. In the event that the Accountants, based upon the assertion of a deficiency by the Internal Revenue Service against either the Company or the Executive which the Accountants believe has a high probability of success determine that an Overpayment has been made, any such Overpayment paid or distributed by the Company to or for the benefit of the Executive shall be treated for all purposes as a loan to the Executive which the Executive shall repay to the Company together with interest at the applicable federal rate provided for in Section 7872(f)(2) of the Code; provided, however, that no such loan shall be deemed to have been made and no amount shall be payable by the Executive to the Company if and to the extent such deemed loan and payment would (A) violate Section 402 of the Sarbanes-Oxley Act of 2002, or (B) not either reduce the amount on which the Executive is subject to tax under Section 1 and Section 4999 of the Code or generate a refund of such taxes. In the event that the Accountants, based upon controlling precedent or substantial authority, determine that an Underpayment has occurred, any such Underpayment shall be promptly paid by the Company to or for the benefit of the Executive together with interest at the applicable federal rate provided for in Section 7872(f)(2) of the Code.
Page | 13 (v) All fees and expenses of the Accountants in implementing the provisions of this Section 7(h) shall be borne by the Company. (vi) Subject to the foregoing provisions, in the event that any Payments are to be reduced pursuant to this Section 7(h), such Payments shall be reduced in a manner providing the smallest reduction of the net after-tax benefit of the compensation to be provided to the Executive. In applying this principle, the reduction shall be made in a manner consistent with the requirements of Section 409A of the Code. (i) Effect of Termination. Upon termination, the exercise, vesting and payment terms of the Executive’s awards under the Share Incentive Plan will be governed in accordance with the terms and conditions of the applicable Share Incentive Plan and respective equity award agreements issued thereunder, and shall be subject to all provisions relating to postemployment exercises set forth in the applicable Share Incentive Plan and equity agreement(s). Note that the Option Agreement(s), Restricted Stock Unit Agreement(s) and Performance Share Agreement(s) provide that the Executive’s undertaking competitive employment at any time shall result in the termination of any options, restricted stock units and performance share units granted thereunder (the “Equity Non-Competes”). The Company’s actions or decisions regarding the Non-Compete provision in this Agreement shall not modify, control, or supersede the Equity Non-Competes. Subject to the preceding sentences, upon the termination of the Executive’s employment hereunder for any reason, the Company shall have no further obligations hereunder, except as otherwise provided herein. The Executive, however, shall continue to have the obligations provided for in Sections 8 and 9 hereof. Furthermore, upon any such termination, the Executive shall be deemed to have resigned immediately from all offices and directorships held by the Executive in the Company or any of its subsidiaries. (j) Section 409A of the Code. It is the intention of the parties to this Agreement that no payment or entitlement pursuant to this Agreement will give rise to any adverse tax consequences to the Executive under Section 409A of the Code and Department of Treasury regulations and other interpretive guidance issued thereunder, including that issued after the date hereof (collectively, “Section 409A”). The Agreement shall be interpreted to that end and, consistent with that objective and notwithstanding any provision herein to the contrary, the Company may unilaterally take any action necessary to amend any provision herein to avoid the application of an excise tax under Section 409A. Further, no effect shall be given to any provision herein in a manner that reasonably could be expected to give rise to adverse tax consequences under that provision. If as a condition to receive severance payments and benefits Executive is required to deliver an effective release of claims in favor of the Company during a limited period following termination of employment, and such period spans two calendar years, then any such payments and benefits will accrue from the date of termination but commence in the second calendar year. The Company shall from time to time compile a list of "specified employees" as defined in, and pursuant to, Treas. Reg. Section 1.409A-1(i). Notwithstanding any other provision herein, if the Executive is a specified employee on the date of termination, no payment of compensation under this Agreement that constitutes non-qualified deferred compensation subject to Section 409A that is payable upon a “separation from service” (within the meaning of Section 409A) shall be made to the Executive during the period lasting six (6) months from the date of termination. For this purpose, each installment payment shall be considered a separate payment under Section 409A. If any payment to the Executive is delayed pursuant to the foregoing, such payment instead shall be made on the first business day following the expiration of the six-month period referred to in the prior sentence, or if earlier, upon the Executive’s death, unless specified otherwise in Section 7(j)(i) hereof. Although the Company shall consult with Executive in good faith regarding implementation of this Section 7(j), neither the Company nor its employees or representatives shall have liability to the Executive with respect to any additional taxes that the Executive may be subject to in the
Page | 14 event that any amounts under this Agreement are determined to violate Code section 409A. (i) Notwithstanding the above, if Executive is a specified employee on the date of termination, amounts described as being subject to payment in accordance with the provisions of this Section 7(j)(i) that are not otherwise exempt from Section 409A under the short-term deferral or separation pay exceptions to Section 409A shall be subject to a delay in payment for a six-month period following the date of termination and shall be paid as follows: (1) for any such amounts that are installments in a stream of payments to be continued beyond the date of termination and for any Pension Replacement Payment, all such payments that would have been made during the six-month period immediately following the date of termination shall be made in a single cash payment on the first business day following the expiration of such six-month period (or if earlier, upon the Executive’s death), and as of the first business day following the expiration of such six-month period (or the Executive’s death, if applicable), all such payments shall resume in accordance with the regular payroll practices of the Company until the end of the specified period; and (2) any lump-sum payments that are delayed shall be paid in a single lump sum payment on the first business day following the expiration of such six-month period (or if earlier, upon the Executive’s death). (k) Release of Claims. As a condition precedent to the receipt of payments and benefits pursuant to this Section (other than the Accrued Benefits), the Executive, or, in the case of their death or Disability that prevents the Executive from performing their obligation under this Section 7(k), their personal representative, and their beneficiary, if applicable, will execute an effective general release of claims (in a form reasonably satisfactory to the Company) against the Company and its subsidiaries and affiliates and their respective directors, officers, employees, attorneys and agents; provided, however, that such effective release will not affect any right that the Executive, or in the event of their death, their personal representative or beneficiary, otherwise has to any payment or benefit provided for in this Agreement or to any vested benefits the Executive may have in any employee benefit plan of Company or any of its subsidiaries or affiliates, or any right the Executive has under any other agreement between the Executive and the Company or any of its subsidiaries or affiliates that expressly states that the right survives the termination of the Executive’s employment. (l) Modification of Severance Payments and Benefits. Notwithstanding anything to the contrary contained herein, except as provided in Section 7(h) and this Section 7(l), the Company reserves the right with respect to any severance payments or benefits set forth in this Section to modify such payments or benefits or not to provide such payments or benefits. Changes in any severance payment or benefit provided to the Executive may only be made by the Compensation Committee (or the Stock Plan Subcommittee, if there is one, and the change relates to matters subject to the authority of such Subcommittee) and will apply to the Executive only to the extent applied across-the-board to the Company’s other Executive Officers. Unless agreed to by the Executive or as provided in herein, no change to any severance payments or benefits set forth in this Section will be effective until two years after such change is approved by the Compensation Committee (or Stock Plan Subcommittee) or will apply with respect to any termination of employment occurring prior to the effective date of such change. No changes may be made in severance payments or benefits set forth in this Section either (i) at such time the Company is contemplating one or more transactions that will result in a Change of Control or (ii) after
Page | 15 a Change of Control. 8. Confidentiality; Ownership. (a) The Executive agrees that they shall forever keep secret and retain in strictest confidence and not divulge, disclose, discuss, copy or otherwise use or suffer to be used in any manner, except in connection with the Business of the Company, its subsidiaries or affiliates and any other business or proposed business of the Company or any of its subsidiaries or affiliates, any “Protected Information” in any “Unauthorized” manner or for any “Unauthorized” purpose (as such terms are hereinafter defined). (i) “Protected Information” means trade secrets, confidential or proprietary information and all other knowledge, know-how, information, documents or materials owned, developed or possessed by the Company or any of its subsidiaries or affiliates, whether in tangible or intangible form, pertaining to the Business or any other business or proposed business of the Company or any of its subsidiaries or affiliates, including, but not limited to, research and development, operations, systems, data bases, computer programs and software, designs, models, operating procedures, knowledge of the organization, products (including prices, costs, sales or content), processes, formulas, techniques, machinery, contracts, financial information or measures, business methods, business plans, details of consultant contracts, new personnel hiring plans, business acquisition plans, customer lists, business relationships and other information owned, developed or possessed by the Company or its subsidiaries or affiliates; provided that Protected Information shall not include information that becomes generally known to the public or the trade without violation of this Section. (ii) “Unauthorized” means: (A) in contravention of the policies or procedures of the Company or any of its subsidiaries or affiliates; (B) otherwise inconsistent with the measures taken by the Company or any of its subsidiaries or affiliates to protect their interests in any Protected Information; (C) in contravention of any lawful instruction or directive, either written or oral, of an employee of the Company or any of its subsidiaries or affiliates empowered to issue such instruction or directive; or (D) in contravention of any duty existing under law or contract. Notwithstanding anything to the contrary contained herein, the Executive may disclose any Protected Information to the extent required by court order or decree or by the rules and regulations of a governmental agency or as otherwise required by law or to their legal counsel and, in connection with a determination under Section 7(h), to accounting experts; provided that the Executive provide the Company with sufficient advance notice of such disclosure requirement or obligation to permit the Company to seek a protective order or other appropriate remedy (b) The Executive acknowledges that all developments, including, without limitation, inventions (patentable or otherwise), discoveries, formulas, improvements, patents, trade secrets, designs, reports, computer software, flow charts and diagrams, procedures, data, documentation, ideas and writings and applications thereof relating to the Business or any business or planned business of the Company or any of its subsidiaries or affiliates that, alone or jointly with others, the Executive may conceive, create,
Page | 16 make, develop, reduce to practice or acquire during the Executive’s employment with the Company or any of its subsidiaries or affiliates (collectively, the “Developments”) are works made for hire and shall remain the sole and exclusive property of the Company. The Executive hereby assigns to the Company, in consideration of the payments set forth herein, all of their right, title and interest in and to all such Developments. The Executive shall promptly and fully disclose all future material Developments to the Board of Directors of the Company and, at any time upon request and at the expense of the Company, shall execute, acknowledge and deliver to the Company all instruments that the Company shall prepare, give evidence and take all other actions that are necessary or desirable in the reasonable opinion of the Company to enable the Company to file and prosecute applications for and to acquire, maintain and enforce all letters patent and trademark registrations or copyrights covering the Developments in all countries in which the same are deemed necessary by the Company. All memoranda, notes, lists, drawings, records, files, computer tapes, programs, software, source and programming narratives and other documentation (and all copies thereof) made or compiled by the Executive or made available to the Executive concerning the Developments or otherwise concerning the Business or planned business of the Company or any of its subsidiaries or affiliates shall be the property of the Company or such subsidiaries or affiliates and shall be delivered to the Company or such subsidiaries or affiliates promptly upon the expiration or termination of the Term of Employment. (c) During the Term of Employment, the Company, its subsidiaries and affiliates shall have the exclusive right to use the Executive’s name and image throughout the world in its advertising and promotional materials in connection with the advertising and promotion of the Company, its subsidiaries and affiliates, and their products. After the expiration of the Term of Employment, the Company, its subsidiaries and affiliates shall have the non-exclusive right in perpetuity to use the Executive’s name and image throughout the world solely in connection with promotional materials related to the history of the Company, its subsidiaries and affiliates, and their products. The consideration for such rights is the payments set forth herein. The rights conveyed hereby may be assigned by the Company, its subsidiaries or affiliates to a successor in the interest of the Company or the relevant subsidiary or affiliate or their businesses or product lines. (d) The provisions of this Section shall, without any limitation as to time, survive the expiration or termination of the Executive’s employment hereunder, irrespective of the reason for any termination. 9. Covenant Not to Compete. The Executive agrees that during the Executive’s employment with the Company or any of its subsidiaries or affiliates and for a period of two (2) years commencing upon the expiration or termination of the Executive’s employment for any reason whatsoever (the “Non-Compete Period”), the Executive shall not, directly or indirectly, without the prior written consent of the Company: (a) solicit, entice, persuade or induce any employee, consultant, agent or independent contractor of the Company or of any of its subsidiaries or affiliates to terminate his, her or its employment with the Company or such subsidiary or affiliate, to become employed by any person, firm or corporation other than the Company or such subsidiary or affiliate or approach any such employee, consultant, agent or independent contractor for any of the foregoing purposes, or authorize or assist in the taking of any such actions by any third party (the terms “employee,” “consultant,” “agent” and “independent contractor” shall include any persons with such status at any time during the six (6) months preceding any solicitation in question); or (b) directly or indirectly engage, participate, or make any financial investment in, or become employed by or render consulting, advisory or other services to or for any person, firm, corporation or other business enterprise, wherever located, which is engaged or preparing to engage, directly or
Page | 17 indirectly, in competition with the Business and/or any business of the Company or any of its subsidiaries or affiliates as conducted or any business proposed to be conducted at the time of the expiration or termination of the Executive’s employment with the Company and its subsidiaries and affiliates; provided, however, that nothing in this Section shall be construed to preclude the Executive from making any investments in the securities of any business enterprise whether or not engaged in competition with the Company or any of its subsidiaries or affiliates, to the extent that such securities are actively traded on a national securities exchange or in the over-the-counter market in the United States or on any foreign securities exchange and represent, at the time of acquisition, not more than 3% of the aggregate voting power of such business enterprise. (c) In the event that: (i) the Executive engages in or notifies the Company that the Executive will engage in activity which the Company deems to violate the non-competition provisions of this Agreement; (ii) the Company enforces such non-competition provisions; and, (iii) Executive complies with such non-competition provisions, the Company shall pay or cause to be paid to the Executive for the duration of the enforcement period the Executive’s Base Salary under Section 3(a) hereof and continue to provide the Executive with benefits hereunder to the extent permitted by applicable law and regulations and the applicable benefit plan, program or arrangement, in any and all healthcare, life insurance and accidental death and dismemberment insurance benefit plans, programs or arrangements, on terms identical to those applicable to full-time senior officers of the Company. Any such payments described above will not be made in the event that the Executive is receiving termination payments pursuant to Section 7 hereof. For purpose of clarity, the Company will only be obligated to make payments to the Executive pursuant to this Section for the specific duration of time in which the Company enforces the non-competition restrictions in this Agreement. To the extent the Company agrees to a written modification of the non- competition provision in this Agreement (other than to its duration) which would enable the Executive to accept another role, the Company will not be obligated to provide the pay and benefits to Executive described herein. As stated above, the Company’s actions or decisions regarding the Non-Compete provision in this Agreement shall not modify, control, or supersede the Equity Non-Competes. Notwithstanding the above, any amounts payable under this Section that are separation pay as described under Treas. Reg. §1.409A-1(b)(9)(iii)(A) shall be paid no later than December 31 of the second calendar year following the year in which the Employee’s termination pursuant to Section 7 occurs; any amounts payable under this Section that are not otherwise exempt from Code Section 409A are subject to, and payable in accordance with, Section 7(j) of this Agreement. (d) So that the Company may confirm your compliance with your obligations under this Agreement, you agree to inform the Company in advance in writing any time you intend to assume a new position during the first twenty-four (24) months following the termination of your employment with the Company. You agree to provide the identity of the entity and of your job title and responsibilities in writing and other information as reasonably requested by the Company. You further agree to communicate the terms of this Agreement to any person, business, entity, or organization that you intend to be employed by, associate with, or represent during the twenty-four (24) months following the termination of your employment with the Company. (e) To the extent permitted by law, the restrictive periods set forth in this Agreement shall not expire, and shall be tolled, during any period in which Executive is in violation of Executive’s obligations under this Agreement. 10. Remedies The Executive acknowledges and agrees that the services to be rendered by the Executive are of a special, unique and extraordinary character and, in connection with such services, compliance with the covenants set forth in this Agreement is necessary to protect the confidential information (including Protected
Page | 18 Information as defined herein), business and goodwill of the Company, and that any breach of section 8 or 9 hereof will result in irreparable and continuing harm to the Company and its subsidiaries and affiliates, for which money damages cannot provide adequate relief. Accordingly, in the event of any breach or anticipatory breach of this Agreement by the Executive, the parties agree that, in addition to any other legal remedies and damages available, the Company and its affiliates and subsidiaries shall be entitled to injunctions, both preliminary and permanent, enjoining or restraining such breach or anticipatory breach, and the Executive hereby consents to the issuance thereof forthwith and without bond by any court of competent jurisdiction. Nothing contained herein shall be construed as prohibiting the Company or any of its subsidiaries or affiliates from pursuing any other remedies available to it or them for such breach or threatened breach, including the recovery of damages from the Executive. This provision shall, without any limitation as to time, survive the expiration or termination of the Executive’s employment hereunder, irrespective of the reason for any termination. 11. Defend Trade Secrets Act Notice Under the federal Defend Trade Secrets Act, you shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that: (a) is made (i) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney, and (ii) solely for the purpose of reporting or investigating a suspected violation of the law; or (b) is made to your attorney in relation to a lawsuit for retaliation against you for reporting a suspected violation of the law; or (c) is made in a complaint or other document filed in a lawsuit or proceeding, if such filing is made under seal. 12. Deductions and Withholding. The Executive agrees that the Company or its subsidiaries or affiliates, as applicable, shall withhold from any and all compensation paid to and required to be paid to the Executive pursuant to this Agreement, all Federal, state, local and/or other taxes which the Company determines are required to be withheld in accordance with applicable statutes or regulations from time to time in effect and all amounts required to be deducted in respect of the Executive’s coverage under applicable employee benefit plans. For purposes of this Agreement and calculations hereunder, all such deductions and withholdings shall be deemed to have been paid to and received by the Executive. 13. Entire Agreement. Except for the Share Incentive Plan, the Executive’s outstanding stock option and other equity- compensation agreements, the Executive Annual Incentive Plan, the Executive Perquisites Program, the Executive Automobile Program, the term life insurance arrangement between the Company and the Executive, the Company’s qualified and non-qualified defined benefit pension plans, the Company’s qualified defined contribution retirement savings plan and applicable successor plans or agreements, this Agreement embodies the entire agreement of the parties effective as of the date on which it is executed for all periods as of and after the Effective Date with respect to the Executive’s employment, compensation, perquisites and related items and supersedes any other prior oral or written agreements, arrangements or understandings between the Executive and the Company or any of its subsidiaries or affiliates, including without limitation the 2023 Agreement, and any such prior agreements, arrangements or understandings are hereby terminated and of no further effect after the Effective Date. This Agreement may not be changed or terminated orally but only by an agreement in writing signed by the parties hereto. 14. Waiver. The waiver by the Company of a breach of any provision of this Agreement by the Executive shall not operate or be construed as a waiver of any subsequent breach by the Executive. The waiver by the
Page | 19 Executive of a breach of any provision of this Agreement by the Company shall not operate or be construed as a waiver of any subsequent breach by the Company. 15. Governing Law; Jurisdiction. (a) This Agreement shall be subject to, and governed by, the laws of the State of New York applicable to contracts made and to be performed therein, without regard to conflict of laws principles. (b) Any action to enforce any of the provisions of this Agreement shall be brought in a court of the State of New York located in the Borough of Manhattan of the City of New York or in a Federal court located within the Southern District of New York. The parties consent to the jurisdiction of such courts and to the service of process in any manner provided by New York law. Each party irrevocably waives any objection which it may now or hereafter have to the laying of the venue of any such suit, action or proceeding brought in such court and any claim that such suit, action or proceeding brought in such court has been brought in an inconvenient forum and agrees that service of process in accordance with the foregoing sentences shall be deemed in every respect effective and valid personal service of process upon such party. 16. Assignability. The obligations of the Executive may not be delegated and, except with respect to the designation of beneficiaries in connection with any of the benefits payable to the Executive hereunder, the Executive may not, without the Company’s written consent thereto, assign, transfer, convey, pledge, encumber, hypothecate or otherwise dispose of this Agreement or any interest herein. Any such attempted delegation or disposition shall be null and void and without effect. The Company and the Executive agree that this Agreement and all of the Company’s rights and obligations hereunder may be assigned or transferred by the Company to and shall be assumed by and be binding upon any successor to the Company. Unless assumption occurs by operation of law, the Company shall require any successor by an agreement in form and substance satisfactory to the Executive, expressly to assume and agree to perform this Agreement in the same manner and to the same extent as the Company would be required to perform if no such succession had taken place. The term “successor” means, with respect to the Company or any of its subsidiaries, any corporation or other business entity which, by merger, consolidation, purchase of the assets or otherwise acquires all or a majority of the operating assets or business of the Company. 17. Severability. If any provision of this Agreement or any part thereof, including, without limitation, Sections 8 and 9 hereof, as applied to either party or to any circumstances, shall be adjudged by a court of competent jurisdiction to be void or unenforceable, the same shall in no way affect any other provision of this Agreement or remaining part thereof, or the validity or enforceability of this Agreement, which shall be given full effect without regard to the invalid or unenforceable part thereof. If any court construes any of the provisions of Section 8 or 9 hereof, or any part thereof, to be unreasonable because of the duration of such provision or the geographic scope thereof, such court may reduce the duration or restrict or redefine the geographic scope of such provision and enforce such provision as so reduced, restricted or redefined. 18. Notices. All notices to the Company or the Executive permitted or required hereunder shall be in writing and shall be delivered personally, by courier service providing for next-day or two-day delivery or sent by registered
Page | 20 or certified mail, return receipt requested, to the following addresses: The Company: The Executive: The Estée Lauder Companies Inc. Stéphane de La Faverie 767 Fifth Avenue President and Chief Executive Officer New York, New York 10153 767 Fifth Avenue Attn: EVP Human Resources New York, New York 10153 Either party may change the address to which notices shall be sent by sending written notice of such change of address to the other party. Any such notice shall be deemed given, if delivered personally, upon receipt; if sent by courier service providing for next-day or two-day delivery, the next business day or two business days, as applicable, following deposit with such courier service; and if sent by certified or registered mail, three days after deposit (postage prepaid) with the U.S. mail service. 19. No Conflicts. The Executive hereby represents and warrants to the Company that their execution, delivery and performance of this Agreement and any other agreement to be delivered pursuant to this Agreement will not (i) require the consent, approval or action of any other person or (ii) violate, conflict with or result in the breach of any of the terms of, or constitute (or with notice or lapse of time or both, constitute) a default under, any agreement, arrangement or understanding with respect to the Executive’s employment to which the Executive is a party or by which the Executive is bound or subject. The Executive hereby agrees to indemnify and hold harmless the Company and its directors, officers, employees, agents, representatives and affiliates (and such affiliates’ directors, officers, employees, agents and representatives) from and against any and all losses, liabilities or claims (including interest, penalties and reasonable attorneys’ fees, disbursements and related charges) based upon or arising out of the Executive’s breach of any of the foregoing representations and warranties. 20. Legal Fees. Following a Change of Control, the Company shall reimburse the Executive up to $20,000, in the aggregate, for all legal fees and related expenses (including the costs of experts, evidence and counsel) reasonably and in good faith incurred by the Executive in an action (i) by the Executive to obtain or enforce any right or benefit to which the Executive is entitled under this Agreement or (ii) by the Company to enforce a post- termination covenant referred to in Section 8 or 9 against the Executive, in each case, provided that the Executive substantially prevails in such action. Such amount shall be reimbursed to the Executive by the end of the calendar year in which the Executive substantially prevails in such action, based on the date of any settlement, judgment, or other official document evidencing same. 21. Cooperation. During the Term of Employment and thereafter, Executive shall provide reasonable cooperation in connection with any action or proceeding (or any appeal therefrom) that relates to events occurring during Executive’s employment with the Company. 22. Paragraph Headings. The paragraph headings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement.
Page | 21 23. Counterparts. This Agreement may be executed in one or more counterparts, each of which shall be deemed to be an original, but all of which taken together shall constitute one and the same instrument. IN WITNESS WHEREOF, the parties hereto have duly executed this Agreement as of the date first written above. THE ESTÉE LAUDER COMPANIES INC. By: /s/ William P. Lauder Name: William P. Lauder Executive Chairman Date: 10/29/24 By: /s/ Stéphane de La Faverie Name: Stéphane de La Faverie Date: October 29, 2024
EX-10.4
5
exhibit104_summaryofdirect.htm
EX-10.4
Document
Exhibit 10.4
Summary of Compensation for Non-Employee Directors of the Company
(Effective November 8, 2024)
The following summary describes compensation for non-employee directors.
Annual Cash Retainers
•Board Service. Each non-employee director receives an annual cash retainer of $100,000, payable quarterly.
•Committee and Chair Service. Each non-employee director who serves on a committee receives an additional annual cash retainer in the following amounts: $12,000 per year for service on the Audit Committee, $8,000 per year for service on the Compensation Committee (including service on the Stock Plan Subcommittee), and $8,000 per year for service on the Nominating and ESG Committee. The Chair of the Audit Committee receives an additional annual cash retainer of $25,000. The Chairs of the Compensation Committee and the Nominating and ESG Committee each receive an additional annual cash retainer of $15,000 each. Cash retainers for committee and chair service are payable quarterly.
•Chair of the Board. The Chair of the Board receives an additional annual cash retainer of $225,000, payable quarterly.
•Lead Independent Director. The Lead Independent Director receives an additional annual cash retainer of $30,000, payable quarterly.
Deferral of Annual Cash Retainers. Non-employee directors may elect to defer receipt of all or part of their cash-based compensation. Specifically, pursuant to Deferred Compensation Agreements, they may defer any or all of the above-referenced annual cash retainers into either (i) stock units (accompanied by dividend equivalent rights) or (ii) an interest-bearing cash account, in each case to be paid out in a lump sum in cash as of the first business day of the calendar year following the date on which the director ceases to be a member of the Board.
Annual Stock Units Retainer for Board Service. An additional $75,000 is payable to each non-employee director by a grant of stock units (accompanied by dividend equivalent rights) as an annual stock retainer, pursuant to the Amended and Restated Non-Employee Director Share Incentive Plan (the ‘‘Director Share Plan’’). This grant is made on the date of each annual meeting of stockholders. The number of stock units to be awarded is determined by dividing $75,000 by the average closing price of the Class A Common Stock on the twenty trading days next preceding the date of grant. Each stock unit is convertible into one share of Class A Common Stock, and the Class A Common Stock represented by the stock units is distributed to the director on or after the first business day of the calendar year following the one in which the director ceases to be a member of the Board.
Annual Stock Options. In addition to the cash and stock portion of the retainer, each non-employee director receives an annual grant of options valued at no more than $100,000 on the date of grant, pursuant to the Director Share Plan. This grant is made on the date of each annual meeting of stockholders. The exercise price of the options is equal to the closing price of the Class A Common Stock on the date of grant. The options vest and are exercisable one year after the date of grant, provided that the director continues to serve as of such date.
Initial Equity Grant for New Non-employee Directors. On the date of the first annual meeting of stockholders that is more than six months after a non-employee director’s initial election to the Board, the director receives a grant of stock units (accompanied by dividend equivalent rights), pursuant to Director Share Plan. The number of stock units to be awarded is determined by dividing $300,000 by the average closing price of the Class A Common Stock on the twenty trading days next preceding the date of grant; provided, however, that any new non-employee director shall not receive an initial stock unit grant for greater than 2,000 shares. Each stock unit is convertible into one share of Class A Common Stock, and the Class A Common Stock represented by the stock units is distributed to the director on or after the first business day of the calendar year following the one in which the director ceases to be a member of the Board.
Company Products. The Company provides directors with certain Company products from different brands and product categories. The Company believes that providing these products serves a business purpose by expanding the directors’ knowledge of the Company’s business. The Company also provides each non-employee director with the opportunity to purchase up to $1,280 worth of the Company’s products each calendar year (based on suggested retail prices) at no charge; if a director chooses to take advantage of this opportunity and purchase more than $640 worth of the Company’s products, the excess is imputed as taxable income to the director. Non-employee directors may also purchase Company products at a price equal to 50% off the suggested retail price, which is the same discount made available to officers and other employees of the Company.
Reimbursement of Expenses. Non-employee directors are reimbursed for their reasonable expenses (including costs of travel, food, and lodging), incurred in attending Board, committee and stockholder meetings. Directors are also reimbursed for any other reasonable expenses relating to their service on the Board, including participating in director continuing education and Company site visits.
EX-10.5
6
exhibit105_amendmentstoa.htm
EX-10.5
exhibit105_amendmentstoa
Exhibit 10.5 AMENDMENTS TO THE ESTEE LAUDER COMPANIES RETIREMENT GROWTH ACCOUNT PLAN The Estee Lauder Companies Retirement Growth Account Plan, as amended and restated effective as of January 1, 2023 (the “Plan”), is hereby further amended as follows, effective as of January 1, 2025 except for such earlier dates as are specified herein: 1. Section 10.2 of the Plan is amended in its entirety to read as follows: 10.2 Anything elsewhere in the Plan to the contrary notwithstanding, the entire nonforfeitable interest of each Participant shall be either: (a) distributed to the Participant not later than the Participant’s “Required Beginning Date” (as defined in Section 10.2(b)), or (b) distributed to, or for the benefit of, the Participant and the Participant’s contingent annuitant in installments beginning not later than the Participant’s Required Beginning Date and continuing, in accordance with such regulations as the Secretary of the Treasury may prescribe, (i) over the life of the Participant or over the lives of the Participant and the Participant’s contingent annuitant or (ii) over a period certain not extending beyond the life expectancy of the Participant and the Participant’s Beneficiary. For purposes of this Section, the “Required Beginning Date” shall mean the later of April 1 of the calendar year which follows the calendar year in which the Participant attains the Applicable Age (as defined below) or the calendar year in which the Participant retires; provided, however, that a distribution to a Participant who is a “five percent owner” (as defined in Section 416 of the Code) shall begin no later than April 1 of the calendar year which follows the calendar year in which such Participant attains the Applicable Age. For this purpose, “Applicable Age” means (i) Age 70 ½, for Participants who were born before July 1, 1949; (ii) Age 72, for Participants born on or after July 1, 1949 but before January 1, 1951; (iii) Age 73, for Participants born on or after January 1, 1951 but before January 1, 1960; and (iv) Age 75, for Participants born on or after January 1, 1960. Notwithstanding anything to the contrary in this Plan, all distributions will be made in accordance with Section 401(a)(9) of the Code, including the incidental death benefit requirement of Section 401(a)(9)(G) of the Code, and with Treasury Regulation Sections 1.401(a)(9)-1 through 1.401(a)(9)-9. The provisions of Section 401(a)(9) of the Code and such Treasury Regulations, as reflected in this Section 10.2, shall override any distribution options in the Plan inconsistent with Section 401(a)(9) of the Code and such Treasury Regulations. 1
2 If distribution of a Participant’s nonforfeitable interest has begun in accordance with Section 10.2(b) hereof and the Participant dies before his entire nonforfeitable interest has been distributed to him, the remaining portion of such interest shall be distributed at least as rapidly as under the method of distribution being used under Section 10.2(b) hereof as of the date of the Participant’s death. If the Surviving Spouse is the deceased Participant’s Beneficiary, the distribution period for the Surviving Spouse’s distributions shall be determined using the longer of the Participant’s remaining life expectancy under the Single Life Table (SLT) and the Surviving Spouse’s life expectancy under the Uniform Life Table (ULT). If a Participant dies before distribution of the Participant’s nonforfeitable interest has begun in accordance with Section 10.2(b) hereof, the entire nonforfeitable interest shall be distributed within five years after the death of the Participant, except such portion thereof as shall be payable in installments to, or for the benefit of, the Participant’s contingent annuitant, beginning not later than one (1) year after the date of the Participant’s death and continuing, in accordance with such regulations as the Secretary of the Treasury may prescribe, over the life of the contingent annuitant (or over a period certain not extending beyond the life expectancy of the contingent annuitant); provided, however, that if the Surviving Spouse is the Participant’s contingent annuitant, the date on which the distributions are required to begin shall not be later than the Participant’s Required Beginning Date and, if the Surviving Spouse dies before the distributions to the Surviving Spouse begin, this paragraph shall be applied as if the Surviving Spouse was the Participant. The Surviving Spouse’s life expectancy for purposes of this paragraph shall be determined using the Uniform Life Table (ULT). 2. The Plan is amended by adding the following new Appendix FF to the end thereof: APPENDIX FF PROVISIONS GOVERNING CERTAIN EMPLOYEES OF DECIEM USA, LLC SECTION 1.1 SCOPE The provisions of this Appendix FF to The Estee Lauder Companies Retirement Growth Account Plan shall apply with respect to each person actively employed by DECIEM USA, LLC (“DECIEM USA”) on January 1, 2025 (a “DECIEM Employee”). The provisions of this Appendix FF shall apply notwithstanding any contrary provisions of the Plan, of which this Appendix is a part. Except to the extent expressly provided to the contrary herein, all defined terms shall have the same meanings as provided under the Plan. Each reference to the Plan shall be to the Plan as in effect at the time such provision is applied to a DECIEM Employee, as the context shall require.
SECTION 1.2 COMMENCEMENT OF STATUS AS EMPLOYER DECIEM USA shall become an Employer under the Plan on January 1, 2025. SECTION 1.3 COMMENCEMENT OF PLAN PARTICIPATION BY DECIEM EMPLOYEES No DECIEM Employee shall be permitted to become a Participant prior to January 1, 2025. Each DECIEM Employee may become a Participant in the Plan on the first applicable entry date on or after January 1, 2025, in accordance with the provisions of Section 3 of the Plan; however, for purposes of determining eligibility under the Plan, there shall be taken into account all periods attributable to such person’s employment with DECIEM USA that would otherwise have been taken into account for such purpose had DECIEM USA been an Employer throughout such person’s entire period of employment. Any other individual who becomes actively employed by DECIEM USA after January 1, 2025, may become a Participant in the Plan in accordance with the provisions of Section 3 of the Plan. SECTION 1.4 CREDITS TO RETIREMENT ACCOUNTS In determining the amount to be credited to the Retirement Account of a DECIEM Employee who becomes a Participant pursuant to the provisions of Section 5 of the Plan, there shall be taken into account all periods of such person’s employment with DECIEM USA that would otherwise have been taken into account for such purpose had DECIEM USA been an Employer throughout such person’s entire period of employment. SECTION 1.5 VESTING In determining the extent to which any DECIEM Employee is vested in his Retirement Account pursuant to the provisions of Section 8 of the Plan, there shall be taken into account all periods of such person’s employment with DECIEM USA that would otherwise have been taken into account for such purpose had DECIEM USA been an Employer throughout such person’s entire period of employment. 3
EX-31.1
7
el-q2fy2025xex311.htm
EX-31.1
Document
Exhibit 31.1
Certification
I, Stéphane de La Faverie, certify that:
1.I have reviewed this Quarterly Report on Form 10-Q of The Estée Lauder Companies Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
|
|
|
|
|
Date: February 4, 2025 |
|
|
/s/ Stéphane de La Faverie |
|
Stéphane de La Faverie President and Chief Executive Officer |
EX-31.2
8
el-q2fy2025xex312.htm
EX-31.2
Document
Exhibit 31.2
Certification
I, Akhil Shrivastava, certify that:
1.I have reviewed this Quarterly Report on Form 10-Q of The Estée Lauder Companies Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
|
|
|
|
|
Date: February 4, 2025 |
|
|
/s/ Akhil Shrivastava |
|
Akhil Shrivastava Executive Vice President and Chief Financial Officer |
EX-32.1
9
el-q2fy2025xex321.htm
EX-32.1
Document
Exhibit 32.1
Certification
Pursuant to 18 U.S.C. Section 1350
(as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002)
Pursuant to 18 U.S.C. Section 1350 (as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002), the undersigned officer of The Estée Lauder Companies Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:
The Quarterly Report on Form 10-Q for the quarter ended December 31, 2024 (the “10-Q”) of the Company fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (15 U.S.C. 78m or 78o(d)), and the information contained in the 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
|
|
|
|
|
Date: February 4, 2025 |
|
|
/s/ Stéphane de La Faverie |
|
Stéphane de La Faverie President and Chief Executive Officer |
The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350 (as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002) and for no other purpose.
EX-32.2
10
el-q2fy2025xex322.htm
EX-32.2
Document
Exhibit 32.2
Certification
Pursuant to 18 U.S.C. Section 1350
(as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002)
Pursuant to 18 U.S.C. Section 1350 (as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002), the undersigned officer of The Estée Lauder Companies Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:
The Quarterly Report on Form 10-Q for the quarter ended December 31, 2024 (the “10-Q”) of the Company fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (15 U.S.C. 78m or 78o(d)), and the information contained in the 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
|
|
|
|
|
Date: February 4, 2025 |
|
|
/s/ Akhil Shrivastava |
|
Akhil Shrivastava Executive Vice President and Chief Financial Officer |
The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350 (as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002) and for no other purpose.